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VI. Summary 
Dematin is an actin-binding and -bundling protein that was first identified in human 
erythrocytes where it is important for providing mechanical stability.  Two splice 
variants exist in vivo of 48 KDa and 52 KDa, each of which comprises a disordered C-
terminal core domain and a short, highly-ordered, N-terminal headpiece (HP).  
Expression of dematin has now been demonstrated in a wide range of tissues and 
functional roles are emerging for dematin as a tumour suppressor, and regulator of 
wound healing, via negative regulation of RhoA.  Despite these advances, the in vivo 
regulation of dematin remains poorly understood.  This thesis therefore aimed to 
characterise the regulation of dematin by two known cytoskeletal coordinators; the 
p38 mitogen-activated protein-kinase (MAPK), and the adaptor protein 14-3-3.   
Dematin was confirmed as a substrate of p38, and multiple phosphorylation sites 
were identified in both the core and HP regions of the protein using mass 
spectrometry and in vitro kinase assays.  Moreover pulse-chase degradation 
analysis identified dematin as a short-lived protein, with a calculated half-life of 
5.49 +/- 0.44 hours.  Further experiments confirmed that this propensity for 
degradation is at least in part due to the presence of a PEST motif, with the half-life 
of the dematin_ΔPEST construct significantly increased compared to wild-type 
dematin at 7.64 +/- 0.72 hours.  Despite identifying p38 phosphorylation sites 
within and flanking the PEST motif, hyper-activation or inhibition of p38 had no 
significant effect on protein stability.  Finally, it was shown that although p38 
phosphorylated the dematin HP at Ser383, this was not sufficient to disrupt the 
association of the HP and core regions which is known to inhibit actin bundling.   
Additionally dematin was identified as a novel substrate of the 14-3-3 family of 
adaptor proteins.  The 14-3-3β isoform was shown to bind to 52 KDa dematin at 
two phosphorylated motifs; RKTRS269LP and RGNS333LP.  It was not possible to 
identify the kinases that regulate these motifs, but Akt, PKA, or AMPK were ruled 
out as potential candidates.  Immunofluorescence staining and confocal imaging 
confirmed that 14-3-3 regulates dematin by altering its subcellular distribution, 
which is likely to be via masking of an actin-binding motif.  Wild-type dematin was 
distributed throughout the cytoplasm in C2C12 skeletal muscle cells, whereas the 
dematin_S269/333A binding mutant localised strongly to the F-actin cytoskeleton.  
This localisation result was confirmed in quantitative sedimentation experiments, 
which showed a statistically significant decrease in both the actin-binding (42.8%) 
and -bundling (30.1%) ability of dematin upon 14-3-3 association. 
In this thesis I have characterised both the p38 MAPK and the adaptor protein 14-3-
3 as novel regulators of dematin, adding considerably to the understanding of 
dematin regulation in vivo.  This provides a basis for further investigation into the 
ability of dematin to coordinate the actin cytoskeleton, which has implications for a 
wide array of dematin functions due to its ubiquitous tissue expression profile. 
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MAPK - mitogen-activated protein kinase 
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Ser381 [Ser403] - number in brackets refers to position in the 52 KDa dematin isoform 
NOTE - In the literature the system used to number the residues within a particular 
dematin construct traditionally begins at 0 from the first amino acid of that specific 
construct.  This can lead to confusion when studies focus on just the N-terminal 
headpiece of dematin, or use the shorter 48 KDa isoform of dematin, as a particular 
residue can then by referred to by three different numbers.  For example, Ser403 in 
the 52 KDa isoform = Ser381 in the 48 KDa isoform = Ser74 in the headpiece.  For 
simplicity, all constructs created for use in this thesis are numbered relative to the 
52 KDa isoform of dematin - which ranges from 0-405 aa.  Therefore the headpiece 
domain, which is referred to in the literature as 0-76 aa, is here annotated as 315-
405.  In line with this numbering approach, where a reference is made to a specific 
residue from the literature that does not correlate with this system, the relative 
position in the 52 KDa isoform of dematin is given in [ ]. 
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1.1 Dematin 
Dematin, also known as EPB49 and protein 4.9, was first identified in 1985 as a 
component of the erythrocyte cytoskeleton (Siegel & Branton).  The name derives 
from the Greek word Dema, which translates as ‘to bundle’, and refers to the ability 
of dematin to both bind and bundle actin filaments (AFs).  Expression of dematin 
has subsequently been demonstrated in a wide variety of tissues, including the 
brain, heart, lungs, kidneys, and skeletal muscle (Kim et al., 1998; Rana et al., 1993).  
In erythrocytes dematin forms a linkage between the cell membrane and the actin 
cytoskeleton, providing mechanical stability to the cell (Khan et al., 2008).   The non-
erythroid functions of dematin have yet to be fully characterised, but it has been 
implicated in wound healing (Mohseni & Chishti, 2008a; Mohseni & Chishti, 2009), 
and tumour suppression (Kim et al., 1998). 
1.1.1 Primary structural features of dematin 
Dematin is composed of a large N-terminal core domain, and a shorter C-terminal 
headpiece domain (HP) (Figure 1.1).  The dematin HP is homologous to that of villin, 
a protein found in the epithelial brush borders which is also known to bind to actin 
(Vardar et al., 2002).  In vivo two isoforms of dematin exist, of 48 and 52 KDa, which 
are the result of alternative splicing.  The dematin gene consists of 15 exons and 14 
introns (Kim et al., 1998), with the  22-amino acid insert in the 52 KDa isoform 
encoded by exon 13 (Azim et al., 1995).   The primary structure of the 48 KDa 
isoform of dematin was first determined in 1993 (Rana et al.), followed by that of 
the 52 KDa variant in 1995 (Azim et al.).  This confirmed that the sequences of the 
two isoforms are identical, except for the insert in the HP domain of the 52 KDa 
variant (Figure 1.2).  
The 48 and 52 KDa human isoforms of dematin have sequences of 383 aa and 405 
aa in length respectively (Azim et al., 1995).  Several regions of interest within the 
primary structure of dematin have been identified, based upon the presence of 
characterised sequence motifs.  The functional implications of the majority of these 
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Figure 1.1: The domain structures of the two dematin isoforms 
Dematin exists in vivo as two isoforms of 48 and 52 KDa.  Both isoforms are 
composed of a large N-terminal core domain, with a shorter C-terminal headpiece.  
The sequence of the core domain of the two isoforms is identical, while the 
headpiece domains differ by a 22-amino acid insert (light blue shaded region) in the 
52 KDa variant. 
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motifs have yet to be investigated, and so it is unclear as to the roles they may play 
in the regulation of dematin. 
1.1.1.1 MAPK phosphorylation motifs 
The mitogen-activated protein-kinase (MAPK) family are a large group of Ser/Thr 
specific kinases that regulate a vast array of cellular outcomes (Ashwell, 2006).  
These are classified as proline-directed kinases due to their preference for a Pro 
residue at the +1 position in the consensus recognition sequence, phosphorylating 
substrates at either Ser-Pro (SP) or Thr-Pro (TP) motifs.  There are thirteen such 
motifs within the primary sequence of dematin (Figure 1.2; purple boxes).   
1.1.1.2 MAPK docking motif (D-motif) 
In addition to the presence of MAPK phosphorylation motifs, dematin contains the 
potential MAPK docking sequence 49KDKAILDI56 (Figure 1.2; green box).  D-motifs 
are found in MAPK substrates at sites distal to the phosphorylation motifs and act 
to enhance substrate recognition; however they are not essential for 
phosphorylation of a substrate (Bardwell et al., 2009). 
1.1.1.3 PEST degradation motif 
PEST motifs are short sequences rich in the amino acids Pro, Glu, Ser, and Thr 
(Rogers et al., 1986).  Dematin contains the sequence 89KSTSPPPSPEVWADSR104 
(Figure 1.2; blue box), which meets the criteria for such a motif.  The presence of a 
PEST motif in a protein sequence has been linked to a propensity for degradation, a 
process which is often regulated through phosphorylation of internal serine and 
threonine residues (Rechsteiner & Rogers, 1996).   
1.1.1.4 14-3-3 binding motifs 
The 14-3-3 family of adaptor proteins bind to a wide array of substrates at defined 
phospho-serine / phospho-threonine containing motifs.  The dematin sequence 
contains seven of these motifs (Figure 1.2; yellow boxes).  The association of 14-3-3 
can have a wide variety of effects on a target, including altering the subcellular 
localisation and interaction properties (Bridges & Moorhead, 2005). 
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Figure 1.2: Notable features of the human dematin sequence 
Identified sequence motifs in the 48 KDa and 52 KDa isoforms of human dematin. 
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1.1.1.5 Actin binding domains 
Regulation of the actin cytoskeleton is coordinated by a large group of proteins 
capable of binding to actin and dynamically modulating its function.  Dematin 
contains two actin binding sequences, one in the HP domain (Figure 1.2; grey box) 
and a second undefined site in the core domain (Azim et al., 1995).   
1.1.1.6 Cysteine residues 
Both the 48 and 52 KDa isoforms of dematin contain a cysteine residue at Cys194, 
and the 52 KDa variant has an additional site in the HP-insert at Cys336 (Figure 1.2; 
brown boxes).  These residues have been implicated in the potential trimerisation 
of dematin through the formation of disulphide bonds between monomers (Azim et 
al., 1995).  
1.1.1.7 Cluster of negatively charged residues 
Dematin contains a cluster of ten negatively charged residues 216EEEEEEEDDD225 
(Figure 1.2; orange box).  This sequence is found in protein which associate with the 
cell nucleus (Rana et al., 1993). 
1.1.2 Secondary structure of dematin 
The large N-terminal core region of dematin displays a natively unfolded structure, 
consistent with the high proline percentage of 10.7 % (double the average value of 
5.2 % (Doolittle, 1989)), and any alpha-helical motifs present can be attributed to 
the folding of the HP region (Chen et al., 2009).   The core region also contains a 
large proportion of charged residues (128 / 405 in the 52 KDa isoform), a property 
shared by many intrinsically disordered proteins.  Although disordered, the dematin 
core domain does not undergo fully unrestrained motions, and is instead thought to 
exist in a number of states that lack significant secondary structure but still possess 
some form of order.  This theory is supported by the extremely high (> 94%) 
sequence conservation between dematin homologues in mammalian species (Chen 
et al., 2013).  The core domain of dematin also shares around 36% sequence 
homology with another actin binding protein called limatin (Kim et al., 1997). 
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In contrast to the core domain, the C-terminal HP of dematin is highly ordered.  The 
HP of the 48 KDa isoform shows a fully folded conformation (Figure 1.3A), whereas 
the extra 22-amino acid insertion in the longer isoform is mostly unfolded (Frank et 
al., 2004).  The dematin HP structure is similar to that of villin, with an N-terminal 
sub-domain of loops and turns, and 3 alpha helices in the C-terminal sub-domain 
(Frank et al., 2004; Jiang & McKnight, 2006).   
Folding of the dematin HP appears to be independent of the core domain.  
Overlaying the 1H-15N HSQC NMR spectrum for full-length dematin with that of just 
the HP showed that the two correlate (Chen et al., 2009), confirming that the 
dematin HP is independently folded.  The only exception to this was in the extreme 
N-terminal linker region where the two domains join, at which point a slight change 
in conformation was observed.  This independent folding mechanism is also seen 
with the HP of villin (Smirnov et al., 2007).  The NMR spectrum for recombinant 
dematin shows narrow resonances and no chemical shift, indicating that the core 
and HP domains don’t interact (Chen et al., 2009). 
Solving the 3D structure of the dematin HP using multidimensional NMR methods 
revealed that dematin has several novel characteristics compared to villin (Frank et 
al., 2004).  In dematin the HP has a buried cluster of charged residues: a salt bridge 
cluster of Glu39 [Glu368], Arg66 [Arg395], and Lys70 [Lys399], and c-terminal carboxylate 
of Phe76 [Phe405].  Villin has only a single buried salt bridge that holds N- and C-
terminal domains together.  Compared to villin, the variable loop (found in all HP 
domains; Figure 1.3A) of dematin can undergo a far greater range of movements 
than the rest of the protein.  The conformational change in the V-loop is induced by 
phosphorylation of Ser74 [Ser403] in the HP by PKA (Frank et al., 2004). 
In order to further investigate the conformational change that occurs in dematin 
upon phosphorylation of the HP, Jiang and McKnight (2006) created a phospho-
mimicking form of the HP with Ser74 [Ser403] mutated to Glu74 (DHP_S74E).  Initial 
NMR analysis confirmed that the conformation adopted by this construct closely 
resembled that of the phosphorylated wild-type HP.  The NMR spectrum indicates 
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Figure 1.3: NMR structure of the headpiece domain of 48 KDa human dematin 
(A) A ribbon representation of the minimised average solution NMR structure of the 
headpiece domain of the 48 KDa isoform of dematin.  The predicted α-helices are 
shown in dark blue, with the linker regions in light blue.  (B) The amino acid 
sequence of the 48 KDa dematin headpiece, colour coded to match the NMR 
structure.  The sequence is numbered in black according to the longer 52 KDa 
isoform, with the dashed region indicating the 22-amino acid insert not present in 
this shorter variant.  The numbers in red refer to the headpiece specific numbering 
that is often quoted in the literature.  (The NMR structure was obtained from RCSB 
Protein Data Bank; structure of the human dematin headpiece domain, 1QZP.  The 
image was created using Swiss-PDB viewer 4.1.0). 
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only very small changes in localised structure of the C-terminal region of DHP_S74E, 
with the majority of residues forming the hydrophobic core remaining buried.  The 
most notable change is an increased distance between residues Arg66 [Arg395], and 
Glu39 [Glu368], which would prevent the formation of a salt bridge, and could 
potentially explain the reduction in actin-binding that has previously been reported 
upon phosphorylation of Ser74 [Ser403] (Azim et al., 1995).  In contrast, the structure 
of the N-terminal region of DHP_S74E from residues 9-42 [346-379] altered 
dramatically.  This lead to the hypothesis that the phosphate group attracts Lys24 
[Lys353] in the V-loop and this electrostatic interaction causes the N-terminal loop to 
move closer to the C-terminal helix, forming a structure that allows stabilising 
hydrophobic interactions to occur (Jiang & McKnight, 2006). 
The V-loop region of DHP_S74E is much better resolved than the wild-type HP, 
indicating a greater number of constraints on the structure, and is located in closer 
proximity to the C-terminus.  The altered conformation of the V-loop could 
potentially alter the relative orientations of the dematin core and HP domains 
making the two sites unfavourable for bundling.  Alternatively if the two regions are 
connected by a flexible loop, then phosphorylation of the HP could lock the 
structure into a specific position relative to the core that is unfavourable.  A 
selection of complimentary NMR approaches were employed to compare the 
backbone dynamics of DHP and DHP_S74E in more detail (Vugmeyster & McKnight, 
2009).  These results correlated with those seen previously, and suggested that the 
additional salt bridge formed between the core and HP domains is likely to be 
responsible for the reduction in mobility. 
1.1.3 Oligomerisation of dematin 
Rotary shadowed electron micrograph (EM) images of dematin revealed what 
appeared to be tri-lobed structures (Husain-Chishti et al., 1989; Husain-Chishti et al., 
1988; Siegel & Branton, 1985).  This correlated with the calculated molecular weight 
of the complex in solution of approximately 145 KDa.  Analysis of these protein 
complexes revealed a 48:52 KDa isoform ratio of 2:1 (Husain-Chishti et al., 1989).  
This led to the proposed model of dematin forming a functional trimer in vivo, 
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composed of two 48 KDa and one 52 KDa subunits (Figure 1.4).  The formation of 
this structure was proposed to be mediated through interactions between cysteine 
residues, of which there are four in total in such a trimeric configuration; at Cys194 in 
each of the three core domains, and at Cys336 in the HP insert of the 52 KDa 
protomer (Azim et al., 1995). 
Not all data supports the trimerisation model of dematin, however.  Recent 
experiments using analytical ultracentrifugation suggest that dematin actually exists 
in a monomeric state.  Sedimentation velocity data indicated that dematin was 
present in a single oligomeric state, which was most consistent with the protein 
being monomeric.  Further sedimentation equilibrium experiments, capable of 
detecting weak oligomeric interactions, were again unable to detect the presence of 
higher order structures (Chen et al., 2013).  It is currently unclear whether the 
trimerisation of dematin detected in the EM imaging is an artefact due to the 
experimental conditions used (Chen et al., 2013), or whether dematin can form 
oligomeric structures in vivo.  Interestingly it has recently been demonstrated that 
platelets predominantly express the 52 KDa isoform of dematin with very little of 
the 48 KDa isoform (Wieschhaus et al., 2012), suggesting that the trimerisation 
mechanism may not be equally relevant in all cell types. 
1.1.4 Dematin as an actin binding and bundling protein 
The dematin HP shares sequence homology with the actin binding protein villin, 
which is found in epithelial brush-borders.  Villin and dematin share common HP 
features but have unique core domains (Azim et al., 1995).  The actin binding and 
bundling properties of dematin have been well documented.  Both isoforms contain 
two actin binding motifs, one at the extreme C-terminus of the protein, and the 
other in the core domain.  The independent motions of the core and HP regions 
allows each of the actin binding sites within a dematin monomer to interact with 
separate AFs, forming parallel arrays of actin bundles (Chen et al., 2013).  
Despite the high structural homology with other villin-type HP proteins, the 
dematin HP is unique in its ability to be phosphorylated in vivo.  Phosphorylation of  
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Figure 1.4: Proposed model of the trimerisation of dematin 
Some evidence suggests that dematin may form a trimeric structure in vivo, 
consisting of two 48 KDa and one 52 KDa subunits.  This model was proposed based 
upon rotary shadowed electron micrograph (EM) images that appear to show tri-
lobed structures and the calculated molecular weight of the complex in solution of 
approximately 145 KDa.  Oligomerisation is potentially mediated through 
interactions between cysteine residues.  Each protomer contains a cysteine residue 
within the core domain, with an additional site in the headpiece of the 52 KDa 
variant. 
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dematin at Ser381 [Ser403] by cAMP-dependent protein kinase induces a 
conformational change in the protein that controls its actin-bundling ability (Chen et 
al., 2013; Frank et al., 2004; Jiang & McKnight, 2006).  In the phosphorylated state 
F-actin bundling is inhibited, with this function resuming rapidly upon 
dephosphorylation (Husain-Chishti et al., 1988). Dematin is able to bind to actin in 
both the phosphorylated and un-phosphorylated states (Azim et al., 1995; Chen et 
al., 2013), however the binding affinity may be lower when phosphorylated (Vardar 
et al., 2002).  Recent NMR analysis of this process indicates that the inhibition of 
bundling is due to the normally independent core and HP regions coming into close 
proximity with one another (Chen et al., 2013).  Phosphorylation of the HP increases 
its affinity for the core domain, which sterically hinders one of the two actin binding 
sites.  This leaves each monomer capable of binding to just a single AF, therefore 
losing its ability to bundle filaments together.   
1.1.5 Characterised functions of dematin in erythrocytes 
Dematin was first identified and characterised in human erythrocytes, where it is 
localised to spectrin-actin junctions (Husain-Chishti et al., 1989; Husain-Chishti et al., 
1988; Siegel & Branton, 1985).  This network of proteins is responsible for stabilising 
the cell and controlling morphological changes.  The junctional complex assembly is 
coordinated around tetramers of spectrin and actin dimers, with which a number of 
other proteins, including tropomyosin, adducin, and protein 4.1 associate (Bennett, 
1989; Mohandas & An, 2006).  
A connection between the spectrin-actin network and the cell membrane occurs via 
two mechanisms: protein 4.1R and p55 associating with glycophorin C in the 
membrane, and ankyrin binding to band 3 (Bennett, 1989; Reid et al., 1990).  It was 
previously thought that the 4.1R connection was wholly responsible for maintaining 
erythrocyte structural integrity; however recent findings have indicated that this 
function may be shared across additional cytoskeletal proteins (Anong et al., 2009; 
Chen et al., 2007; Khan et al., 2008).  Confirmation of the presence of dematin in 
this region (Derick et al., 1992), in addition to biochemical analysis of binding 
characteristics, led to the current model in which dematin acts as an additional 
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adaptor protein, binding to the transmembrane glucose-transporter 1 (GLUT1) and 
stabilising the cell (Figure 1.5) (Khan et al., 2008).  Knocking out the dematin HP 
domain (HPKO) in mice  is non-lethal, but erythrocytes become fragile and more 
deformable, and as a result animals display compensatory anaemia (Chen et al., 
2007; Khanna et al., 2002).  As the primary sequences of human and mouse 
dematin share 95% homology (Azim et al., 1999), phenotypic and functional data 
obtained from mouse knock out studies are of significant potential relevance when 
looking at the function of human dematin.  
1.1.6 Characterised functions of dematin in non-erythroid cells 
Dematin expression has now been demonstrated in a broad range of non-erythroid 
human tissues including the brain, heart, lungs, kidneys, testis, endothelial and 
epithelial cells, adipose tissue, and skeletal muscle (Kim et al., 1998; Mohseni & 
Chishti, 2008b; Rana et al., 1993).  This suggests that dematin may have far more 
widespread functions than those that have been defined in erythrocytes.  Several 
non-erythroid functions of dematin have been characterised, but there is still 
relatively limited understanding of these additional roles.   
1.1.6.1 The involvement of dematin in wound healing   
HPKO experiments have shown that loss of expression of the dematin HP domain, 
which leads to inhibition of actin binding, results in abnormal phenotypes in mouse 
embryonic fibroblasts.  Cells displayed altered morphological, motile, and adhesive 
properties, resulting in a significantly decreased efficiency of wound healing.  This 
was attributed to dematin acting as a negative regulator of the RhoA pathway, 
which was independent of Focal Adhesion Kinase (FAK) activation (Mohseni & 
Chishti, 2008a; Mohseni & Chishti, 2009).  The current data is insufficient to 
precisely determine the mechanism by which dematin suppresses RhoA activation, 
however several plausible models have been proposed.  Firstly, dematin may bind 
to guanine nucleotide exchange factor (GEF) thereby preventing it from associating 
with, and activating, RhoA.  Alternatively dematin may act as a guanidine nucleotide 
dissociation inhibitor (GDI), or may bind to another GDI, tethering RhoA and again 
preventing activation (Mohseni & Chishti, 2008a). 
Chapter 1 - Introduction 
 
14 
 
  
 
Figure 1.5: Dematin is located in the erythrocyte junctional complex 
In erythrocytes dematin is located at the spectrin-actin network and has been 
shown to be important for mechanical stability.  Previous research suggested that 
the link between the actin cytoskeleton and the cell membrane was coordinated by 
the interaction of glycophorin C in the membrane with p55 and protein 4.1.  It has 
now been demonstrated that dematin is involved in an extra stabilising linkage, 
through direct binding to the basal glucose transporter GLUT1.  Mice lacking the 
dematin headpiece therefore display erythrocyte spherocytosis and compensatory 
anaemia. 
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The delayed wound healing phenotype was further investigated through 
characterisation of the changes that occur in platelets of dematin HPKO mice 
(Wieschhaus et al., 2012).  Morphologically, HPKO platelets were comparable to 
wild-type and were of equal size and quantity; however they displayed reductions in 
adhesion and spreading, impaired aggregation resulting in poor clot retraction, and 
defects in granule secretion.  Loss of dematin expression resulted in reduced 
expression of human inositol 1,4,5-triphosphate 3-kinase form B (IP3KB), an 
important regulator of calcium homeostasis, at the cell membrane while cytosolic 
concentrations increased.  It remains to be determined whether this regulation of 
intracellular calcium by dematin is relevant in other cells types. 
1.1.6.2 The role of dematin as a tumour suppressor 
In humans dematin has been mapped to chromosome 8 at locus 8p21.1 (Azim et al., 
1995),  a region frequently affected by oncogenic deletions (Huang et al., 1996; 
Vocke et al., 1996).  Other actin-binding proteins including tropomyosin, gelsolin, 
and vinculin, have been identified as having roles in tumour suppression in 
epithelial cells (Hall, 2009).  It was therefore proposed that dematin may have 
similar effects on cell proliferation through regulation of its actin-bundling ability 
(Kim et al., 1998).  Deletions in this region are seen particularly frequently in 
prostate cancer, and the loss of one dematin allele was observed in the majority of 
8p21-linked prostate tumours (Kim et al., 1998).  Reduced dematin expression is 
therefore potentially linked to tumour progression and alterations in cell 
morphology, adding to increasing evidence that cytoskeletal proteins can function 
as tumour suppressors.  The prostate adenocarcinoma cell line PC-3 has a single 
allele deletion of dematin.  Overexpression of dematin in the PC-3 tumorigenic cell 
line changes cell morphology to a more typical polarised epithelial phenotype.  
Conversely overexpression of dominant negative dematin mutants compromises 
the normal morphology of 3T3 fibroblasts (Lutchman et al., 1999). 
1.1.6.3 Other non-erythroid functions of dematin 
Dematin has been proposed as a candidate gene for Marie Unna Hereditary 
Hypotrichiosis (MUHH).  Patients suffering from MUHH are born with hair of normal 
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to sparse density, but this gradually becomes wiry and eventually is lost 
permanently.  Attempts to locate the gene responsible for MUHH pinpointed 
chromosomal region 8p21.2, which lies next to the dematin locus, as one region of 
interest.  The involvement of dematin in this disorder was further supported by 
phenotypic observations in dematin HPKO mice, approximately a third of which 
display facial hair-loss as they age, with some losing all hair from their dorsal region.  
Skin samples from these mice showed decreased expression of the dematin core 
domain in the dermis, hypodermis, and skeletal muscle.  This effect is not seen in 
heterozygous HPKO animals (Mohseni & Chishti, 2008b). 
The majority of functions that have been investigated to date involve the HP of 
dematin, with relatively little still known about the function of the core domain.  
The lack of secondary structure led to one hypothesis that the region may act as a 
scaffold on which other junctional complex proteins can associate, however this has 
yet to be confirmed (Chen et al., 2009). 
Given the widespread tissue expression profiles, and limited understanding of the 
regulation of dematin, it is likely that there are numerous functions that have yet to 
be discovered.  Dematin is expressed in skeletal muscle and adipose tissue, the two 
main metabolic tissues of the body, and yet there has been no specific research into 
its function in either of these systems.  This thesis will focus on the function and 
regulation of dematin in skeletal muscle, with particular emphasis on the potential 
phospho-regulation of dematin by the p38 MAPK, and interaction with the adaptor 
protein 14-3-3.  The effects of these regulatory mechanisms on the actin-binding 
and bundling properties, and stability, of dematin will be determined.  The 
background to these areas is covered in sections 1.2-1.5. 
1.2 The actin cytoskeleton    
The actin cytoskeleton is a dynamic three-dimensional structure found in the 
cytoplasm of all eukaryotic cells.  It plays essential roles in a diverse range of cellular 
processes, including the control of cell morphology and motility, and the 
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endocytosis and intracellular trafficking of proteins (Pollard & Cooper, 2009).  In 
order to meet the continually changing demands of the cell, AFs form highly 
dynamic structures which are regulated by the actions of numerous actin-binding 
proteins (ABPs) (Blanchoin et al., 2014). 
1.2.1 Actin 
Actin is a 42 KDa protein that comprises 10% of the total protein mass found in 
muscle, and approximately 1-5% in non-muscle cells.  There are three main isotypes 
of actin in mammals: α-actin, β-actin, and γ-actin.  These display greater than 90% 
sequence homology at the amino acid level, with the majority of variation in the N-
terminal 30 residues (Herman, 1993).  Three isoforms of α-actin exist, which are 
expressed in cardiac, skeletal and smooth muscle.  The β-actin and γ-actin isoforms 
are expressed in both muscle and non-muscle cells (Perrin & Ervasti, 2010).  Actin 
exists in two structural forms, monomeric or globular-actin (G-actin), and 
polymerised filamentous-actin (F-actin).  Actin monomers are composed of a single 
polypeptide chain of 375 residues, which folds to form a two-lobed structure with a 
central cleft in which ATP and Mg2+ bind.  A flexible hinge region connects the two 
lobes, allowing them to rotate relative to one another (Otterbein et al., 2001).   
1.2.2 Actin filaments  
Monomers of G-actin are polymerised into F-actin chains, forming two right-handed 
long-pitch helices (Holmes et al., 1990).  Polymerisation begins with an initial 
activation phase where G-actin undergoes a conformational change to correctly 
align monomers for incorporation into a polymer; the two lobes of each actin 
monomer rotate approximately  20° relative to one another, creating a flatter 
molecule (Oda et al., 2009).  Following this is the nucleation phase.  This involves 
the initial polymerisation of these conformationally altered G-actin monomers, a 
process that is energetically unfavourable until three monomers have associated.  
Once a sufficient number of these unstable dimers and trimers have accumulated, 
rapid polymerisation occurs (Wegner & Engel, 1975).  
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AFs are polar, with a fast growing barbed (+) end and a slow growing pointed (-) end 
(Pollard, 1986).  Elongation of AFs involves the preferential addition of ATP-actin 
monomers to the + end of the filament, into the exposed ATP binding cleft of the 
neighbouring monomer (Figure 1.6).  Actin has intrinsic ATPase activity and 
irreversible hydrolysis of the bound ATP leads to de-stabilisation of the AF, resulting 
in disassembly of ADP-actin monomers and phosphate from the - end.  The 
available pool of ATP-actin is then restored through nucleotide exchange, ready for 
incorporation into a new polymer (Figure 1.6).  Polymerisation rates are regulated 
by the availability of ATP-actin monomers; at high concentrations monomers are 
added to both ends of the filament, while at intermediate concentrations AFs 
extend only from the + end.  At low concentrations elongation does not occur 
(Wegner & Engel, 1975).  Cellular concentrations of actin monomers can reach 300 
µM, and under these conditions 3000 subunits can be incorporated into the barbed 
end of the filament every second.  At this speed filaments of 10 µm in length can be 
synthesised in less than two seconds, facilitating rapid remodelling of the cellular 
architecture (Pollard et al., 2000). 
1.2.3 Regulation of actin polymerisation by actin-binding proteins 
In order to meet the demands of the cell, the actin cytoskeleton must be highly 
dynamic and capable of continual and rapid remodelling in response to spatial and 
temporal requirements.  AFs are regulated by signals from both within the cell and 
from the extracellular environment, leading to changes in the local organisation of 
the actin network (Blanchoin et al., 2014).  Control of actin dynamics is achieved 
through the coordinated actions of a set of structurally and functionally diverse 
ABPs.  To date more than 150 proteins containing actin-binding domains have been 
identified, and these can be categorised based on the regulatory effect they have 
on actin (dos Remedios et al., 2003).  
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Figure 1.6: Polymerisation of monomeric G-actin to filamentous F-actin 
Actin is found in vivo in two states, monomers of globular G-actin and polymers of 
these monomers known as filamentous or F-actin.  Polymerised actin forms a polar 
structure, with a barbed (+) end where actin monomers are preferentially added 
and a pointed (-) end where depolymerisation occurs.  Before incorporation into a 
polymer, G-actin monomers undergo a conformational change resulting in flatter 
molecules that align more readily.  Actin polymerisation is facilitated by proteins 
such as profilin that sequester ATP-actin monomers and deliver them to the barbed 
end of the filament.  Following incorporation into the polymer, the intrinsic ATPase 
activity of F-actin hydrolyses ATP to ADP resulting in ADP+Pi-actin.  Upon cofilin-
mediated depolymerisation at the pointed filament end, ADP-actin monomers 
undergo nucleotide hydrolysis, restoring the pool of ATP-actin available for the 
polymerisation of new filaments. 
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1.2.3.1 Nucleation promoting factors 
As the initial polymerisation of monomers is energetically unfavourable, nucleating 
factors operate to overcome this lag-phase and enhance polymerisation rates.  
These include the Arp2/3 complex which is able to initiate the formation of a new 
AF protruding from an existing polymer, creating branched structures (Figure 1.7A) 
(Goley & Welch, 2006).   
1.2.3.2 Monomer binding proteins 
These proteins are involved in regulating the availability of actin monomers for 
incorporation into filaments.  ABPs such as cofilin and twinfilin bind to ADP-F-actin 
at the pointed end of a filament and enhance the dissociation of ADP-actin 
monomers (Carlier et al., 1997).  Profilin then buffers these actin monomers and 
facilitates the nucleotide exchange of ADP for ATP.  ATP-actin monomers are 
delivered exclusively to the barbed end of the AF ready for re-incorporation, 
enhancing the polarity of the growing structure (Pring et al., 1992).  Profilin also 
inhibits the formation of actin dimers and trimers, meaning that de novo synthesis 
of AFs can only occur in conjunction with nucleation-promoting factors (Pollard et 
al., 2000). 
1.2.3.3 Capping proteins 
Capping proteins either stabilise AFs or promote filament disassembly.  Gelsolin and 
tensin form a stabilising cap on the barbed end of AFs, preventing the addition of 
further actin monomers, whereas others such as emerin bind to the pointed end of 
the filament and inhibit depolymerisation (Figure 1.7A) (Pollard et al., 2000).   
1.2.3.4 Severing proteins  
The formation of new polymers is enhanced by severing proteins which bind to 
existing filaments and cut them in two, allowing polymerisation to continue from 
the two barbed ends.  These include cofilin, which binds to actin and perturbs the 
local structure, leading to severing of the filament at a neighbouring site where this 
force is felt most strongly (Figure 1.7A) (Pavlov et al., 2007). 
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Figure 1.7: The regulation of actin by actin binding proteins 
Regulation of the actin cytoskeleton relies on the coordinated actions of a large 
family of actin binding proteins.  These diverse proteins each contain at least one 
actin binding motif, and perform functions that determine the nature of the actin 
structures that are formed.  (A) Filamentous actin structures are stabilised by 
proteins such as the tropomyosin family that act to inhibit depolymerisation.  
Nucleation of new polymers from the sides of existing filaments is catalysed by the 
Arp2/3 complex, which overcomes the lag phase of de-novo polymerisation.  
Enhanced polymerisation rates may also be achieved through the severing of an 
existing polymer by proteins such as cofilin, to produce two barbed ends at which 
polymerisation can occur.  Capping proteins such as gelsolin and emerin bind to the 
barbed and pointed ends of actin filaments, inhibiting polymerisation and 
depolymerisation respectively.  (B) Actin polymers form two main types of higher 
order structure: actin bundles and actin networks.  These structures are 
orchestrated by bundling and crosslinking proteins which are capable of 
simultaneously binding to two actin filaments, either monomers with two actin 
binding sites, or multimeric complexes of proteins.  Actin bundles are either parallel 
or anti-parallel alignments of actin filaments held in a rigid orientation, whereas 
networks are a looser orthogonal arrangement of polymers. 
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1.2.3.5 Stabilising proteins 
Proteins of the tropomyosin family bind along the length of AFs and have a 
stabilising role, preventing spontaneous depolymerisation.  Some family members, 
including tropomyosin itself, also inhibit the actions of filament severing proteins as 
an additional method of increasing filament stability (Figure 1.7A) (Khaitlina et al., 
2013). 
1.2.4 Higher-order actin structures 
AFs in vivo organise themselves into two main types of structures: bundles and 
networks (Figure 1.7B).  Formation of these higher-order structures is essential for 
cellular function, and is facilitated by two classes of ABPs - those that bundle F-actin, 
and those that crosslink F-actin.  These ABPs either contain two distinct actin-
binding domains, or form multimeric complexes where each monomer contains a 
single binding domain, allowing them to simultaneously bind to two different AFs.  
Such proteins play no role in the polymerisation of actin, but instead act upon pre-
formed filaments (Blanchoin et al., 2014). 
1.2.4.1 Actin bundles 
Actin bundles are composed of AFs aligned either parallel or anti-parallel (Figure 
1.7B).  Bundles can be either densely or loosely packed together, a property that is 
determined by the bundling protein involved.  Proteins such as fimbrin, which 
contain two actin binding domains in closely proximity, aid the formation of dense, 
rigidly structured, bundles (Lieleg et al., 2009).  Conversely the loosely associated 
anti-parallel bundles in actin stress fibres are created by α-actinin, which forms a 
dimeric complex with an intermediate spacer region (Courson & Rock, 2010).  
Parallel actin bundles are found in filopodia and microvilli, while anti-parallel 
bundles are required for cytokinesis and cell adhesion (Blanchoin et al., 2014). 
1.2.4.2 Actin networks 
The actin in networks is loosely packed and less organised than in bundles, with 
filaments lying perpendicular to one another (Figure 1.7B).  Network formation is 
Chapter 1 - Introduction 
 
23 
 
coordinated by crosslinking proteins in which the two actin-binding domains are 
orientated at greater distances, such as in dimeric filamin or tetrameric spectrin, 
allowing for the formation of looser, less organised structures (Feng & Walsh, 2004).  
Planar networks are associated with the plasma membrane and form 2D web-like 
structures, whereas the cytosol gains gel-like qualities from 3D networks.  In some 
instances, networks can form denser meshes, coordinated by smaller monomeric 
proteins such as fascin (Courson & Rock, 2010).  Actin networks are important in 
controlling cell shape and maintaining mechanical integrity (Blanchoin et al., 2014). 
1.2.5 Functions of the actin cytoskeleton 
The actin cytoskeleton has been shown to be involved in a wide array of important 
cellular functions.  F-actin is essential in numerous processes including maintaining 
cell morphology, endocytosis and intracellular trafficking, cell motility, and 
cytokinesis (Pollard & Cooper, 2009).   
1.2.5.1 Endocytosis and intracellular trafficking 
F-actin assembles at the cell membrane at sites of endocytosis, forming structures 
known as actin patches.  These patches are involved in the latter stages of 
endocytotic vesicle formation, and also provide the force required to deform the 
membrane and internalise the vesicle (Kaksonen et al., 2006).  Actin is essential for 
scission of the vesicle from the membrane, with filaments orientating themselves 
with all of the barbed ends around the neck of partially invaginated vesicles to 
constrict the membrane (Collins et al., 2011).  As the vesicle moves into the 
cytoplasm the AFs rapidly depolymerise (Kaksonen et al., 2005).   
1.2.5.2 Cell contractility and motility 
Cell motility is dependent upon the actin cytoskeleton.  This movement is 
coordinated by a dense branched network of short AFs under the membrane of the 
leading edge of the cell, which polymerise in the direction of migration (Pollard & 
Cooper, 2009).  This locomotion is physiologically important during development, 
for example in the migration of neurons from the neural crest to the intestine 
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(Anderson et al., 2006).  Immune cells also employ this mechanism in the search for 
pathogens.  Actin-mediated motility is also involved in pathological processes.  
Metastatic cancer cells employ actin bundles to generate protrusions with sufficient 
mechanical force to migrate through the extracellular matrix and invade 
surrounding tissues (Stevenson et al., 2012). 
1.2.5.3 Cytokinesis 
The final stage of cytokinesis requires the physical separation of a dividing cell into 
two distinct daughter cells.  This process involves a contractile ring of AFs, which 
needs to be perfectly positioned to bisect the anaphase spindle along a plane with 
sister chromosomes segregated on either side (Pollard, 2010).  Mitotic exit signals 
then activate cell-cycle kinases which initiate the constriction of the actin ring by 
myosin II, which results in pinching of the membrane and the formation of a 
cleavage furrow (Glotzer, 2005).   Membrane fusion then occurs to create two 
daughter cells, and the contractile ring structure rapidly disassembles (Montagnac 
et al., 2008). 
1.3 p38 MAPK    
Reversible phosphorylation is an important mechanism for regulating protein 
function which is involved in a wide variety of cellular processes, and is essential for 
signal transduction (Ubersax & Ferrell, 2007).  The human kinome consists of over 
500 protein kinases.  Phosphorylation of serine residues accounts for the 86% of 
phosphorylation reactions, with phosphorylation of threonine and tyrosine 
comprising the remaining 12% and 2% respectively.  These kinases are classified 
into groups, families, and sub-families based upon their sequence conservation and 
biochemical function (Manning et al., 2002).   
1.3.1 The MAPK family 
One well-characterised family of kinases are the MAPKs (Cargnello & Roux, 2011). 
These are a group of serine / threonine specific kinases that coordinate a range of 
intracellular functions in response to external stimuli.  Four major subfamilies of 
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mammalian MAPKs have been characterised: the extracellular signal-regulated 
kinases (ERK) 1/2, ERK5, JUN N-terminal kinases (JNKs) and p38.  Each subfamily is 
activated by specific extracellular stimuli that activate a kinase signalling-cascade, 
leading ultimately to transcription of target proteins in the nucleus, or regulation of 
cytosolic constituents (Ashwell, 2006). 
Exposure to extracellular activating stimuli initiates a three-tiered downstream 
MAPK signalling cascade, where a series of phosphorylation reactions sequentially 
activate a MAPK kinase kinase (MAPKKK), MAPK kinase (MAPKK) and MAPK in turn 
(Cuadrado & Nebreda, 2010).  Between them, the MAPKs regulate a vast array of 
biological processes, including apoptosis, differentiation, proliferation, and 
cytoskeletal rearrangement (Figure 1.8).  Many of these processes are regulated by 
multiple MAPKs (Gehart et al., 2010). 
1.3.2 p38 MAPK 
p38 is a 38 KDa protein involved in the cellular stress response.  Four isoforms of 
p38, each encoded by separate genes, have been identified: p38α, p38β, p38γ, and 
p38δ.  These can be further subdivided into p38α/β and p38δ/γ groupings based 
upon their sequences, and the observation that only p38α and p38β are susceptible 
to inhibition by SB203580 and SB202190 (Kuma et al., 2005).  Sequence homology 
at the amino acid level is approximately 74% between α and β, and 63% and 61% 
between α and γ / δ respectively (Jiang et al., 1996).  The p38α and p38β isoforms 
are fairly ubiquitously expressed, p38γ is found mainly in skeletal muscle and p38δ 
is expressed in the kidney, pancreas, small intestine and testes (Ono & Han, 2000).  
1.3.3 Activation of p38 signalling 
Along with the JNK family, p38 is classified as a stress-activated MAPK.  Activation of 
p38 in vivo can occur in response to changes in pH, heatshock, high osmolarity, UV 
radiation and exposure to inflammatory cytokines or reactive oxygen species (ROS) 
(Freshney et al., 1994) (Raingeaud et al., 1995).  These external stimuli activate 
receptor tyrosine kinase or G-protein coupled receptors, leading to activation of the  
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Figure 1.8: A simplified overview of the MAPK family signalling cascades 
The MAPK family comprises four major sub-families: ERK 1 and 2, p38, JNKs, and 
ERK 5.  These kinases respond to a variety of extracellular stimuli, which leads to 
activation of MAPKKKs, which in turn activate MAPKKs, which go on to activate the 
MAPKs themselves.  Activation of MAPKs results in a variety of biological responses, 
some of which are specific to a particular subfamily whereas others involve multiple 
MAPK signalling pathways.  (ERK; extracellular signal-regulated kinases, GPCR; G-
protein coupled receptor, JNK; JUN N-terminal kinases, MAPK; mitogen-activated 
protein-kinase, MAPKK; mitogen-activated protein-kinase-kinase, MAPKKK; 
mitogen-activated protein-kinase-kinase-kinase, MEKK; MLK, mixed-lineage kinase, 
Raf; rapidly accelerated fibrosarcoma). 
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Rho family of GTP-binding proteins, including Rho, Rit, Rac1, and Cdc42 (Marinissen 
et al., 2001; Sakabe et al., 2002).  These proteins activate an array of MAPKKKs 
including MEKK (MAPK/ERK kinase kinase) 1-3, ASK1 (apoptosis signal-regulating 
kinase 1), TAK1 (TGF (transforming growth factor) β-activated kinase 1), and TAO 
(thousand-and-one amino acid) 1 and 2 (Cheung et al., 2003; Ichijo et al., 1997).  
These MAPKKKs in turn phosphorylate the highly specific MAPKKs MKK3 and MKK6 
through the phosphorylation of two conserved residues in their activation loops 
(Figure 1.9) (Dérijard et al., 1995; Han et al., 1996).  
Activation of p38 results from the phosphorylation of a specific Thr180-Gly-Tyr182 
motif in the flexible activation loop of subdomain VIII, at both the threonine and 
tyrosine residues.  The p38-specific activators MKK3 or MKK6 mediate this reaction, 
with the exception of p38β that can only be phosphorylated by MKK6 (Raingeaud et 
al., 1996).  MKK4 may also be capable of activating p38, however this is not specific 
and is better characterised as an activator of JNK (Dérijard et al., 1995).  This dual 
phosphorylation of Thr180 and Tyr182 induces a global conformational change in p38, 
altering the relative positions of the N- and C-terminal domains, and stabilising the 
activation loop in an open state which enables substrate binding (Bellon et al., 1999; 
Canagarajah et al., 1997).  
Transient activation of p38 in vivo is essential for the fine control of signalling 
outcomes, and this regulation is primarily controlled through the balance of 
phosphorylation and dephosphorylation.  MAPK phosphatases target the Thr180 and 
Tyr182 residues in the activation loop and revert kinases to their inactive state, 
thereby decreasing signalling through the pathway (Cuadrado & Nebreda, 2010).  In 
mammalian cells the phosphatases PP2A, PP2C, and PTP have been shown to 
regulate p38 (Takekawa et al., 2000; Takekawa et al., 1998).  This dynamic balance 
between the actions of MKK3 and MKK6 in activating p38, and the counter actions 
of these phosphatases enables tight control over the regulation of p38, and 
therefore the activation and function of p38 substrates.   
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Figure 1.9: The p38 MAPK signalling cascade
Activation of p38 mitogen-activated protein-kinase (MAPK) in vivo can occur in 
response to growth factors, environmental stresses and inflammatory cytokines.  
These external stimuli activate receptor tyrosine kinase or G-protein coupled 
receptors on the cell surface, leading ultimately to activation an intracellular kinase 
signaling cascade.  MAPKKKs phosphorylate the highly specific p38 MAPKKs MKK3 
and MKK6 through the phosphorylation of two conserved residues in their 
activation loops.  These then phosphorylate p38 at Thr180 and Tyr182 inducing and 
activating conformational change.  Targets of p38 phosphorylation include both 
nuclear transcription factors and cytosolic proteins. 
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1.3.4 Substrates of the p38 MAPK 
MAPKs including p38 phosphorylate substrates at serine or threonine residues that 
are followed by a small amino acid, preferably a proline.  These are often referred 
to as Ser-Pro / Thr-Pro or SP / TP motifs.  Current estimates suggest that MAPKs 
may each have around 200-300 substrates, although many of these have not been 
confirmed (Cuadrado & Nebreda, 2010).  Known substrates of p38α include other 
protein kinases, nuclear proteins including transcription factors, and a wide array of 
cytosolic proteins including cytoskeletal components (Trempolec et al., 2013). 
As the presence of SP / TP motifs in proteins is very common, additional 
mechanisms of substrate recognition are essential for p38 signalling fidelity.  
Substrates for MAPKs often contain a docking or D-motif, a region consisting of 
positively charged and hydrophobic residues, often located 10-50 amino acids to 
the C-terminal side of the phosphorylation sites (Reményi et al., 2005).  These 
domains can be regulated by phosphorylation of either this sequence on the 
substrate, or the interacting region of p38 itself and act to enhance the efficiency 
and specificity of kinase substrate interactions.  However the presence of a D-motif 
is not essential for the phosphorylation of a substrate by a MAPK.   
1.3.5 Biological function of the p38 MAPK 
Activation of p38 has been linked to a number of physiological and pathological 
conditions.  Many of the studies involving gene-targeted mice have focused on the 
p38α isoform, and it has been demonstrated that the constitutive deletion of either 
p38α or of MKK3 and MKK6 is embryonically lethal (Adams et al., 2000; Brancho et 
al., 2003).  Activation of the p38 pathway has been implicated in tissue homeostasis, 
cell migration, and inflammation (Cuenda & Rousseau, 2007).   
1.3.5.1 Cell differentiation  
Signalling through the p38 pathway is essential for myoblast differentiation into 
myotubes during embryogenesis, and constitutive overexpression of MKK6 in vitro 
leads to termination of proliferation and induction of differentiation (Wu et al., 
2000).  These effects are mediated through control of transcription factors such as 
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myocyte enhancer factor-2 (MEF-2) (Han et al., 1997), targeting of chromatin-
remodelling enzymes to muscle specific loci (Simone et al., 2004), and stabilisation 
of muscle-specific mRNA turnover (Briata et al., 2005).  The differentiation of many 
other cell types also involves alterations in p38 signalling, including in adipocytes 
(Aouadi et al., 2006), osteoclasts (Huang et al., 2006), intestinal epithelial cells 
(Houde et al., 2001), and in neuronal plasticity (Butler et al., 2004). 
1.3.5.2 Cell migration 
Chemotactic cell migration requires p38 signalling, a function which has been 
shown to be specific to the p38α isoform (Rousseau et al., 2006).  This process has 
been demonstrated in neutrophils, endothelial cells, epithelial cells, smooth muscle 
cells and neuronal cells (Cuenda & Rousseau, 2007).  The majority of research into 
the role of p38 in cell migration focuses on the regulation of the actin cytoskeleton.  
Mice lacking MAPK-activated protein kinase 2 (MAPKAP-K2), which is a direct 
substrate of p38, display impaired migration of fibroblasts, macrophages, and 
vascular smooth muscle cells.  This has been linked to the MAPKAP-K2 substrate 
heatshock protein 27 (HSP27), which can block actin polymerisation in its 
unphosphorylated state through binding to actin capping proteins (Lavoie et al., 
1995).  LIM domain Kinase 1 (LIMK1), also a substrate of MAPKAP-K2, regulates 
actin remodelling through inhibition of the actin-depolymerising protein cofilin 
(Kobayashi et al., 2006).  p38 modulated regulation of cell migration and invasion 
also occurs through inhibition of matrix metalloprotease (MMP) proteins which  
degrade a range of extracellular matrix proteins (Simon et al., 2001). 
1.3.5.3 Inflammation 
The p38 pathway has been implicated in a number of inflammatory disorders 
including Rheumatoid arthritis (Clark & Dean, 2012), Alzheimer’s disease (Johnson & 
Bailey, 2003), and inflammatory bowel conditions (Hollenbach et al., 2004).  The 
production of inflammatory cytokines, such as Interleukin-1 (IL-1), IL-6, and tumour 
necrosis factor alpha (TNF-α), has been linked to p38 pathway activation.  Again 
p38α is thought to be the main isoform mediating this function, with p38β knockout 
mice displaying no defects in cytokine production (Beardmore et al., 2005). 
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1.4 The 14-3-3 protein family     
The 14-3-3 proteins are a family of small acidic phospho-serine / phospho-threonine 
binding proteins that interact with substrates at specific motifs, resulting in a vast 
range of biological outcomes.  Moore and Perez first purified these proteins from 
bovine brain tissue in 1967, with the name 14-3-3 deriving from this original 
purification procedure.  The 14-3-3 protein eluted from a diethyl-aminoethyl (DEAE) 
cellulose chromatography column in the 14th fraction, and then migrated to position 
3.3 during starch gel-electrophoresis (Moore, 1967). 
1.4.1 Isoforms and expression patterns 
The human brain homologue of 14-3-3 was purified in 1982 (Boston et al.), and 14-
3-3 proteins have since been shown to be ubiquitously expressed throughout 
mammalian tissues.   Expression of 14-3-3 has been demonstrated in all eukaryotic 
species examined to date, including Xenopus (Martens et al., 1992), Drosophila 
(Swanson & Ganguly, 1992), and yeast (Ford et al., 1994), and they are also found in 
plants (Hirsch et al., 1992).   
In humans, seven distinct genes encoding 14-3-3 isoforms β, γ, ε, ζ, η, θ and σ have 
been identified (Ichimura et al., 1988; Toker et al., 1992).  These names derive from 
the fractions that each isoform eluted in during high performance liquid 
chromatography (HPLC) experiments (Ichimura et al., 1988).  The α and δ isoforms 
originally described are now known to be phosphorylated forms of the β and ζ 
isoforms respectively (Aitken et al., 1995).  The molecular weight of each isoform is 
in the region of 29-32 KDa, and they share a high degree of sequence homology 
(Figure 1.10).  Isoform-specific knockouts in mice show no major changes in 
phenotype, indicating a high degree of functional compensation between isoforms 
(Aitken, 2006).  The exception to this is the σ isoform, expressed primarily in 
epithelial cells, which is essential for control of DNA damage checkpoints (Chan et 
al., 1999). 
Chapter 1 - Introduction 
 
32 
 
 
 
Figure 1.10: Sequence conservation across the seven human isoforms of 14-3-3 
Seven isoforms of 14-3-3 are expressed in humans, each of which is composed of 
nine anti-parallel alpha helices connected by short loops.  Human 14-3-3 isoforms 
show considerable sequence homology, with residues shared by all isoforms shown 
in blue and those shared by at least 4 isoforms in pink.  A particularly high degree of 
sequence conservation is seen across helices 3, 5, 7 and 9, which are involved in 
ligand binding.  The other helices form the outer surface of the 14-3-3 dimer, and 
the increased variability between isoforms may be responsible for isoform-specific 
ligand interactions.  (Protein sequences were obtained from the NCBI database and 
aligned using Clustal X2 alignment software). 
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epsilon      WRIISSIEQKEENKGGEDKLKMIREYRQMVETELKLICCDILDVLDKHLIPAAN--TGES 
zeta         WRVVSSIEQKT--EGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNAS--QAES 
eta          WRVISSIEQKTMADGNEKKLEKVKAYREKIEKELETVCNDVLSLLDKFLIKNCNDFQYES 
theta        WRVISSIEQKT--DTSDKKLQLIKDYREKVESELRSICTTVLELLDKYLIANAT--NPES 
sigma        WRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAG--DAES 
              
 
beta         KVFYLKMKGDYFRYLSEVASGDNKQTTVSNSQQAYQEAFEISKKEMQPTHPIRLGLALNF 
gamma        KVFYLKMKGDYYRYLAEVATGEKRATVVESSEKAYSEAHEISKEHMQPTHPIRLGLALNY 
epsilon      KVFYYKMKGDYHRYLAEFATGNDRKEAAENSLVAYKAASDIAMTELPPTHPIRLGLALNF 
zeta         KVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNF 
eta          KVFYLKMKGDYYRYLAEVASGEKKNSVVEASEAAYKEAFEISKEQMQPTHPIRLGLALNF 
theta        KVFYLKMKGDYFRYLAEVACGDDRKQTIDNSQGAYQEAFDISKKEMQPTHPIRLGLALNF 
sigma        RVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNF 
              
 
beta         SVFYYEILNSPEKACSLAKTAFDEAIAELDTLNEESYKDSTLIMQLLRDNLTLWTSENQG 
gamma        SVFYYEIQNAPEQACHLAKTAFDDAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDQQD 
epsilon      SVFYYEILNSPDRACRLAKAAFDDAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDMQG 
zeta         SVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDTQG 
eta          SVFYYEIQNAPEQACLLAKQAFDDAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDQQD 
theta        SVFYYEILNNPELACTLAKTAFDEAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDSAG 
sigma        SVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWTADNAG 
 
 
beta         DEGDAGEGEN-------- 
gamma        DDGGEGNN----------    XXXX = residue conserved across  
epsilon      DGEEQNKEALQDVEDENQ     all isoforms 
zeta         DEAEAGEGGEN------- 
eta          EEAGEGN-----------    XXXX = residue conserved across 
theta        EECDAAEGAEN-------        4 or more isoforms 
sigma        EEGGEAPQEPQS------ 
                                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Helix 1 Helix 2 Helix 3 
Helix 4 
Helix 5 Helix 6 Helix 7 
Helix 8 Helix 9 
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1.4.2 Structure of 14-3-3 proteins 
The crystal structures of the θ and ζ isoforms of 14-3-3 were the first to be 
determined, and showed that monomers are composed of nine antiparallel α-
helices each connected by short loops (Liu et al., 1995; Xiao et al., 1995).  14-3-3 
monomers dimerise via their N-terminal domains (Jones et al., 1995) to create a 
rigid, horseshoe-shaped, structure with two internal ligand-binding grooves (Liu et 
al., 1995; Xiao et al., 1995).  Helices 1, 3, 5, 7 and 9, which are known to be the most 
highly conserved between the seven isoforms (Figure 1.10), form the internal 
surface of the dimer (Figure 1.11) and are involved in ligand binding.  Helices 2, 4, 6 
and 8, which display the greatest degree of variability, form the outer surfaces of 
the dimer (Figure 1.11) (Wang & Shakes, 1996; Wilker et al., 2005).  Most 14-3-3 
isoforms are found as both homo- and hetero-dimers, the exception being the σ 
isoform that preferentially homo-dimerises.  Unlike other isoforms the 14-3-3σ 
homo-dimer contains additional stabilising salt bridge interactions, and in the 
hetero-dimeric conformation it is thought the electrostatic interactions with other 
isoforms may destabilise the dimer in vivo (Wilker et al., 2005). 
1.4.3 Binding of 14-3-3 to target proteins 
Binding of 14-3-3 involves residues Lys49, Arg56, Arg127, and Tyr128, which bind to the 
phosphate moiety of the target protein (Yaffe et al., 1997).  These are basic residues 
which are conserved across all isoforms, both within and across species (Rittinger et 
al., 1999).  14-3-3 dimers are rigid structures, and it appears that binding causes 
conformational changes to the target protein leaving 14-3-3 relatively unchanged 
(Obsil et al., 2001; Yaffe, 2002).  14-3-3 family members generally bind to specific 
motifs that have been designated as mode I RSx(pS/pT)xP and mode II 
Rxϕx(pS/pT)xP, where pS/pT indicates a phosphorylated serine / threonine residue, 
ϕ is an aromatic or aliphatic residue, and x is any amino acid (Muslin et al., 1996; 
Yaffe et al., 1997).  In some instances a 14-3-3 dimer can also interact with a 
substrate at the extreme C-terminal mode III   –(pS/pT)x1-2-COOH motif (Coblitz et 
al., 2005).   
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Figure 1.11: Crystal structure of the human 14-3-3β dimer. 
The crystal structure of the human 14-3-3β dimer, with depictions of both the 
ribbon diagram (left) and space-filled models (right).  Each 14-3-3 monomer is 
composed of nine α-helices, and the two monomers interact via their N-terminal 
regions to form a functional dimer.  (A) The 14-3-3β dimer viewed from the side, 
showing the W shaped formation with two ligand-binding pockets.  Note that odd-
numbered helices, which are highly conserved between isoforms, form the internal 
ligand-binding grooves.  Conversely all even-numbered helices are found on the 
external surfaces of the dimer, and are more variable between isoforms.  (B) The 
14-3-3β dimer depicted from above, showing the relative positions of the nine 
helices.  (The crystal structure was obtained from RCSB Protein Data Bank; 14-3-3 
Protein Beta (Human), 2BQ0, Biological Assembly 1.  Images were created using 
Swiss-PDB viewer 4.1.0).  
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Many of the characterised 14-3-3 binding partners contain binding sequences that 
deviate to varying extents from the idealised mode I-III motifs (Johnson et al., 2010).  
It has been proposed that deviations such as these may relate to the dimeric nature 
of 14-3-3 (Tzivion et al., 2000). Each 14-3-3 monomer is capable of independent 
binding to a discrete motif in a target protein, either at two sites on the same target, 
or to two individual proteins.  Affinity of a peptide with two binding motifs for a 14-
3-3 dimer is over 30 times greater than for a ligand with a single binding site (Yaffe 
et al., 1997).  In proteins which lack a high affinity 14-3-3 binding site, a stable 
interaction may instead be achieved through coordinated binding at these two 
individual sites (Obsil et al., 2003). It may also be of physiological relevance to have 
a sub-optimal binding site as 14-3-3 dissociates more readily from these proteins 
than those containing perfect consensus motifs (Bridges & Moorhead, 2005). 
Although the majority of interactions with 14-3-3 appear to require a 
phosphorylated serine or threonine within the binding motif, there are rare 
examples of 14-3-3 interacting with non-phosphorylated targets.  These include the 
ADP-ribosyltransferase toxin Exoenzyme S which interacts with 14-3-3 via a C-
terminal DALDL motif (Masters et al., 1999), and the RhoA-specific GEF p190RhoGEF 
which is bound by 14-3-3 at the motif IQAIQNL (Zhai et al., 2001).  A synthetic R18 
peptide containing an LDL sequence was capable of binding to 14-3-3, and 
suggested that phosphorylation-independent binding of 14-3-3 is of the same 
affinity as binding at phosphorylated motifs (Wang et al., 1999). 
1.4.4 Regulation of 14-3-3 binding 
Recognition of a target motif by 14-3-3 generally requires a phosphorylated residue 
within the consensus motif (Muslin et al., 1996), a process which is regulated in vivo 
by the actions of protein kinases and phosphatases.  Kinases known to 
phosphorylate 14-3-3 motifs include Akt (Mohammad et al., 2013), PKA (Neukamm 
et al., 2013), PKC (Hunter et al., 2009), and AMPK (Shen et al., 2013).  
Dephosphorylation of residues proximal to the binding motif may also be required 
for an interaction with 14-3-3.  Phosphorylation at these sites provides an additional 
mechanism through which the interaction can be inhibited.  The tumour suppressor 
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protein p53 is phosphorylated at residues Ser376 and Ser378, with dephosphorylation 
of the Ser376 site exposing a consensus motif and leading to 14-3-3 association and 
DNA binding (Waterman et al., 1998). 
14-3-3 proteins themselves are also subject to regulation by phosphorylation 
(Mackintosh, 2004).  Residues Ser58 and Ser63 are located at the interface of the two 
monomers, and phosphorylation of Ser58 in 14-3-3ζ disrupts the dimer both in vitro 
and in vivo (Woodcock et al., 2003).  This site is conserved across all isoforms except 
for 14-3-3θ and 14-3-3σ (Wilker et al., 2005).  A further two phosphorylatable 
residues at positions Ser184 and Ser / Thr232 are situated in close proximity to the 
ligand binding groove, and phosphorylation of either residue has been shown to 
decrease binding affinity (Aitken et al., 2002; Obsilova et al., 2004).  The interaction 
between 14-3-3 and a target protein can also be regulated by the actions of small 
ligands.  Binding of 14-3-3 to the plant plasma membrane H+-ATPase is enhanced by 
fusicoccin, a molecule secreted by a plant pathogen, which acts by stabilising 
binding of H+-ATPase to the binding groove of 14-3-3 (Würtele et al., 2003).   
There is some evidence to suggest that there may be isoform-specific functions of 
some 14-3-3 proteins, adding an additional layer of regulation to these interactions.  
A number of interactome studies have been conducted to identify novel 14-3-3 
targets (Benzinger et al., 2005).   The binding proteins identified using 14-3-3σ as 
the bait showed only a 17% overlap with those which bound 14-3-3ζ, in studies 
using comparable methodologies and starting material (Bridges & Moorhead, 2005).  
Although some of this variation will be attributable to experimental conditions, or 
other regulatory mechanisms, it is likely that within this there are also examples of 
isoform-specific 14-3-3 binding.  Sequence analysis shows that 14-3-3 isoforms are 
highly conserved within the ligand-binding groove.  Helices 2, 4, 6 and 8, which form 
the outer surfaces of the dimer, are less well conserved and these amino acids may 
therefore be involved in mediating isoform-specific ligand interactions.  Of the 
human isoforms, 14-3-3σ is evolutionarily distinct from the other family members 
and crystallisation of 14-3-3σ provided a structural explanation for its specificity in 
target interactions.  A second ligand binding site, containing three residues which 
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are unique to 14-3-3σ, appears to regulate substrate discrimination (Wilker et al., 
2005).  In isoforms other than 14-3-3σ, an additional layer of complexity is added 
through the potential for hetero-dimerisation, with the possibility of certain isoform 
combinations having specific binding characteristics not present in other pairings.   
1.4.5 Modes of action of 14-3-3 proteins 
Although 14-3-3 binding can mediate a vast array of biological outcomes, the 
mechanisms of action through which these changes occur can be broadly grouped 
into three categories.  14-3-3 binding may induce a conformational change in the 
ligand, mask a specific sequence in the ligand, or act as a scaffold protein to 
enhance the interactions between the ligand and other proteins (Figure 1.12) 
(Bridges & Moorhead, 2005). 
1.4.5.1 Altering the structural conformation of a target protein 
As 14-3-3 dimers are rigid structures, substrate binding has little effect on the 
conformation of 14-3-3 itself, and instead the dimer can act as a mould for the 
target protein.  This conformational change can subsequently affect the intrinsic 
catalytic activity of the target protein.  One example of this is the serotonin-N-
acetyltransferase (AANAT), which is approximately 50% more active when 14-3-3 is 
bound than in the unbound state.  Association of 14-3-3 alters the structure of the 
catalytic domain, promoting substrate binding, and thereby enhancing melatonin 
synthesis (Obsil et al., 2001).  Conversely 14-3-3 binding can induce an allosteric 
modification that catalytically inactivates a target protein.  This is seen in plants in 
both the nitrate reductase (Athwal et al., 1998) and ATP-synthase enzymes (Bunney 
et al., 2001). 
1.4.5.2 Masking a specific sequence on the target protein 
The association of 14-3-3 with a target can prevent the ligand from localising in its 
usual site of action by masking a localisation signal, or a structural feature.  
Phosphorylation of Cdc25c facilitates binding of 14-3-3, which masks a nuclear 
localisation signal (NLS) leaving Cdc25c sequestered in the cytosol where it is unable  
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Figure 1.12: Mechanisms of action of 14-3-3 binding to a target protein 
Binding of 14-3-3 can induce a wide variety of effects on a target protein, but these 
functional outcomes can be classified into three general modes of action.  (A) 
Binding of 14-3-3 can induce a direct conformational change in a target protein, 
which may enhance or inhibit the intrinsic catalytic activity.  (B) Association of 14-3-
3 may mask a specific sequence within the target protein, which often results in a 
change in subcellular localisation of the target.  Such sequences include localisation 
signals for the nucleus or membrane, binding motifs for other proteins, or 
sequences that interact with DNA.  (C) The 14-3-3 dimer can act as a scaffold 
protein, binding to two separate proteins at each of the phosphate binding sites, 
and increasing the probability of an interaction. 
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to promote mitosis (Kumagai & Dunphy, 1999).  There is some evidence to suggest 
that this may be due to direct interaction of 14-3-3 dimers with NLS sequences 
(Obsilova et al., 2005). Alternatively, proteins such as telomerase reverse 
transcriptase (TERT) can be held in the nucleus upon 14-3-3 binding through 
masking of a nuclear export signal (NES) (Seimiya et al., 2000).  The Forkhead box O 
(FOXO) transcription factors are found in the unphosphorylated active state in the 
nucleus, and upon phosphorylation are exported to the cytosol.  Phosphorylation by 
protein kinase B (PKB) at two sites leads to 14-3-3 association and masking of the 
DNA binding domain which lies between these residues, terminating gene 
transcription (Obsil et al., 2003).   Binding of 14-3-3 is essential for the cytoplasmic 
retention of of the kinase suppressor of Ras 1 (KSR1) protein in quiescent cells.  
Cdc25C-associated kinase 1 (C-TAK1) constitutively associates with the N-terminus 
of KSR1, and phosphorylates Ser392 to facilitate 14-3-3 binding.  KSR1 is a 
cytoplasmic protein that translocates to the plasma membrane upon growth factor 
stimulation, resulting in MEK activation.  In the absence of 14-3-3, KSR1 is 
constitutively localized to the membrane resulting in hyperactivated signaling 
through the Ras / MAPK pathway (Müller et al., 2001). 
1.4.5.3 Acting as a scaffold protein to enhance protein-protein interactions 
As dimeric 14-3-3 is capable of binding to two proteins, it can act as a scaffold to 
increase the likelihood of two proteins coming together.  The first protein is bound 
to one binding pocket of the 14-3-3 dimer, and held in place bringing it in close 
proximity to the second protein that in turn binds to the other binding site (Bridges 
& Moorhead, 2005).  For example one half of a dimer can bind a protein kinase, 
with its substrate bound by the other half – thereby upon activation of the kinase 
the substrate is in close proximity ready to be phosphorylated and continue the 
downstream signalling cascade.  This scaffolding effect is known to enhance the 
phosphorylation of Tau by glycogen synthase kinase-3β (GSK-3β) (Agarwal-Mawal et 
al., 2003), and of Raf-1 by protein kinase C (PKC) (Van Der Hoeven et al., 2000).  
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1.4.6 Functions of 14-3-3 binding 
The first function attributed to 14-3-3 proteins was the regulation of serotonin and 
noradrenaline biosynthesis in the brain, through activation of tryptophan 5-
monooxygenase and tyrosine 3-monooxygenase (Ichimura et al., 1987).  Since this 
discovery the known functional roles of the 14-3-3 family have expanded 
dramatically, and they have been implicated in a vast array of both physiological 
and pathological processes.  Novel functions are continually being discovered, in 
line with the identification of new 14-3-3 binding targets by mass spectrometry (Jin 
et al., 2004), protein microarrays (Satoh et al., 2006), and in vitro affinity 
chromatography (Pozuelo Rubio et al., 2004).  Current figures estimate that there 
are now over 300 known 14-3-3 binding proteins, but for many of these the 
physiological relevance of 14-3-3 binding has yet to be determined.  Two 
characterised functions of 14-3-3 proteins are in regulating intracellular signalling 
pathways, and in coordinating the actin cytoskeleton. 
1.4.6.1 14-3-3 and regulation of intracellular signalling 
The 14-3-3 proteins have been implicated in the regulation of a wide variety of 
signalling pathways through interaction with both substrates and regulators of 
these pathways.  Raf-1, an upstream activator of MAPK signalling, has been 
identified as a 14-3-3 binding protein and contains three interaction motifs at Ser259, 
Ser621 and a third site between residues 136-187 (Tzivion et al., 1998).  Association 
with 14-3-3 holds Raf-1 in the inactive state in the absence of activation signals, 
however once these signals are present, 14-3-3 switches one of the binding sites 
resulting in Raf-1 activation and functions as a stabiliser of this active conformation 
(Fischer et al., 2009).  The growth factor receptor-bound protein 2 (Grb2) adaptor / 
GRB2-associated-binding protein 2 (Gab2) docking protein complex is also regulated 
by 14-3-3.  Binding of 14-3-3 to Gab2 at phosphorylated Ser210 and Thr391 promotes 
the dissociation of the complex, thereby reducing Gab2 signalling.  This 
phosphorylation is dependent upon the PI3K/PKD/Akt cascade (Brummer et al., 
2008). 
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1.4.6.2 14-3-3 and regulation of the actin cytoskeleton  
The apparent co-localisation of actin and 14-3-3 using confocal microscopy was first 
demonstrated in astrocytes, and was initially taken as evidence for a direct 
interaction between these two proteins (Chen & Yu, 2002).  Subsequent co-
sedimentation experiments were not able to validate this hypothesis however, and 
it is now thought that this is more likely to be an indirect link mediated through the 
direct interaction of 14-3-3 with actin-binding proteins (Birkenfeld et al., 2003).   
A number of proteins involved in regulating the cytoskeleton have been shown to 
bind 14-3-3 (Angrand et al., 2006; Jin et al., 2004; Pozuelo Rubio et al., 2004).  These 
include slingshot 1-like (SSH1L) and cortactin, both of which contain 14-3-3 binding 
motifs that are phosphorylated by protein kinase D (PKD).  SSH1L is a phosphatase 
which activates cofilin, an F-actin severing protein, through dephosphorylation of 
Ser3 (Andrianantoandro & Pollard, 2006).  SSH1L itself is activated through 
interaction with F-actin, but when bound to 14-3-3 it loses this actin-binding ability 
(Nagata-Ohashi et al., 2004).  Localisation studies confirmed that upon activation of 
RhoA, PKD phosphorylates SSH1L within its F-actin binding domain at Ser978, leading 
to 14-3-3 association, which sequesters SSH1L in the cytosol away from the actin-
rich region (Eiseler et al., 2009; Peterburs et al., 2009).  Cortactin is an F-actin 
binding protein found in a number of actin structures that interacts with the Arp2/3 
complex to enhance actin polymerisation.  Phosphorylation of the Ser298 motif by 
PKD results in 14-3-3 association and negative regulation of cortactin function 
(Eiseler et al., 2010).  
1.5 PEST-mediated protein degradation 
The synthesis and degradation of proteins is tightly regulated to ensure that 
sufficient quantities of each protein are available to meet the spatial and temporal 
requirements of a cell.  Proteins with rapidly changing requirements have short in 
vivo half-lives, and use degradation pathways as a method of regulating protein 
concentration.  When combined with the temporary termination of protein 
synthesis, this provides a mechanism by which the total intracellular pool of a 
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protein can be rapidly depleted as required.  This degradation process is largely 
mediated by the ubiquitin proteasome system, and to a lesser extent the lysosome 
pathway.  These mechanisms are also essential for the degradation of proteins that 
have been incorrectly synthesised, damaged, or mis-folded, which must be rapidly 
removed from the cell to prevent potential problems with aberrant function (Bukau 
et al., 2006).   
1.5.1 Intracellular protein half-lives 
The intracellular half-life of a protein is the time it takes for half of the protein that 
was originally synthesised within a cell to be depleted.  Intracellular half-lives of 
proteins vary dramatically depending on their function.  Ornithine decarboxylase, 
which catalyses the first committed reaction in polyamine synthesis and therefore 
needs to be tightly regulated, has an intracellular half-life of 16 minutes (Isomaa et 
al., 1983).  At the other end of the spectrum is collagen, which shows little variation 
in physiological requirements, and consequently has a calculated half-life of 117 
years (Verzijl et al., 2000).  A large-scale analysis of the intracellular turnover rates 
of over 5000 mammalian proteins showed that half-lives fit a normal distribution, 
with a median half-life of 46 hours (Schwanhäusser et al., 2013). 
1.5.2 Regulators of intracellular protein half-lives 
Several determinants of protein half-lives have been described.  The N-end rule 
predicts the stability of a protein based upon its N-terminal amino acid, and first 
originated following observations that the N-terminal residue can have dramatic 
effects on protein stability (Bachmair et al., 1986).  Mutagenesis experiments using 
the protein beta-galactosidase showed that by changing only the extreme N-
terminal residue the protein half-life could be dramatically altered.  These 
experiments have now been conducted in yeast in vivo, mammalian reticulocytes in 
vitro, and in E.coli in vivo.  The half-life of a given protein was also shown to be 
dependent upon the experimental model used (Bachmair et al., 1986; Gonda et al., 
1989; Tobias et al., 1991).  In mammalian cells the half-life of beta-galactosidase 
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with an N-terminal glutamine was less than an hour, compared to over 100 hours 
when substituted for a valine residue (Bachmair et al., 1986). 
The half-live of a protein has also been linked to the presence of specific amino acid 
sequences within a substrate that serve as targets for ubiquitination and 
subsequent degradation.  Many of these are classed as primary degrons, requiring 
phosphorylation of an internal residue(s) for activation.  Some of these motifs, such 
as DpSGXXpS, show highly conserved sequences across substrates (Liu et al., 2010; 
Zhao et al., 2010).  Others contain conserved and variable regions, including a 20-
residue motif with a core sequence of ɸ-x-x-Ala-x-x-x-Ser-x-x-Ac, where ɸ is a large 
hydrophobic residue and Ac is an acidic residue (Hofmann & Falquet, 2001).  Finally 
there are motifs that show no sequence conservation.  These include PEST motifs, 
which are short regions rich in proline, glutamic acid, serine, and threonine residues 
in no particular sequence (Rogers et al., 1986). 
1.5.3 PEST degradation motifs 
In an attempt to determine what makes some proteins degrade so much faster than 
others, Rogers et al (1986) scanned the sequence of ten proteins with intracellular 
half-lives of less than two hours.  They found that all of these proteins contained 
one or more regions that were rich in the amino acids proline (P), glutamic acid (E), 
serine (S) and threonine (T) – which they designated PEST motifs.  Analysis of 
proteins with longer half-lives indicated that they rarely contained such sequences.  
Estimates suggest that fewer than 10% of all proteins contain PEST motifs 
(Rechsteiner and Rogers, 1996).  Deletion of a PEST motif can have dramatic effects 
on the stability of a protein, with the half-life of ornithine decarboxylase increasing 
ten-fold (Ghoda et al., 1989).  Conversely, transplanting a PEST motif into a protein 
that doesn’t naturally contain one has been shown to have the opposite effect 
(Ghoda et al., 1990; Loetscher et al., 1991).   
In their initial analysis, Rogers et al (1986) noted that although all of the rapidly 
degraded proteins that they examined contained a PEST motif, not all PEST 
containing proteins were unstable.  For some proteins, such as the carboxy-
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terminus of mouse ornithine decarboxylase, the presence of a PEST motif acts as a 
constitutive signal for degradation.  However in the majority of proteins the PEST 
motif appears to act as a primary destruction signal, requiring activation by a 
second regulatory mechanism for protein degradation to occur.  This conditional 
activation can occur through a number of mechanisms.  Phytochrome has a half-life 
of approximately 100 hours before light activation induces a conformation change, 
thought to expose a PEST motif, which dramatically decreases the half-life to just 
one hour.  Tetramerisation of the regulatory and catalytic subunits of cAMP-
dependent protein kinase increases the protein half-life from one to ten hours 
compared to the monomers, which is likely to be caused by masking of external 
PEST motifs (Rechsteiner, 1990).  However by far the most common regulatory 
mechanism identified is phosphorylation of the PEST motif at the integral serine and 
threonine residues (Rechsteiner & Rogers, 1996).  Regardless of the mechanism, 
activation of a PEST domain acts as a signal for ubiquitination and subsequent 
degradation of the protein (Rechsteiner & Rogers, 1996). 
1.5.4 Ubiquitination of degradation substrates  
Ubiquitin is a 76 amino acid protein that is enzymatically attached to proteins 
destined for degradation.  As it targets primary degrons within proteins, ubiquitin is 
classed as a secondary degron.  The sequential addition of multiple ubiquitin tags to 
internal lysine residues of substrates allows the protein to be recognised by the 
proteolytic machinery and subsequently to be degraded (Varshavsky, 1991).   
Three enzymes, E1, E2, and E3, control the addition of ubiquitin to proteins being 
targeted for destruction (Figure 1.13).  E1 is the ubiquitin-activating enzyme, which 
binds to the C-terminus of ubiquitin at Gly76 in an ATP-dependent reaction.  The 
ubiquitin moiety is then transferred to a cysteine residue on one of the E2 ubiquitin-
conjugating enzymes.  The E2 enzyme then associates with E3, the ubiquitin protein 
ligase, which facilitates the polymerisation of one or more ubiquitin molecules onto 
the substrate (Figure 1.13).  In mammalian cells only a single E1 protein has been 
identified, however there are over 30 E2 enzymes and over 1000 different forms of 
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Figure 1.13: Ubiquitination of target proteins. 
Ubiquitination of proteins in vivo is catalysed by the E1-E3 ubiquitin enzymes.  
Initially a single ubiquitin group is bound to the E1 ubiquitin-activating enzyme in an 
ATP-dependent reaction (1).  The ubiquitin group is then transferred to one of the 
E2 ubiquitin-conjugating enzymes, and the unbound E1 recycled (2).  E2 then 
associates with one of the hundreds of E3 ubiquitin-ligases, which transfers 
ubiquitin groups to the target protein (3).  This process is reversible, and ubiquitin 
groups may also be removed through the actions of de-ubiquitinating enzymes (4).  
A protein with four or more attached ubiquitin groups is a target for degradation via 
the proteasome. 
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E3.  The functions of the majority of these variants are not yet known, but the large 
number of proteins at the E2 and E3 stages enables the cell to have greater control 
over protein degradation.  For a substrate to be recognised for proteolysis, it needs 
to be conjugated to a chain of four or more ubiquitin molecules.  Whilst the E1-3 
enzymes catalyse the polymerisation of these chains, there are also a large family of 
de-ubiquitinating enzymes that can reverse this process.  This removal of ubiquitin 
groups provides an additional method of regulating the degradation process. 
1.5.5 Degradation pathways 
Two main structures mediate protein degradation in eukaryotic cells – lysosomes 
and proteasomes (Figure 1.14), and PEST-mediated proteolysis can involve either of 
these mechanisms (Rechsteiner & Rogers, 1996).   
1.5.5.1 Proteasomal degradation 
Proteasomes are responsible for the degradation of the majority of intracellular 
proteins, either those identified as being mis-folded or those targeted for 
degradation through activation of signalling pathways and subsequent 
phosphorylation (Rock et al., 1994).  The 26S proteasome is a 1.5 MDa complex 
consisting of over 60 proteins.  These can be divided into 2 sub-domains; a central 
catalytic 20S core particle (CP) with 19S regulatory particle (RP) capping either one 
or both ends (Figure 1.14).  The 20S CP forms a cylindrical structure composed of 
four layers of seven-subunit rings, with two interior β layers and two outer α layers.  
The 19S RP can be further divided into a base structure, and a lid complex. 
A protein conjugated to a chain of ubiquitin molecules signals to the proteasome 
that it is a substrate for degradation.  Ubiquitin is recognised by the 19S cap of the 
proteasome, which opens the outer α-ring to allow substrates into the central 20S 
domain (Baboshina & Haas, 1996).  Proteins are unravelled by 19S and inserted into 
the central core, which contains proteases that digest the internalised proteins into 
short peptides.  The ubiquitin molecules are not taken into the proteasome, but 
instead are released back into the cytosol and recycled (Kisselev et al., 1999). 
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1.5.5.2 Lysosomal degradation 
There is evidence that PEST mediated degradation may also occur through the 
lysosomal pathway (Zhuang et al., 2012).  Lysosomes are membrane-bound vesicles 
located in the cytoplasm that contain a wide range of proteases and other 
hydrolytic enzymes.  They commonly degrade extracellular and transmembrane 
proteins that are brought into the cell in endocytotic vesicles (Figure 1.14).  
Cytosolic proteins may also be degraded in lysosomes if they are first engulfed in 
autophagic vesicles that fuse with lysosomes.  This mechanism also regulates the 
digestion of intracellular organelles (Figure 1.14). 
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Figure 1.14: The proteasomal and lysosomal pathways of protein degradation 
Intracellular protein degradation is mediated by two main pathways, the ubiquitin-
proteasome pathway, and the lysosomal degradation pathway.  Ubiquitin targets 
mis-folded or phosphorylated proteins to the proteasome where they are degraded 
into small peptides.  Lysosomal degradation is commonly associated with the 
degradation of external and membrane proteins, in addition to intracellular 
organelles such as mitochondria. 
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1.6 Thesis aims 
There is currently very little understanding of how dematin is regulated in vivo, and 
in particular what coordinates its ability to both bind and bundle actin.  Given the 
ubiquitous expression of dematin, gaining a better understanding of this regulation 
has widespread implications not only for the known functions of dematin, but for 
those that have yet to be discovered.  This thesis therefore aims to investigate the 
potential regulation of dematin by the p38 MAPK, and the adaptor protein 14-3-3, 
both of which have increasingly well documented roles in cytoskeletal regulation.  
Significant expression of dematin has been demonstrated in skeletal muscle and the 
C2C12 skeletal muscle cell line will therefore be used as a model system for 
investigating the regulation of dematin.      
1.6.1 Aim 1 - To characterise the regulation of dematin by the p38 MAPK 
Preliminary data from our lab has identified dematin as a novel substrate of the p38 
MAPK (Müller 2010, unpublished).  Furthermore, the primary sequence of dematin 
contains a number of phosphorylation motifs for the p38 MAPK (Figure 1.2).  This 
thesis therefore aims to characterise the regulation of dematin by p38, with 
particular focus on PEST-mediated dematin instability and the core / HP interaction. 
Objectives: 
 To use a multi-technique approach to confirm that dematin is 
phosphorylated by p38, and begin to characterise the specific motifs in 
dematin that are phosphorylated both in vitro and in vivo. 
 To assess whether the stability of dematin is regulated by its PEST 
degradation motif, and to determine whether p38 phosphorylation of 
internal residues within the motif regulates the degradation process. 
 To identify the region of the dematin core domain that the HP binds to, and 
to determine whether p38 phosphorylation of the HP has a regulatory 
effect on this interaction. 
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1.6.2 Aim 2 - To characterise the regulation of dematin by 14-3-3 
The 14-3-3 family are known to regulate the functions of a number of cytoskeletal 
proteins.  Analysis of the primary sequence of dematin identified seven potential 
14-3-3 binding motifs (Figure 1.2), suggesting that dematin may be a novel binding 
partner.  This thesis therefore aims to characterise both the interaction and 
function of the dematin / 14-3-3 association.  
Objectives: 
 To determine whether dematin and 14-3-3 interact, to identify the 14-3-3 
consensus motifs that are phosphorylated in vivo, and to confirm the 
specific motifs that are responsible for this interaction 
 
 To identify which kinases phosphorylate the 14-3-3 binding motifs in 
dematin to facilitate a dematin / 14-3-3 interaction, and to determine 
whether p38 phosphorylation of neighbouring residues negatively regulates 
this interaction 
 
 To characterise the function of the dematin / 14-3-3 interaction in C2C12 
skeletal muscle cells, with particular focus on the known actin-binding and -
bundling abilities of dematin 
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2.1 Suppliers of reagents and chemicals 
Plastic lab-ware, including cell culture dishes and plates, were purchased from 
Beckton Dickinson (UK).  Reagents were obtained from a variety of companies, as 
detailed at the relevant points throughout the methods.  Chemicals were obtained 
from Fisher (UK) unless otherwise stated in the text. 
2.2 Growth and maintenance of E.coli 
2.2.1 Media 
Liquid E.coli cultures were grown aerobically in Luria-Bertami medium (LB) (10 g/l 
NaCl; 10 g/l bactotryptone; and 5 g/l yeast extract) at 37°C with shaking at 220 rpm.  
E.coli cells were also grown on plates containing 16% (w/v) agar in LB, which were 
cultured at 37°C.  Antibiotics were used in both solid and liquid cultures when 
required; 100 µg/ml ampicillin or 25 µg/ml kanamycin (Sigma, UK).    
2.2.2 Preparation of competent E.coli cells 
Starter cultures were prepared by inoculating 5 ml of LB with a single colony of 
TOP10 E. coli cells (Invitrogen, UK) and incubating overnight at 37°C with shaking at 
220 rpm.  This was used to inoculate 400 ml of LB, which was incubated at 37°C with 
shaking until it reached an OD590nm  = 0.35-0.4.  The culture was divided into 8 x 50 
ml aliquots and cooled on ice for 10 minutes.  Cells were pelleted at 4000 x g at 4°C 
for 15 minutes, and each aliquot resuspended in 10 ml sterile-filtered ice-cold 
calcium buffer (60 mM CaCl2, 15% (v/v) glycerol, 10 mM pipes; pH 7.0).  Cells were 
then re-pelleted under the same conditions, resuspended in calcium buffer, and 
incubated on ice for 30 minutes.  Following a final centrifugation, pellets were 
gently resuspended in 2 ml of ice-cold calcium buffer and aliquots stored at -80°C. 
2.2.3 Transformation of competent E.coli cells 
TOP10 competent E.coli cells (section 2.2.2) were transformed with 50 - 100 ng of 
plasmid DNA.  Following 30 minutes incubation on ice, the DNA and cell mix was 
heat-shocked at 42C for 45 seconds.  After cooling on ice, samples were combined 
with 1 ml LB and incubated at 37C for 1 hour with shaking at 220 rpm.  Samples 
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were centrifuged at 5,000 x g for 2 minutes, supernatants removed and pellets 
resuspended in LB.  Cells were plated onto LB agar plates containing the relevant 
antibiotic and incubated for 16-18 hours at 37C. 
2.3 DNA manipulation  
2.3.1 DNA purification 
Small-scale plasmid DNA isolation (1.5 ml of a 5ml LB culture) was conducted using 
a GeneJet Plasmid MiniPrep Kit (Thermo Scientific, UK).  DNA extraction was 
performed according to the standard protocol, and eluted in 100 µl of buffer.  Large 
scale DNA extraction (from 200 ml LB cultures) was conducted using the PureYield 
Midiprep System (Promega, UK) according to the standard vacuum-pump protocol 
with elution in 1 ml nuclease-free water.  DNA concentration and purity were 
quantified using 1.5 μl samples on a Nanodrop ND1000 Spectrophotometer with 
NanoDrop 1000 3.6.0 software (Thermo Scientific, UK).  The A260:280 nm and 
A260:230 nm ratios were used to asses DNA purity, with accepted values of ≈ 1.8 
and 2.0-2.20 respectively.  Samples were stored at -20C. 
2.3.2 DNA oligonucleotides 
DNA oligonucleotides (Invitrogen, UK or Sigma, UK) were synthesised on a 25 nmol 
scales with desalting.  Primer pairs were designed to have melting temperature 
within 5C of one another, and minimal predicted dimer formation.  Lyophilised 
primers were resuspended in sterile distilled water at a concentration of 100 µM 
and stored at -20C. 
2.3.3 Polymerase chain reaction (PCR) 
PCR reactions were conducted in 25 µl volumes containing 50 ng template DNA, 0.1 
µM each of sense and antisense primers, 0.2 mM dNTPs (from single nucleotide 
stocks), 1x Pfu buffer with 1.5 mM MgSO4 and 0.5 units Pfu DNA polymerase (all 
Promega, UK).  PCR was performed on an Eppendorf Mastercycler personal thermal 
cycler (Eppendorf, Germany) with a heated lid (105C) using the following 
conditions:  
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Initial denaturation  95C  3 minutes                    
Denaturation   95C  30 seconds                            
Annealing    Tm - 5C 3 minutes             30 cycles                     
Extension    72C  2 min / Kb                                                        
Final extension   72C        15 minutes                                    
Hold    4C 
PCR primers were designed to amplify the gene of interest, and add a unique 
restriction site onto the 3’ and 5’ ends of the PCR product to facilitate high 
efficiency cloning into the pENTR11 entry vector.  The primer sequences, template 
DNA, and melting temperature (Tm) used for each reaction are detailed in (Table 
2.1). 
2.3.4 Agarose gel electrophoresis 
Agarose gels were prepared by dissolving 1-2% agarose (w/v) in Tris / Borate / EDTA 
(TBE) buffer (89 mM Tris; 89 mM H3BO3; 2 mM EDTA, pH 8.0), with 0.5 µg/ml 
ethidium bromide (Sigma, UK).  DNA samples were combined with 5x loading buffer 
(Fermentas, UK) and the gels electrophoresed at 100 V in TBE buffer.  Images were 
captured using a GelDoc 2000 UV transilluminator with Quantity One software 
(BioRad, UK). 
2.3.5 Restriction endonuclease digests of DNA 
PCR amplified DNA products were digested with the relevant restriction enzymes 
(Table 2.1) to produce compatible ends for ligation reactions.  Restriction 
endonuclease digestion was conducted according to the standard manufacturer’s 
protocol, with incubation at 37°C for approximately 3 hours.  The number of units of 
each restriction enzyme required per µg of DNA was calculated relative to the 
reference information for the digestion of linear lambda DNA.  The volume of 
restriction enzymes was kept below 10% of the total reaction volume. 
2.3.6 Phenol-chloroform DNA extraction and ethanol precipitation 
Restriction digested PCR products were purified using phenol extraction and 
ethanol precipitation.  DNA samples were mixed with equal volumes of phenol /
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Name Primer Sequence (5’-3’) 
Restriction 
Site 
Template 
DNA 
Product 
size 
(bp) 
Dematin 
for TACCATGGAACGGCTGCAGAAGCAACCAC NcoI 
Origene EPB49 
(BC017445) 
Human cDNA 
Clone 
(Origene, USA) 
1418 
rev ATCTCGAGTCAGAAGAGAGAGGCCTTCTTCTTGAGCTC XhoI 
N1 
for TACCATGGAACGGCTGCAGAAGCAACCAC NcoI 
pENTR11FLAG-
dematin 
234 
rev TACTCGAGCTACAGCTCCACGTGTTCCAGGAGGGAAT XhoI 
N2 
for TACCATGGAACGGCTGCAGAAGCAACCAC NcoI 
pENTR11FLAG-
dematin 
588 
rev TTCTCGAGCTACGGGGGGCATGGCCAGTAGTCG XhoI 
N3 
for AGCCATGGATTCCCTCCTGGAACACGTGGA NcoI 
pENTR11FLAG-
dematin 
384 
rev TTCTCGAGCTACGGGGGGCATGGCCAGTAGTCG XhoI 
C1 
for AAGCCATGGCGGTTACTTCCAACTTGGGAAAGATGA NcoI 
pENTR11FLAG-
dematin 
489 
rev ATCTCGAGTCAGAAGAGAGAGGCCTTCTTCTTGAGCTC XhoI 
DHP 
for AACCATGGGGGAGAACCTGTACTTCCAGGGCCCAGGCCT NcoI 
pENTR11FLAG-
dematin 
204 
rev ATCTCGAGTCAGAAGAGAGAGGCCTTCTTCTTGAGCTC XhoI 
DHP+22 
for TACCATGGACCAGGCCTGCAGAACGGAGAG NcoI 
pENTR11FLAG-
dematin 
270 
rev ATCTCGAGTCAGAAGAGAGAGGCCTTCTTCTTGAGCTC XhoI 
 
Table 2.1: Primers 
for the PCR 
amplification of 
genes of interest 
Provided are the 
sequences and 
details of the PCR 
primer us d in this 
study.  Cloning 
restriction sites are 
shown in are bold 
and underlined. 
 
 
Chapter 2 - Materials and Methods 
 
56 
 
/ chloroform / iso-amyl alcohol (25:24:1 v:v:v ratio), vortexed thoroughly and 
centrifuged for 15 seconds at 14,000 x g.  The top aqueous layer was removed and 
combined with 1/10 volume of 3 M sodium acetate (pH 5.2), followed by 2.5 
volumes of ice cold 100% ethanol and incubated on dry ice for 15 minutes.  After a 
5-minute centrifugation at 14,000 x g, the supernatant was removed and the pellet 
washed twice with 1 ml of 70% ethanol.  Pellets were dried in an Eppendorf 
Concentrator Plus (Eppendorf, UK) for 5 minutes and resuspended in the required 
amount of sterile distilled water.  
2.3.7 Preparation of vector DNA 
All genes were initially cloned into a pENTR11 entry vector (Figure 2.1) for use with 
the Gateway® expression system (Invitrogen, UK).  The vectors used in this study 
were modified forms of the commercially available pENTR11, which had been 
altered to contain either a FLAG or MYC protein tag at the 5’ end of the multiple-
cloning site.  pENTR11FLAG or pENTR11MYC vectors were digested with the 
relevant restriction enzymes as in section 2.3.5.  The digested vector was then 
dephosphorylated to minimise self-ligation.  This was conducted using 0.5 U/µg 
vector DNA of CIP alkaline phosphatase (New England Biolabs, UK) with one hour 
incubation at 37C.  Digested pENTR11 vector DNA was electrophoresed and the 
desired band (of approximately 2200 bp) was excised from the gel.  DNA extraction 
was conducted using a GenElute Gel Extraction Kit (Sigma, UK) according to the 
manufacturer’s guidelines, and eluted in the appropriate volume of buffer for 
subsequent procedures. 
2.3.8 DNA Ligation and product verification 
Following enzyme digests the relevant inserts were ligated into the pENTR11 entry 
vector in 10 µl reactions with insert : vector DNA ratios of between 1:3 and 3:1, 1 µl 
T4 DNA ligase buffer and 0.5 units T4 DNA ligase.  Samples were incubated at 16C 
for 18 hours before transformation in TOP10 E.coli cells (section 2.2.3).  Overnight 
cultures inoculated with single colonies were prepared in LB supplemented with 25 
µg/ml kanamycin.  Test digests with relevant restrictions enzymes were performed 
to identify successful ligation reactions.  Enzymes were chosen to digest both the
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Figure 2.1: Gateway DNA entry and expression vectors used in this study 
All DNA constructs were first cloned into the kanamycin resistant pENTR11 entry 
vector (A) for use with the Invitrogen gateway system.  The attL1 and attL2 
recombination sites allowed efficient transfer into a variety of mammalian 
expression vectors - (B) a modified version of the commercial pcDNA3.1 shown here 
that has with the gateway transfer cassette cloned into the XbaI / HindIII sites 
(referred to as pcDNA3.1-DEST), and (C) the standard destination vectors pT-Rex-
DEST30 and pDEST27.  These were selected on the basis of the properties required 
in each individual experiment.  All of the expression vectors express the CMV 
immediate-early promoter/enhancer for efficient, high-level expression of the 
recombinant protein, and an ampicillin resistance gene to allow selection.   
A             B 
C 
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insert and the vector, and produce DNA fragments that were easily distinguishable 
from incorrectly ligated products by gel electrophoresis. 
2.3.9 Gateway® recombination cloning 
Gateway cloning® of successfully ligated constructs from pENTR11 entry vectors 
into mammalian expression vectors was conducted according to the standard 
Invitrogen protocol.  Reactions of 5 µl containing 75 ng of entry vector DNA in the 
pENTR11 vector, 75 ng of destination plasmid DNA and 2 µl TE buffer (pH 8.0) were 
incubated at 25C for 90 minutes with 1 µl of LR Clonase enzyme II mix (Invitrogen, 
UK).  The reaction was terminated by the addition of 1 µl Proteinase K (Invitrogen, 
UK), and incubated for 10 minutes at 37C.  The destination vectors used in this 
study were a version of pcDNA3.1 which was modified to contain the necessary 
Gateway® recombination sequences, pT-RExDEST30, and pDEST27.  These were 
selected according to the properties required for each specific experiment (see 
Figure 2.1 for further details).  The total 6 µl gateway reaction was transformed into 
TOP10 competent E.coli cells (section 2.2.3).  Successfully ligated clones were 
identified by conducting test digests with the appropriate restriction enzymes. 
2.3.10 Plasmids 
Details of the pENTR11 entry-vector and pcDNA3.1, pTrexDEST30, and pDEST27 
expression-vector plasmids created for use in this study are provided in Table 2.2. 
2.3.11 Sequencing of plasmid DNA 
Sequencing was performed externally (GATC, UK).  Sequencing reactions of 10 µl 
contained 100-500 ng plasmid DNA and 2.5 µM sequencing primer.  The sequences 
obtained were compared to the expected sequences using Clustal-X alignment 
software (European Bioinformation Institute, UK).  Details of the sequencing 
primers used are provided in Table 2.3. 
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Table 2.2: Plasmids created for use in this study 
Dematin constructs were first cloned into the pENTR11 entry vector, before 
gateway transfer into pcDNA3.1, pTrexDEST30, or pDEST27 as required.  The 
protein molecular weight (MW) refers to the mass of the protein product that is 
expressed upon transfection of mammalian cells with a given construct. 
Insert Vector 
Plasmid size 
(bp) 
Protein MW 
(KDa) 
Antibiotic 
Resistance 
Dematin 
pENTR11FLAG 3957 / kanamycin 
pTrexDEST30FLAG 8335 56.1 ampicillin 
pDEST27FLAG 7656 83.4 ampicillin 
N1 
pENTR11FLAG  2773 / kanamycin 
pcDNA3.1FLAG 5501 11.6 ampicillin 
pDEST27FLAG 6472 38.9 ampicillin 
N2 
pENTR11FLAG 3127 / kanamycin 
pcDNA3.1FLAG 5855 24.7 ampicillin 
pDEST27FLAG 6826 52.0 ampicillin 
N3 
pENTR11FLAG 2923 / kanamycin 
pcDNA3.1FLAG 5651 18.1 ampicillin 
pDEST27FLAG 6622 45.4 ampicillin 
C1 
pENTR11FLAG 2974 / kanamycin 
pcDNA3.1FLAG 5702 22.3 ampicillin 
pDEST27FLAG 6673 49.6 ampicillin 
DHP 
pENTR11FLAG 2743 / kanamycin 
pTrexDEST30FLAG 7481 11.5 ampicillin 
pDEST27FLAG 6442 38.8 ampicillin 
DHP+22 
pENTR11FLAG 2809 / kanamycin 
pTrexDEST30FLAG 7187 12.7 ampicillin 
pDEST27FLAG 6506 40.0 ampicillin 
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Table 2.3: Sequencing primers used in this study 
All cloned and mutagenised plasmids were sequenced to confirm that the correct 
products had been created.  Constructs in the pENTR11 entry vector were 
sequenced with pENTR11-forward and/or pENTR11-reverse, which recognise the 
ATTL recombination sites preceding and succeeding the start and stop codons.  The 
T7 primer was used to sequence plasmids in either the pTrexDEST30 or pDEST27 
vectors, which both contain a T7 reverse priming site at the C-terminal end of the 
insert. 
Primer Target Primer sequence (5’ - 3’) 
pENTR11-forward attL1 TAAGCAGAAGGCCATCCTCACG 
pENTR11-reverse attL2 GTAACATCAGAGATTTTGAGACAC 
T7-forward T7 TAATACGACTCACTATAGGG 
Bgh reverse Bgh TAGAAGGCACAGTCGACG 
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2.3.12 Mutagenesis of plasmid DNA 
Single point mutations were introduced in plasmid DNA using the QuikChange 
Site-Directed Mutagenesis Kit (Stratagene, USA).  This was conducted according the 
standard manufacturer’s protocol, except for the use of Pfu DNA polymerase 
instead of Pfu Turbo.  All mutagenesis reactions were conducted in 25 µl volumes 
containing 50 ng of template DNA, 60 ng each of sense and antisense primers, 0.2 
mM dNTPs, 1x Pfu buffer with MgSO4 and 0.5 units Pfu DNA polymerase.  The 
following thermal cycling conditions were used: 
Initial denaturation  95C  30 seconds                    
Denaturation   95C  30 seconds                            
Annealing    55C  1 minute                16 cycles                     
Extension    68C  2 min / Kb                                     
Hold    4C     
The reaction was incubated with 1 µl of DpnI for 3 hours at 37C to digest 
methylated template DNA.  Reactions were transformed into TOP10 E.coli as in 
section 2.2.3, and transformants selected on agar plates containing the appropriate 
antibiotic.  Colonies were used to inoculate 5 ml cultures and the DNA extracted as 
in section 2.3.1.  Where possible the introduced diagnostic restriction site was used 
to facilitate easy identification of correct mutants (see Table 2.4 and Table 2.5 for 
specific sites).  Multiple amino acid changes in a single plasmid were created by 
sequentially introducing individual mutations using the above method. 
2.3.13 Mutagenesis primers 
Primers for the mutagenesis of plasmid DNA were designed according to 
manufacturer’s specifications for use with the QuikChange Site-Directed 
Mutagenesis Kit.  When possible, primers were designed to introduce a diagnostic 
restriction site into the mutated region, without changing the surrounding amino 
acid sequence.  Mutagenesis was used to introduce serine / threonine to alanine, 
aspartic acid, or glutamic acid mutations of kinase phosphorylation sites, using the 
primers provided in Table 2.4 and Table 2.5.  Mutagenesis was also for sequence 
deletions, as detailed in Table 2.6. 
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Table 2.4: Primers for the mutagenesis of p38 phosphorylation motifs 
Serine residues (S) within p38 phosphorylation motifs were mutated to alanine (A), 
aspartic acid (D), or glutamic acid (E) residues using site directed mutagenesis.  
Diagnostic restriction sites were introduced to identify positive mutants.  Amino 
acid changes are underlined, with bases in bold type indicating those that are 
different to the wild-type sequence. 
Mutation Primer Primer sequence 5’ - 3’ 
Restriction 
site added 
S11A 
For CAGAAGCAACCACTTACGGCGCCCGGGAGCGTG NarI 
GG/CGCC Rev CACGCTCCCGGGCGCCGTAAGTGGTTGCTTCTG 
S16A 
For CCCGGGAGCGTGGCGCCCTCCCGAGATTCCAG NarI 
GG/CGCC Rev CTGGAATCTCGGGAGGGCGCCACGCTCCCGGG 
S26A 
For CAGTGTGCCTGGCGCCCCCTCCAGCATCG NarI 
GG/CGCC Rev CGATGCTGGAGGGGGCGCCAGGCACACTG 
S87A 
For CGCGAGCGCTCGCTGGCGCCCAAATCCAC NarI 
GG/CGCC Rev GTGGATTTGGCGCCAGCGAGCGCTCGCG 
S87E 
For CGCGAGCGCTCGCTGGAGCCCAAATCCAC 
(no site) 
Rev GTGGATTTGGGCTCCAGCGAGCGCTCGCG 
S92A 
For CCCAAATCCACAGAGCCCCCACC NarI 
GG/CGCC Rev GGTGGGGGCTCTGTGGATTTGGG      
S92E 
For CCCAAATCCACAGAGCCCCCACC 
(no site) 
Rev GGTGGGGGCTCTGTGGATTTGGG 
S96A 
For CCCCCACCGGCGCCAGAGGTGTGGGCGGACAGCCGG NarI 
GG/CGCC Rev CCGGCTGTCCGCCCACACCTCTGGCGCCGGTGGGGG 
S96E 
For CCCCCACCAGAGCCAGAGGTGTGGGCGGACAGCCGG 
(no site) 
Rev CCGGCTGTCCGCCCACACCTCTGGCTCTGGTGGGGG 
S105A 
For CGGACAGCCGGGCGCCTGGAATCATC NarI 
GG/CGCC Rev GATGATTCCAGGCGCCCGGCTGTCCG 
S105E 
For CGGACAGCCGGGAGCCTGGAATCATC 
(no site) 
Rev GATGATTCCAGGCTCCCGGCTGTCCG 
S383A 
For CTCAAGGGTATTTGCCATGGCGCCTGAAGAGTTTGGCAAG NarI 
GG/CGCC Rev CTTGCCAAACTCTTCAGGCGCCATGGCAAATACCCTTGAG 
S383D 
For CTCAAGGGTATTTGCCATGGATCCTGAAGAGTTTGGCAAG 
BamHI 
Rev CTTGCCAAACTCTTCAGGATCCATGGCAAATACCCTTGAG 
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Table 2.5: Primers for the mutagenesis of 14-3-3 binding motifs 
Serine (S) residues within 14-3-3 binding motifs were mutated to alanine (A) 
residues using site directed mutagenesis.  Diagnostic restriction sites were 
introduced to identify positive mutants.  Amino acid changes are underlined, with 
bases in bold type indicating those that are different to the wild-type sequence. 
Mutation Primer Primer sequence 5’ - 3’ 
Restriction 
site added 
S22A 
For CCCTCCCGAGATTCCGCGGTGCCTGGCTCTCCCTC     SacII 
CCGC/GG Rev GAGGGAGAGCCAGGCACCGCGGAATCTCGGGAGGG     
S85A 
For CCGCGAGCGCGCGCTGTCACCCAAATC    BssHII 
G/CGCGC Rev GATTTGGGTGACAGCGCGCGCTCGCGG 
S269A 
For GGAAAACCCGCGCGCTGCCTGACCGGAC BssHII 
G/CGCGC Rev GTCCGGTCAGGCAGCGCGCGGGTTTCC 
S289A 
For CGTCTAAATCTTCAGCGCTCCCCGCCTATGGC AfeI 
AGC/GCT Rev GCCATAGGCGGGGAGCGCTGAAGATTTAGACG 
S333A 
For GGATGGACCGGGGGAAAGCGCTGCCCTGTGTGCTGG AfeI 
AGC/GCT Rev CCAGCACACAGGGCAGCGCTTTCCCCCGGTCCATCC 
S403A 
For CAAGAAGAAGGCCGCTCTCTTCTGACTCGAG 
(no site) 
Rev CTCGAGTCAGAAGAGAGCGGCCTTCTTCTTG   
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Table 2.6: Mutagenesis primers for the deletion of regions of interest 
Site directed mutagenesis was used to delete the headpiece insert of dematin, and 
the PEST motif.  Primer sequences are given, with ___ indicating the region that has 
been deleted. 
Deletion 
Construct 
created 
Primer Primer sequence 5’ - 3’ 
Headpiece 
Insert  
(aa 320-341)  
Dematin48 
For GGAAGCCCAGGCCTGCAGA___TCTATCCCTATGAAATG 
Rev CATTTCATAGGGATAGA___TCTGCAGGCCTGGGCTTCC 
PEST motif  
(aa 89-104) 
Dematin_ 
ΔPEST 
For GCGCTCGCTGTCACCC___TCGCCTGGAATCATC    
Rev GATGATTCCAGGCGA___GGGTGACAGCGAGCGC        
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2.4 Culture of mammalian cell lines 
Cell culture procedures were performed in a class II microbiological safety cabinet 
(Walker, UK) under sterile conditions.  All media and reagents were filter-sterilised 
through a 0.22 µM filter, and warmed to 37°C prior to use.  Cells were maintained in 
a CO2 incubator (Sanyo, UK) at 37°C with 5% CO2 in a humidified atmosphere.  
Cultured cells were visualised using a Nikon Eclipse TS1500 inverted light-
microscope (Nikon, UK). 
2.4.1 Culture of HEK293T Cells 
Human Embryonic Kidney (HEK) 293T cells (ATCC, USA) were cultured in Dulbecco’s 
Modified Eagles Medium (DMEM; Gibco, UK) supplemented with 10% Foetal Bovine 
Serum (FBS; Biosera, UK) and 100 units/ml of Penicillin/Streptomycin (PenStrep; 
Gibco, UK).  Cells were removed for passaging by washing with PBS, and pelleted 
with centrifugation at 130 x g for 4 minutes.  Cells were resuspended in the relevant 
volume of media and seeded in appropriate culture vessels at the required density. 
2.4.2 Transient transfection of HEK293T cells using calcium phosphate 
24 hours prior to transfection HEK293T cells were seeded at a density of 1.4 x 106 
cells per 100 mm plate, or 5 x 105 cells per 60 mm plate, as required.  Media was 
replaced 2-4 hours before transfection.  Per 1 ml of transfection reagent 500 µl 
DNA/calcium solution (20 µg of plasmid DNA, 50 µl 2.5 M CaCl2 in water) was added 
dropwise to 500 µl HBS with vortexing, mixed thoroughly and incubated at room 
temperature for 20 minutes.  The solution was added to cells (1 ml / 100 mm plate, 
333 µl / 60 mm plate) and incubated at 37C.  Culture media was replaced 24 hours 
after transfection, and cells lysed for analysis after a further 24 hours. 
2.4.3 Culture of C2C12 Cells 
C2C12 mouse pre-myocytes (ATCC, USA) were cultured in low-glucose (5.5 mM) 
DMEM (Gibco, UK) supplemented with 10% FBS and 100 units / ml PenStrep.  Cells 
were removed for passaging with a 5 minute incubation at 37°C with trypsin-EDTA 
(0.25% v/w trypsin with 0.53 mM EDTA in HBSS; GIBCO, UK), and the enzyme 
inhibited with 5 ml of culture medium.  Cells were centrifuged at 130 x g for 4 
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minutes and the cells resuspended and seeded as required.  Cells were maintained 
at 10 - 60% confluence to prevent contact mediated differentiation.  To 
differentiate C2C12 cells from myocytes to myotubes, cells were grown to 
approximately 80% confluence in normal growth medium before being switched to 
low-serum DMEM containing 2% Horse serum.  Cells were incubated at 37°C for 5-
10 days as required, and the media replaced every 2-3 days.  Differentiation was 
assessed by monitoring the distinct morphological changes in the cells, from 
compact individual myocytes to elongated multi-nucleated myotubes.   
2.4.4 Transient transfection of C2C12 myocytes by electroporation 
C2C12 cells for use in immunofluorescence experiments were transfected using 
electroporation.  Cells at 50-60% confluence were trypsinised, pelleted at 130 x g 
for 4 minutes, and resuspended in 1 x HBS at a concentration of 2 x 106 cells / ml.  
10 µg of the relevant DNA was added to each 0.4 cm electroporation cuvette 
(BioRad, UK), followed by 400 µl of cell solution, and flicked thoroughly to mix.  Cells 
were electroporated using the Gene Pulser MXcell™ Electroporation System, with a 
ShockPod™ Cuvette Chamber attachment (BioRad, UK), under the following 
conditions: 
Pulse type   Square wave                                                                                                         
Number of pulses  1                                                                                 
Pulse duration   25 ms                                                     
Capacitance   960 µF                                                                   
Voltage               350 V                                                                  
Resistance   ∞ Ω 
 
Electroporated cells were transferred to the appropriate culture vesicle containing 
complete culture media, and incubated at 37°C for 2 days until the desired 
confluence was reached.  Culture media was replaced after 24 hours. 
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2.4.5 Transient transfection of C2C12 myocytes using PEI 
Cells were seeded at a density of 2.8 x 106 / 100 mm dish at 24 priors to transfection, 
to be approximately 60% confluent at the time of transfection.  Per 100 mm dish, 
800 µl serum-free low-glucose DMEM was combined with 16 µg of DNA.  After the 
addition of 100 µl of 1 mg/ml branched polyethylenimine (PEI; Sigma, UK) samples 
were immediately pulse-vortexed 15 times.  Solutions were incubated at room 
temperature for 10 minutes before the addition of 5 ml low-glucose DMEM.  
Culture medium was removed from the cells, and the total volume of transfection 
mix evenly distributed across the plate.  Cells were incubated for 3 hours at 37°C 
before the addition of a further 5 ml of media.  Cells were used for subsequent 
experiments 48 hours post-transfection. 
2.4.6 Activation and inhibition of protein kinases 
Cells were treated with a number of different compounds to determine the effects 
of activation or inhibiting protein kinases of interest.  The concentrations and 
treatment times for each compound are shown in Table 2.7. 
2.4.7 Cryopreservation of cell lines 
Cells were resuspended in complete culture medium containing 10% DMSO, and 
aliquotted into 1 ml volumes into cryovials.  Vials were placed inside polystyrene 
inserts to slow the freezing process, and placed at -80C for 2 days before being 
transferred to liquid nitrogen for long-term storage.  On revival cells were rapidly 
defrosted in a 37C waterbath, resuspended in 5 ml of complete culture medium, 
and centrifuged at 130 x g for 4 minutes to remove all DMSO.  Pellets were 
resuspended in 10 ml complete culture media, seeded in a 10 cm culture dish, and 
incubated overnight to allow viable cells to adhere. 
2.5 Western blotting  
Western blots and immunoprecipitation experiments were conducted on C2C12 
and HEK293T cell lysates.  Where appropriate, cells were first transiently 
transfected with proteins of interest as in sections 2.4.2 and 2.4.5.  
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Table 2.7: In vivo activation and inhibition of protein kinases 
The kinases AKT, AMPK, p38 and PKA were activated and inhibited in HEK293T and 
C2C12 cells under the conditions given.  p38 was activated through transfection of a 
pcDNA3.1-MKK6DD construct using the standard method for each cell type.  All 
other compounds were diluted to a 1000 x concentration in DMSO, and then 
further diluted for use in complete culture media.   
Kinase Product Name Company Concentration Time  
AKT 
Activator Insulin Gibco 100 nm 1 hour  
Inhibitor AKT Inhibitor VIII Calbiochem  10 μM 4 hours 
AMPK 
Activator AICAR Sigma 500 μM 1 hour 
Inhibitor Compound C Calbiochem 10 μM 4 hours 
p38 
Activator MKK6DD / / / 
Inhibitor SB203580 Calbiochem  10 μM 4 hours 
PKA 
Activator Forskolin Sigma 10 μM 1 hour 
Inhibitor H89 Calbiochem  10 μM 4 hours 
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2.5.1 Cell lysis and protein extraction 
For standard western blotting experiments cells were lysed in RIPA buffer (20 mM 
Tris pH 8.0, 137 mM NaCl, 2 mM EDTA, 10% glycerol, 1% Triton X-100, 0.1% SDS, 
0.5% sodium deoxycolate).  Cells were washed twice with PBS prior to the addition 
of lysis buffer (500 µl/100 mm dish; 250 µl/60 mm dish).  Cells were scraped from 
the dishes and incubated on ice for 30 minutes.  Lysates were cleared by 
centrifugation at 13,000 x g for 10 minutes at 4C.  Supernatants were used 
immediately or stored at -20C until required. 
2.5.2 Protein quantification 
Where appropriate the protein content of cell lysates was determined using a 
Bicinchoninic Acid (BCA) assay (Sigma, UK).  Samples were diluted by a factor of 1/5 
to 1/20 in lysis buffer between, and 25 μl of each added to a 96-well plate in 
duplicate.  Dilutions of BSA between 0 -1 mg/ml were used as standards.  200 μl of 
detection reagent was added to each sample well, and the plate incubated at 37C 
for 30 minutes.  Absorbance was measured on an iMark Microplate Absorbance 
Reader (BioRad, UK) at 570 nm.  A calibration curve of the standard absorbance 
values versus concentration was produced, and linear regression used to calculate 
the equation of the trendline.  This was used to determine the unknown sample 
concentrations. 
2.5.3 SDS-PAGE separation of proteins 
Protein samples were mixed with 5x loading buffer (10% SDS; 10 mM DTT; 20 % 
glycerol; 0.1 M Tris pH 6.8; 10% blue bromophenol) and heated to 95C for 5 
minutes prior to loading.  Proteins were separated on 8 x 8 cm tris-glycine gels 
prepared at the relevant percentage for optimum separation of the proteins of 
interest, after passing through a stacking gel (Table 2.8).  Pre-stained protein ladder 
(Fermentas, UK) was used as a size reference.  Proteins were separated by 
electrophoresis at 160 V for 90 minutes in running buffer (2.5 M Tris Base 
(Foremedium, UK); 192 mM glycine (Fischer, UK); 0.1% SDS (Sigma, UK); pH 8.3).  
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Table 2.8: Composition of protein stacking and separating gels 
Tris-glycine gels of varying acrylamide percentages were selected to provide 
optimum separation of proteins of interest.  The lower portion of the gel was 
composed of 7.5 ml separating gel (A) with 2.5 ml stacking gel (B) on top.  (APS; 
ammonium persulphate, SDS; sodium dodecyl sulphate, TEMED; 
Tetramethylethylenediamine) 
             A 
 
                          B 
Separating Gel (10ml) 8 % 10 % 12 % 
Water 4.6 ml 4.0 ml 3.3 ml 
1.5 M Tris pH 8.8 2.5 ml 2.5 ml 2.5 ml 
10 % SDS 100 µl 100 µl 100 µl 
Acrylamide / Bis (30/0.8 %) 2.7 ml 3.3 ml 4.0 ml 
10 % APS 90 µl 90 µl 90 µl 
TEMED 10 µl 10 µl 10 µl 
Stacking Gel (5 ml) 
Water 2.94 ml 
0.5 M Tris pH 6.8 1.25 ml 
10 % SDS 50 µl 
Acrylamide / Bis (30/0.8 %) 700 µl 
10 % APS 50 µl 
TEMED 10 µl 
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2.5.4 Protein transfer onto nitrocellulose membrane 
Following SDS-PAGE separation, proteins were transferred onto nitrocellulose 
membrane (GE Healthcare, UK) at 40 V for 90 minutes in transfer buffer (12 mM Tris 
Base; 96 mM glycine; pH 8.3) with 20 % methanol.   
2.5.5 Detection of protein by immunoblotting 
Non-specific binding sites were blocked with 5% BSA in TBST (137 mM sodium 
chloride, 20 mM Tris, 0.1% Tween-20; pH 7.6) for 1 hour at room temperature.  
Membranes were incubated overnight at 4C with primary antibodies against the 
relevant proteins.  Antibodies were diluted in 5% BSA/TBST at concentrations 
indicated in Table 2.9.  Excess antibody was removed with washes in TBST; 3 x 10 
seconds followed by 3 x 10 minutes.  Membranes were incubated with secondary 
antibody in TBST for 1 hour at room temperature, at dilutions shown in Table 2.10.  
Residual antibody was removed by washing in TBST as before.  
2.5.6 Chemiluminescent visualisation of proteins 
Proteins were visualised using chemiluminescence.  Membranes were incubated 
with 1 ml of a 1:1 ratio of Supersignal West Pico Stable Peroxidise Solution to 
Supersignal West Pico Luminol Enhancer Solution (Pierce, UK) for 5 minutes, before 
the excess solution was removed.  Blots were developed on x-ray film (Fujifilm, UK) 
using a Curix 60 Processor (Agfa, Belgium) with exposure times of 1 second - 60 
minutes performed as required. 
2.5.7 Relative quantification of protein expression 
Western blot exposures were selected to ensure that none of the bands of interest 
were overexposed.  Films were scanned, saved as .tif files and imported into ImageJ 
(Schneider et al., 2012).  Bands were selected and the Gel Analysis feature used to 
determine the density of each.  Values obtained were normalised against control 
values as appropriate. 
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Table 2.9: Primary antibodies for western blotting an immunoprecipitation 
All primary antibodies were diluted to the concentrations given in 5% BSA/TBST.  
Antibody dilutions were stored in sealed tubes at 4C for re-use.  Incubation was 
conducted at the temperatures stated with gentle agitation.  (BSA; bovine serum 
albumin, IP; immunoprecipitation, O/N; overnight, TBST; tris-buffered saline solution) 
 
Antibody Supplier 
Host 
Species 
Dilution for 
western 
Amount 
per IP 
Incubation 
conditions 
14-3-3β Santa Cruz Rabbit 1/500 1 µg O/N 4C 
c-MYC Santa Cruz Rabbit 1/500 / RT 1 hour 
c-MYC Serotek Mouse / 1 µg / 
Dematin Santa Cruz Mouse 1/500 / O/N 4C 
Dematin Sigma Rabbit / 1 µg / 
FLAG M2 Stratagene Mouse 1/5000 / RT 1 hour 
FLAG M5 Sigma Mouse / 1 µg / 
GAPDH Abcam Mouse 1/5000 / RT 1 hour 
MK2 Millipore Mouse 1/2000 / O/N 4C 
MK2-phospho Cell Signalling Rabbit 1/1000 / O/N 4C 
MPM2 Millipore Mouse 1/500 / O/N 4C 
p38 Cell Signalling Rabbit 1/1000 / O/N 4C 
p38-phospho Cell Signalling Rabbit 1/1000 / O/N 4C 
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Table 2.10: Secondary antibodies for western blotting  
Secondary antibodies of compatible species with the primary used were diluted as 
stated in TBST, and incubated with gentle agitation.  Where lysates had been 
immunoprecipitated and the protein of interest was of a similar molecular weight to 
antibody heavy / light-chain, a chain specific antibody was used.  All secondary 
antibodies were HRP-conjugated for compatibility with chemiluminescent detection.  
(HC; heavy chain, LC; light chain, TBST; tris-buffered saline solution). 
Antibody Supplier 
Heavy / light 
chain specificity 
Dilution for 
western 
Incubation 
conditions 
anti-Mouse Pierce Heavy + Light 1/20,000 
O/N 4C or  
RT 1 hour 
anti-Mouse-LC Jackson Labs Light 1/120,000 
O/N 4C or  
RT 1 hour 
anti-Rabbit Cell Signalling Heavy + Light 1/20,000 
O/N 4C or  
RT 1 hour 
anti-Rabbit-HC Jackson Labs Heavy 1/50,000 
O/N 4C or  
RT 1 hour 
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2.6 Immunoprecipitation 
Cells for immunoprecipitation (IP) and GST-pulldown assays were lysed in Triton 
Lysis Buffer (20 mM Tris pH 7.4, 137 mM NaCl, 10% glycerol, 0.5% Triton X-100) in 
order to maintain protein-protein interactions.   
2.6.1 Co-Immunoprecipitation 
Cells were lysed immediately prior to IP experiments, and a sample of each lysate 
retained to confirm protein expression.  IP assays were performed using 1 µg of the 
relevant antibody per sample (Table 2.9), and the antibody-protein complex 
collected on 15 µl Protein-G-Agarose beads (Millipore, UK) that were equilibrated 
prior to use by washing 3 x in triton lysis buffer.  Following a 3 hours incubation at 
4C, non- specifically bound proteins were removed with a further 3 washes in 
triton lysis buffer.  Lysis buffer was removed, and proteins were eluted with 5x 
loading buffer and a 5 minute incubation at 95C. 
2.6.2 GST pulldown assay 
GST-tagged proteins were purified on GST-bind Resin columns (Millipore, UK).  Cells 
were lysed, and the columns washed and run as in section 2.6.1. 
2.6.3 Protein detection and visualisation 
Proteins eluted from IP and GST columns were subjected to SDS-PAGE separation 
and immunoblotting, as detailed in sections 2.5.3 - 2.5.7. 
2.7 Mass spectrometry 
2.7.1 Protein preparation 
Twenty-five 100 mm dishes of HEK293T cells were transfected with pDEST27FLAG-
dematin using the calcium-chloride method (section 2.4.2).  Dematin was purified 
using a large-scale GST-pulldown assay (section 2.6) with 500 μl of GST-bind resin, 
and of 5x sample buffer to elute proteins from the beads.  Following SDS-PAGE 
separation (section 2.5.3) the gel was stained for 1 hour with an instant coomassie 
stain (Expedeon, UK) to detect the eluted proteins.  The band corresponding to 
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dematin was excised from the gel, and lyophilised in a vacuum concentrator 
(Eppendorf, UK).   
2.7.2 Mass spectrometry 
Mass spectrometry was conducted externally by Tine Tingholm (Sweden). 
2.8 p38 kinase assay 
2.8.1 Protein preparation 
HEK293T cells were transfected with the required constructs as described in section 
2.4.1.  Protein was extracted and purified on GST-pulldown columns (section 2.6).  
After washing 3 x in lysis buffer, columns had an additional final wash with 1 ml of 
40 mM Tris, pH 7.5.   
2.8.2 Kinase assay 
Columns were incubated for 20 minutes at 30°C with 20 µl kinase mix containing 5 
µCi γ-ATP 32P and 0.2 µl p38 (Invitrogen, UK) in kinase buffer (40 mM Tris, 10 mM 
MgCl2, 1 mM DTT).  Proteins were eluted with 5x sample buffer, and separated by 
SDS-PAGE (section 2.5.3).   
2.8.3 Protein detection and quantification 
Gels were exposed to x-ray film for the required amount of time to detect the bands 
of interest, from 1 hour to overnight, and films developed as in section 2.5.6. 
2.9 Immunofluorescence staining 
C2C12 cells were transfected with the relevant constructs in the pTrexDEST30 
mammalian expression vector using electroporation (section 2.4.4), and seeded 
onto 18 mm glass coverslips that were pre-sterilised with 100% ethanol. 
2.9.1 Sample processing 
Two days after transfection, coverslips were transferred to a 12-well plate and 
washed twice with PBS.  Cells were fixed with 4% paraformaldehyde (PFA) for 10 
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minutes at room temperature.  After two washes in PBS, cells were permeabilised 
with 1% Triton X-100 in PBS.  Cells were then blocked in 3% BSA/TBST for 30 
minutes at room temperature.   
2.9.2 Fluorescent antibody detection of proteins 
Cells were incubated with primary antibody (Error! Reference source not found.) in 
3% BSA/TBST for 1 hour at room temperature.  Unbound primary antibody was 
removed by washing with PBS for 3 short washes followed by one 15-minute wash 
with gentle shaking.  Cells were incubated in the dark with secondary antibody 
(Error! Reference source not found.) in 3% BSA/TBST for 1 hour at room 
temperature.  Unbound secondary antibody was removed by washing as before.  
Cells were mounted onto microscope slides using Prolong Gold antifade mountant 
(Invitrogen, UK).  Slides were stored at room temperature overnight to set the 
mounting medium, and kept at -20°C for long-term storage. 
2.9.3 Confocal Microscopy 
Images were captured on an inverted TCS SP5 Confocal Laser Scanning Microscope 
connected to a Leica DM RBE epifluorescence microscope (Leica, Germany).  
Immunofluorescent staining was examined using a 60x or 100x oil-immersion 
objective, and images acquired using Leica Microsystem LAS AF AF6000 software, 
and saved as .tiff files.  Sequential scanning was used to prevent bleed-through 
between channels.  For proteins detected with Alexa-Fluor®488 conjugated 
secondary antibodies a 488nm Argon Laser was used, staining with Alexa Fluor® 568 
Phalloidin was imaged with a Ti Sapphire Laser 561nm, and nuclear staining with 
DAPI was detected using a Blue Diode Laser.  The scan speed was set to 550 Hz, and 
images were taken at a resolution of 512 x 512 pixels. Optical sections were taken 
at 0.8 µm intervals, and pinhole diameter was set at 1.0 airy unit.  Confocal images 
were processed using the Leica LAS AF Lite software (Leica, UK). 
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Primary 
Antibody 
Supplier 
Host 
Species 
Dilution  Secondary Antibody / stain Supplier 
Host 
Species 
Dilution  
Dematin Santa Cruz Mouse 1/100 
Alexa Fluor® 568 goat anti-mouse 
IgG (H+L) 
Invitrogen Goat 1/1000 
FLAG M2 Stratagene  Mouse 1/200 
Alexa Fluor® 488 goat anti-mouse 
IgG (H+L) 
Invitrogen Goat 1/1000 
Alexa Fluor® 568 goat anti-mouse 
IgG (H+L)  
Invitrogen  Goat 1/1000 
c-MYC Santa Cruz Rabbit 1/200 
Alexa Fluor® 488 chicken anti-
rabbit IgG (H+L) 
Invitrogen  Chicken 1/1000 
/ / / / Alexa Fluor® 568 Phalloidin Invitrogen  / 1/100 
/ / / / 
DAPI (4',6-Diamidino-2-
Phenylindole, Dihydrochloride) 
Invitrogen   / 1/1000 
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2.10 Pulse-chase labelling 
Cells were maintained in a CO2 incubator at 37°C with 5% CO2 in a humidified 
atmosphere for all incubation steps.  A schematic of the experimental protocol is 
given in Figure 2.2. 
2.10.1 Preparation of cells 
For experiments using overexpressed protein, C2C12 cells were seeded at a density 
of 8 x 105 cells / p60 dish 48 hours prior to the start of the experiment.  Cells were 
transfected 24 hours later using the PEI method detailed in section 2.4.5.  
2.10.2 Activation and inhibition of p38 MAPK 
For p38-hyperactivated samples, cells were transfected with 4.6 µg dematin DNA 
and 1.5µg pcDNA3.1FLAG-MKK6 per p60 dish.  To assess the effects of p38 
inhibition, cells were incubated with the specific inhibitor SB203580 (Table 2.7) for 2 
hours prior to the depletion period, and throughout the depletion, labelling, and 
chase periods.  
2.10.3 Labelling of protein with 35S methionine / cysteine 
Cells were washed with 3 x 2 ml PBS and incubated for 1 hour in 2 ml of Depletion 
Medium (cysteine- and methionine-free DMEM (CMF-DMEM; Invitrogen)).  Media 
was aspirated and replaced with 0.5 ml Pulse Medium (CMF-DMEM with 100 µCi / 
ml 35S labelled methionine and cysteine; Perkin Elmer) for 30 minutes.  Cells were 
washed with 3 x 2 ml PBS, and incubated with 2 ml of Chase Media (DMEM with 1 
mM L-cysteine and 3 mM L-methionine). 
2.10.4 Cell lysis and immunoprecipitation  
Samples were taken at chase intervals of 0-24 hours (measured from the end of the 
pulse period) as appropriate.  At the immediate end of the chase period, cells were 
washed with 2 x 2ml warm PBS and scraped into 500 µl triton lysis buffer.  Lysates 
were snap frozen in liquid nitrogen and stored at -80°C until all samples had been 
collected.  Cell lysates were immunoprecipitated with an anti-FLAG antibody as 
described in section 2.6.1, and separated by SDS-PAGE as in section 2.5.3. 
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Figure 2.2: Schematic of the experimental protocol for pulse-chase experiments 
An outline of the protocol used for pulse-chase experiments, the full details of 
which are described in the text.  (cys; cysteine, IP; immunoprecipitation, met; 
methionine, PBS; phosphate-buffered saline) 
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2.10.5 Protein detection and quantification 
SDS-PAGE gels were exposed to a white phosphor imaging plate (Fuji, Germany).  
Plates were imaged on a Typhoon FLA 95000 laser scanner (GE Healthcare).  
Standard Phosphorimaging settings were used; 635 nm laser with an imaging plate 
filter.  Images were taken at a 10 µm resolution and saved as .tif files. 
2.10.6 Statistical analysis 
The density of each band was quantified using Image J.  Within each treatment, 
values were normalised to the 0 chase period timepoint.  Data presented are means 
of these normalised values from three independent experiments ± SEM.  Statistical 
analysis was performed using GraphPad Prism 6 (GraphPad, USA).  Data was fitted 
to a one phase decay equation, with the plateau constrained to y=0.  Intracellular 
protein half-life values for each condition were interpolated from the graphs. 
2.11 Actin binding and bundling assays 
2.11.1 Strep-tag purification 
HEK293T cells were co-transfected with the relevant strep-tagged dematin 
construct, and 14-3-3β, as described in section 2.4.2.  Cells were lysed in triton lysis 
buffer, and the lysates cleared as described in section 2.5.1.  Strep-tagged proteins 
were purified from the lysates on Strep-bind Resin columns (Millipore, UK).  
Columns were washed and run as in section 2.6.1.  Bound proteins were eluted 
from the columns in 2.5 mM desthiobiotin in triton lysis buffer at room temperature 
for 10 minutes.   
2.11.2 Visualisation of purified proteins 
Eluted proteins were separated by SDS-PAGE as in section 2.5.3.  Gels were stained 
with InstantBlue coomassie-based stain (Expedeon, UK) for 1 hour at room 
temperature to confirm that products of the expected molecular weights had been 
purified, and the protein-protein interactions were maintained where appropriate. 
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2.11.3 Preparation of F-actin binding and bundling reactions 
Actin binding and bundling reactions were prepared using the same reagents, as 
detailed in Table 2.11.  Reagents were added in the order specified in the table, and 
mixed after addition of the test protein by gently pipetting up and down three times. 
2.11.4 F-actin binding 
Samples were incubated at 24°C for 30 minutes, before being centrifuged at 
150,000 x g for 1.5 hours at 24°C. 
2.11.5  F-actin bundling 
Samples were incubated at 24°C for 30 minutes, before being centrifuged at   
14,000 x g for 1 hour at 24°C. 
2.11.6 Sample processing 
Supernatants from the binding and bundling reactions were removed, and 
combined with 10 µl 5x Laemmli reducing sample buffer.  Pellets were resuspended 
in 30 µl Milli-Q water and pipetted for 2 minutes to fully resuspend.  Samples were 
incubated on ice for 10 minutes before a further 2 minutes of resuspending.  
Resuspended pellets were combined with 30 µl 2x Laemmli reducing sample buffer. 
2.11.7 Visualisation of proteins 
SDS-PAGE was used to separate 20 µl of each sample, using the method detailed in 
section 2.5.3.  Proteins were visualised with InstantBlue coomassie-based stain as in 
2.11.2. 
2.11.8 Protein quantification and analysis 
Coomassie stained gels were imaged, and the intensity of the protein bands present 
in each of the supernatant and pellet samples quantified using ImageJ.  The 
percentage of the protein found in each fraction was then calculated and compared 
to the control values.  
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Table 2.11: 
Composition 
of the actin 
binding and 
bundling 
reactions 
The 
components 
of each of the 
control and 
test-protein 
reactions 
were added in 
the order 
listed in the 
table, and 
pipetted 
gently to mix 
the contents.  
Samples were 
then 
processed for 
either actin-
binding or 
actin-bundling 
as described 
in the text.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample 
F-actin 
Buffer 
F-actin 
Test 
Protein 
Protein 
Buffer 
α-actinin 
1M Tris 
pH 6.5 
BSA Water 
F-actin only            
control 
/ 40 µl / 10 µl / / / / 
α-actinin only        
control 
40 µl / / / 10 µl 2 µl / / 
Positive control           (α-
actinin and F-actin) 
/ 40 µl / / 10 µl 2 µl / / 
Negative control     (BSA 
and F-actin) 
/ 40 µl / / / / 2 µl 9 µl 
Test protein               only 40 µl / 10 µl / / / / / 
Test protein               and 
F-actin 
/ 40 µl 10 µl / / / / / 
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3.1 Introduction 
The p38 MAPK is activated by the specific upstream kinases MKK3 and MKK6 
(Raingeaud et al., 1996), and subsequently phosphorylates its substrates at either 
Ser or Thr residues that are generally followed by a Pro (Cuadrado & Nebreda, 
2010). Confirmed substrates of p38 include a number of cytoskeletal components 
(Trempolec et al., 2013), but the role of p38 in regulating the cytoskeleton is not 
well defined.  Identification of further cytoskeletal-associated p38 substrates will 
therefore aid in the characterisation of this regulation.  Preliminary data obtained in 
our lab, from both microarray experiments and in vitro kinase assays, identified the 
actin binding and bundling protein dematin as a novel substrate of the p38 MAPK 
kinase.  Furthermore, sequence analysis identified 13 potential phosphorylation 
motifs that could be targeted by p38 (Figure 1.2).  There is currently a limited 
understanding of the regulation of dematin, and therefore investigating the 
potential regulation of dematin by p38 MAPK may offer insights into both the 
regulation of dematin and the role of p38 in cytoskeletal control. 
There are several regions of dematin that could potentially be regulated by p38 
phosphorylation.  Analysis of the primary sequence of dematin identified the 
presence of a PEST degradation motif (Rana et al., 1993), which has previously been 
correlated with protein instability (Rogers et al., 1986).  The majority of PEST motifs 
act as primary destruction signals and must be activated by a second regulatory 
mechanism, the most common of which is phosphorylation (Rechsteiner & Rogers, 
1996).  Interestingly the PEST sequence in dematin contains two internal Ser-Pro 
phosphorylation motifs, and is flanked by a further two sites (Figure 1.2), suggesting 
that p38 could be a prime candidate for the phospho-regulation of dematin stability.  
Most know functions of dematin involve the HP domain, making this region an 
important target for regulatory phosphorylation.  A single p38 phosphorylation 
motif is located in the HP at Ser383 (Figure 1.2).  The position of this motif at the 
extreme end of an α-helix (Figure 1.2 means that phosphorylation of Ser383 could 
potentially induce a localised conformational change in the HP.  Recent NMR 
experiments have demonstrated that PKA phosphorylation of the dematin HP at 
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Ser381 [Ser403] increases its affinity for the normally independent core domain.  This 
change in proximity sterically hinders one of the two actin binding sites, preventing 
dematin from bundling actin (Chen et al., 2013).  Phosphorylation of the HP at Ser383 
may therefore induce a conformational change that disrupts this function, providing 
a mechanism through which p38 could regulate actin bundling. 
The experiments presented in this chapter aimed to answer the following questions: 
1) Is dematin phosphorylated by the p38 MAPK in vivo? 
2) Which regions of dematin are phosphorylated by p38? 
3) Is degradation of dematin mediated by its PEST motif? 
4) Does p38 phosphorylation regulate PEST mediated degradation of dematin? 
5) Which region of the core domain does the dematin headpiece bind to? 
6) Is this binding regulated by p38 phosphorylation of the headpiece? 
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3.2 Cloning of dematin constructs 
In order to investigate the function and regulation of dematin, a number of 
constructs were cloned for expression in mammalian cell lines.  These included both 
the 48 and 52 KDa full-length splice variants of dematin that occur in vivo, in 
addition to a number of truncated dematin constructs for investigations into 
specific regions of the protein.  
3.2.1 Cloning of dematin into the pENTR11 entry vector 
PCR was used to amplify the coding region of the Homo sapiens dematin gene 
(Homo sapiens erythrocyte membrane protein band 4.9 (dematin); BC017445.1), 
using pCMV6-XL5-dematin as a template.  Primers were designed to amplify the 
dematin gene and add NcoI and XhoI restriction sites onto the 5’ and 3’ ends of the 
PCR product respectively in order to facilitate high efficiency, directional, cloning 
into the pENTR11 gateway entry vector (Figure 3.1).  The amplified PCR product and 
the pENTR11FLAG vector were digested with NcoI and XhoI restriction enzymes.  
The dematin gene was then ligated into the pENTR11FLAG vector.  This 
pENTR11FLAG-dematin construct was then used as a template for the PCR 
amplification of a number of truncated dematin constructs.  Primers were designed 
to amplify the following regions of the dematin sequence: dematinN1; aa 0-78, 
dematinN2; aa 0-196, dematinN3; aa 69-196, dematinC1; aa 261-405 and 
dematinHP; aa 316-319/342-405.  The relative positions of these truncated 
constructs are shown in the schematic in Figure 3.2.  These truncated constructs 
were cloned into the pENTR11FLAG vector using the same method as above. 
3.2.2 Cloning of constructs into mammalian expression vectors 
The Invitrogen Gateway® recombination system was then used to transfer the 
constructs into the relevant mammalian expression vectors.  Constructs for use in 
co-immunoprecipitation experiments were transferred to the pTrexDEST30 
expression vector, while those for GST-pulldowns were expressed in pDEST27 which 
creates fusion proteins with an N-terminal GST tag. 
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Figure 3.1: Schematic of the cloning approach used in this study 
The dematin gene (BC017445.1) was PCR amplified from the pCMV6-XL5 vector (A) 
using primers which added NcoI and XhoI restriction sites to the N- and C-terminal 
ends of the product respectively.  NcoI / XhoI digests of the PCR product and the 
entry vector PENTR11FLAG (B) were conducted, before ligation of the two using T4 
ligase (C).  Constructs were then transferred to mammalian expression vectors (D) 
using the Gateway recombination system. 
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Figure 3.2: Schematic of the basic dematin constructs used in this chapter 
Diagram showing the relative positions of full-length dematin and the truncated 
constructs cloned for use in this chapter.  (A) All protein constructs for use in GST-
pulldown experiments were expressed in the pDEST27 vector, creating fusion 
proteins with N-terminal GST tags to facilitate purification and FLAG tags for 
immuno-detection.  (B) Constructs for use in pulse-chase protein degradation 
experiments were expressed in pTrexDEST30 and had only an N-terminal FLAG tag 
to minimise the disruption of normal protein function. 
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3.3 p38 phosphorylation of dematin 
Preliminary screening experiments conducted in our lab identified dematin as a 
novel substrate of the p38 MAPK (Müller; unpublished).  Here we aimed to confirm 
that p38 phosphorylates dematin in vivo as well as in vitro, and to identify the 
specific regions of dematin that are phosphorylated by p38.  Due to its ubiquitous 
expression patterns, and higher levels of expression than p38β, p38α is the model 
isoform for research into the p38 MAPK family (Cargnello & Roux, 2011).   This study 
has therefore focused solely on the p38α isoform. 
3.3.1 Preliminary screening for novel p38 MAPK substrates 
In a protein microarray screen conducted previously in our lab, dematin was 
identified as a substrate of the p38 MAPK, but not of the other MAPK family kinase 
ERK5 (Figure 3.3A).  An in vitro kinase assay was then conducted which showed that 
recombinant p38 MAPK was able to phosphorylate dematin, whereas the ERK5 
MAPK control was not (Figure 3.3B) (Müller; unpublished).  This data provided 
preliminary evidence that dematin is a novel substrate of the p38 MAPK, and 
formed the basis of this study.  
3.3.2 In vitro phosphorylation of dematin by p38 
In vitro kinase assays using recombinant p38 were conducted to determine which 
regions of dematin are phosphorylated by p38.  The pDEST27FLAG constructs of 
full-length dematin and the truncated constructs dematinN1, N2, N3 and C1 (Figure 
3.2) were expressed in HEK293T cells.  GST-pulldown columns were used to purify 
the dematin constructs from the cell lysates, and these proteins were then 
incubated with γ-ATP 32P and recombinant p38α.  After separation of the eluted 
proteins by SDS-PAGE, gels were exposed to radiographic film.  Bands were 
detected for full-length dematin as well as dematinN1, N2, N3, and C1, indicating 
the presence of incorporated 32P in these proteins (Figure 3.4).  This indicates that 
p38 phosphorylates dematin at multiple sites in vitro, and that phosphorylation 
occurs within each of the regions covered by the truncated dematinN1, N3 and C1 
constructs; aa 0-78, aa 79- 196 and aa 261-405. 
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Figure 3.3: Dematin is a novel substrate of the p38 MAPK 
Screening experiments were conducted to identify novel substrates of the p38 
MAPK.  (A) Protein microarray experiments (n=1) were conducted using the 
Invitrogen ProtoArray® Human Protein Microarray system, consisting of > 9,000 full-
length human proteins spotted in duplicate onto a nitrocellulose coated glass slide.  
The arrays were blocked in 1% BSA, and incubated in kinase buffer with γ-ATP 33P 
and either recombinant p38α or ERK5 at 30°C for 60 minutes.  Following thorough 
washing, the slides were dried and exposed to a phosphor-imager screen.  Images 
were taken with a phosphor-imager, and processed with the Invitrogen ProtoArray® 
Prospector software to identify phosphorylated proteins.  The regions in red 
correspond to the dematin spots, indicating that the protein has been 
phosphorylated by p38α but not ERK5.  (B) In vitro kinase experiments (n=3) were 
conducted to confirm the microarray results.  Samples were incubated with γ-ATP 
32P and either recombinant p38α or recombinant ERK5.  Proteins were separated by 
SDS-PAGE and exposed to radiographic film.  A band corresponding to 
phosphorylated dematin was detected in the p38α samples but not in the ERK5 
sample.  This confirmed that recombinant p38α was able to phosphorylate 
recombinant dematin in vitro, whereas an alternative MAPK family member, ERK5, 
could not.  (ATP; adenosine tri-phosphate, ERK; extracellular-signal regulated kinase, 
MAPK; mitogen-activated protein kinase, SDS-PAGE; sodium dodecyl sulphate 
polyacrylamide gel electrophoresis). 
p38α ERK5
p38α ERK5
A 
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Figure 3.4: Dematin is phosphorylated at multiple sites in vitro by p38α MAPK 
In vitro kinase assays were conducted to determine which regions of the dematin 
are phosphorylated by p38α.  pDEST27FLAGdematin, dematinN1, dematinN2, 
dematinN3 and dematinC1 constructs were overexpressed in HEK293T cells, then 
purified on GST-pulldown columns following cell lysis.  Samples were incubated with 
recombinant p38α and γ-ATP 32P, separated by SDS-PAGE and exposed to 
radiographic film.  Bands were detected in the full-length dematin sample and in all 
of the truncated constructs.  The control sample consisted of p38α / γ-ATP 32P 
reaction mix in the absence of protein (n=3). (ATP; adenosine tri-phosphate, SDS-
PAGE; sodium dodecyl sulphate polyacrylamide gel electrophoresis). 
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3.3.3 Mass spectrometry identification of phosphorylated residues in dematin 
Although the kinase assays demonstrated that dematin is phosphorylated by 
recombinant p38α at multiple sites in vitro, this does not necessarily correlate with 
the sites that are phosphorylated in vivo.  To validate this finding, mass 
spectrometry was conducted to determine the specific residues in dematin that are 
phosphorylated by p38 in vivo.  HEK293T cells were co-transfected with the 
pDEST27FLAG-dematin construct along with pcDNA3.1FLAG-MKK6 to hyper-activate 
p38.  Following cell lysis, proteins were purified on a GST-binding column.  The 
bound proteins were eluted, separated by SDS-PAGE, and stained with coomassie 
dye.  A large band corresponding to GSTFLAG-dematin was seen in addition to a 
smaller non-specific band (Figure 3.5A).  The GSTFLAG-dematin band was excised 
from the gel and lyophilised.  Further processing and mass spectrometry detection 
of phosphorylated peptides was conducted by Dr. Tine Tingholm at Lund University, 
Sweden.         
The mass spectrometry results identified residues within dematin that were 
phosphorylated under the experimental conditions used.  MAPK kinases are known 
to phosphorylate their targets are either SP or TP motifs, and the primary sequence 
of dematin contains 13 such sites.  A total of 11 phosphorylated SP / TP motifs in 
dematin were identified, at residues Ser11, Ser16, Ser26, Ser87, Ser92, Ser96, Ser105, 
Thr274, and Ser383.  Four motifs at Ser156, Ser307, Ser315 and Thr120 were not detected 
as being phosphorylated (Figure 3.5B). 
3.3.4 In vitro validation of the MS identified p38 phosphorylation sites 
The mass spectrometry results were then validated in vitro with p38-specific kinase 
assays.  Ser to Ala mutants of the p38 motifs identified as being phosphorylated in 
the mass spectrometry analysis (Figure 3.5) were created using a site-directed 
mutagenesis approach.  The truncated dematin constructs in the pDEST27FLAG 
vector were used as a template for mutagenesis reactions, and sequential reactions 
used to mutate all of the p38 sites identified in each fragment.  An additional 
dematinN3 construct was created where only the S92/96 residues which fall within 
the PEST motif were mutated. 
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Phosphorylatable 
residue 
Phosphorylated in 
mass spectrometry? 
Truncated constructs 
containing this site 
Serine 11 YES N1, N2 
Serine 16 YES N1, N2 
Serine 26 YES N1, N2 
Serine 87 YES N2, N3 
Serine 92 YES N2, N3 
Serine 96 YES N2, N3 
serine 105 YES N2, N3 
Threonine 120 / N2, N3 
Serine 156 / N2, N3 
Threonine 274 YES C1 
Serine 307 / C1 
Serine 315 / C1 
Serine 383 YES C1 
 
Figure 3.5: Phosphorylated MAPK motifs in dematin identified using mass 
spectrometry 
HEK293T cells were co-transfected with pDEST27FLAG-dematin and pcDNA3.1FLAG-
MKK6 to hyper-activate p38.  A GST-column was used to purify the lysate, and the 
eluted proteins were separated by SDS-PAGE and stained with coomassie dye.  (A) 
The band corresponding to GSTFLAG-dematin  was excised from the gel and 
lypholised.  Mass spectrometry detection of phosphorylation sites within the 
dematin protein sample was conducted externally. (B) This data was then correlated 
with the potential SP / TP p38 phosphorylation motifs within the dematin sequence 
(n=1) (GST; glutathione-S-transferase, MAPK; mitogen-activated protein-kinase, 
SDS-PAGE, sodium dodecyl sulphate – polyacrylamide gel electrophoresis). 
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This produced the following constructs: pDEST27FLAG-dematinN1_S11/16/26A (N1-
3A), pDEST27FLAG-dematinN3_S92/96A (N3-2A), pDEST27FLAGdematinN3_ 
S87/92/96/105A (N3-4A), and pDEST27FLAG-dematinC1_S274/383A (C1-2A).  The in 
vitro kinase assays were then repeated with both the wild-type constructs and the 
Ser to Ala mutants.  An aliquot of lysate from each sample was subjected to western 
blot analysis with an anti-FLAG antibody to confirm that the expression levels of the 
wild-type and mutant constructs were comparable.  All blots were scanned and the 
bands quantified using densitometry software.  The intensity of each band was 
normalised to the expression control, and then the values for mutant constructs 
were normalised to the comparable wild-type which was given a value of 1. 
As seen in the previous experiment (Figure 3.4) each of the dematinN1, N3, and C1 
wild-type constructs was phosphorylated by p38 (Figure 3.6).  The average band 
intensity for dematinN1_S11/16/26A had a normalised value of 0.04 compared to 
wild-type which was set to 1.0 (p<0.0001), confirming that p38 phosphorylation of 
dematin is specific to one or more of these sites.  The dematinN3_S92/96A              
and dematinN3_S87/92/96/105A constructs showed relative expression levels of 
0.12 and 0.01 respectively, compared to wild-type dematinN3 (p<0.0001).  This 
indicates that dematin is phosphorylated in vitro at one or both of the S92/96 
motifs, in addition to one or both of S87/105 motifs.  The dematinN3 truncation 
contains a further two p38 phosphorylation motifs at Thr120 and Ser156 that were 
not detected as being phosphorylated in our mass spectrometry analysis.  The lack 
of phosphorylation of the dematinN3_S87/92/96/105A construct confirms this 
initial finding.  Finally phosphorylation of the dematinC1 fragment was abolished in 
the dematinC1_S274/383A mutant construct (p<0.0001), indicating that dematin C1 
is phosphorylated at one or more of these sites.  Again the dematin C1 regions 
contained additional p38 phosphorylation motifs, at Ser307 and Ser315, which were 
not detected as being phosphorylated here or in the mass spectrometry analysis. 
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Figure 3.6: In vitro kinase assays of p38 mutant truncated dematin constructs 
In vitro kinase assays were conducted to determine whether the phosphorylation of 
dematin by p38α was specific to the motifs identified.  The truncated constructs 
dematinN1, N3, and C1, along with their corresponding p38 motif mutants in the 
pDEST27 vector were overexpressed in HEK293T cells, then purified on GST-
pulldown columns following cell lysis.  Samples were incubated with recombinant 
p38α and γ-ATP 32P, separated by SDS-PAGE and exposed to radiographic film.  
Bands were detected in the full-length dematin sample and in all of the truncated 
constructs. (A) Comparison of dematinN1 (N1) and the dematinN1_S11/16/26A 
(N3A) construct.  (B) Comparison of dematinN3 (N3) and the dematinN3_S92/96A 
(N3-2A), and dematinN3_S87/92/96/105A (N3-4A) constructs.  (C) Comparison of 
dematinC1 (C1) and the dematinC1_S274/383A (C1-2A) construct.  Bands were 
quantified and normalised against the anti-FLAG expression controls.  Normalised 
values for each mutant were then further normalised to the corresponsing wild-
type which was set to 1.0.  The statistical significance was determined using an 
unpaired t-test; (n=3).  (ATP; adenosine tri-phosphate, SDS-PAGE; sodium dodecyl 
sulphate polyacrylamide gel electrophoresis). 
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3.3.5 MPM2-detection of SP / TP phosphorylation sites in vivo 
Although the MS analysis provided in vivo phosphorylation data, this technique is 
not applicable to a high-throughput approach that would be required to 
characterise specific residues, and therefore a second technique was tested.  
Western blotting was conducted using an anti-MPM2 antibody that detects context-
dependent phosphorylated Ser-Pro and Thr-Pro motifs.  The pDEST27FLAGdematin 
and truncated constructs dematinN1, N3, and C1 constructs and their 
corresponding p38-motif mutants were overexpressed in HEK293T cells and purified 
from the lysates on GST-pulldown columns.  Following SDS-PAGE separation and 
immunoblotting, membranes were probed with an anti-MPM2 antibody.  Blots 
were then re-probed with an anti-FLAG antibody to confirm that the proteins were 
expressed.  Bands were detected for all constructs (Figure 3.7), indicating that the 
MPM2 antibody recognises at least one of the phosphorylation motifs in each 
fragment and is therefore of potential use for analysing the in vivo phosphorylation 
of dematin.  No band was detected with the MPM2 antibody for the 
dematinN1_S11/16/26A, dematinN3_S87/92/96/105A, and   dematinC1_S274/383A 
constructs (Figure 3.7).  This confirms that the antibody is not recognising other 
non-SP/TP sites within these protein sequences, and that the addition SP/TP 
phosphorylation motifs in the dematinN3 and dematinC1 are either not 
phosphorylated in vivo under these experimental conditions, or are not recognised 
by the antibody. 
3.4 PEST mediated degradation of dematin 
The presence of a PEST degradation motif in the dematin primary sequence, and 
the intrinsic instability of the protein, have been reported in the literature but have 
not been investigated further (Chen et al., 2013; Chen et al., 2009; Rana et al., 
1993).  Here we aimed to determine whether the PEST motif in dematin does 
regulate protein stability, to what extent this affects the intracellular half-life of the 
protein, and whether this degradation is regulated by p38 phosphorylation.  
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Figure 3.7: In vivo phosphorylation of dematin at SP / TP motifs 
The truncated constructs dematinN1, N3, and C1, along with their corresponding 
p38 motif mutants (dematinN1_S11/16/26A (3A), dematinN3_S92/96A (2A), 
dematinN3_S87/92/96/105A (4A), dematinC1_S274/383A (2A) in the pDEST27 
vector were overexpressed in HEK293T cells, and separated by SDS-PAGE.  
Following western blotting, membranes were probed with an anti-MPM2 antibody 
to detect phosphorylated SP/TP motifs (n=3)  (SDS-PAGE; sodium dodecyl sulphate 
polyacrylamide gel electrophoresis). 
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3.4.1 Dematin contains a PEST motif at aa 89-104 
The presence of a PEST motif in dematin has been previously reported, but the 
exact position of this motif is not consistently defined.  Rana et al (1993) first 
described the motif at aa 90-103, however Chen et al assigned aa 89-102 as the 
PEST motif (2009).  In order to obtain an unbiased definition of the dematin PEST 
motif for use in this study, the EMBOSS epestfind algorithm was applied 
(emboss.bioinformatics.nl/cgi-bin/emboss/epestfind ).  This algorithm conducts a 
preliminary scan to identify regions of ≥ 12 aa that contain at least one P, D or E and 
S or T residue which are flanked by positively charged residues.  The validity of 
these initial results in then scored based on two parameters.  Firstly the enrichment 
of D, E, P, S, T residues is expressed as a percentage of the total mass (w/w).  The 
hydrophobicity of the motif is then calculated, using a scale where arginine = 0 to 
isoleucine = 90.  These values are combined to give each motif an overall rating, 
where the PEST score = 0.55 * DEPST - 0.5 * hydrophobicity index.  PEST motifs that 
meet the required criteria but score below the threshold of 5.0 are considered poor, 
whilst those above this value are of potential biological interest.  The epestfind 
algorithm was applied to the amino acid sequence of the longer 52 KDa isoform of 
human dematin (BC017445).  Seven potential PEST motifs were identified (Figure 
3.8) but six were rated as poor with PEST scores from -27.63 to 4.08.  A single viable 
motif of 14 aa was identified at 89KSTSPPPSPEVWADSR104 (Figure 3.8) which was 
assigned a PEST score of 11.51, with a hydrophobicity index of 34.69 and a DEPST of 
52.47 % (w/w).  This motif is also present in the sequence of the shorter 48 KDa 
isoform of dematin. 
3.4.2 Intracellular degradation of dematin 
The intracellular half-life of the 52 KDa isoform of dematin was determined using 
pulse-chase degradation experiments.  C2C12 cells were transfected with 
pTrexDEST30FLAG-dematin and after 24 hours intracellular stores of sulphur 
containing amino acids were depleted with a one-hour incubation in cysteine- and 
methionine-free DMEM.  Cells were pulsed with 100 µCi / ml 35S labelled 
methionine and cysteine for 30 minutes to label all newly synthesised proteins. 
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Figure 3.8: PEST motifs in the primary sequence of human dematin 
The EMBOSS epestfind algorithm was used to identify potential PEST degradation 
motifs in the primary sequence of human dematin.  The preliminary scan revealed 7 
sites in dematin (blue boxes) which were then analysed for enrichment of DEPST 
residues and hydrophobicity, and given a rating where < 5.0 indicates a poor site 
while 5.0 and above indicates a site of potential biological interest (red text).  The 
dematin sequence contains a single viable PEST motif at residues 89-104 as 
indicated by the shaded box.  The green lines indicate the p38 phosphorylation 
motifs both within and flanking the PEST motif.   
 
of 34.69 and a DEPST of 52.47 % (w/w).  This motif is also present in the sequence 
of the shorter 48 KDa isoform of dematin. 
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Figure 1: PEST motifs in the primary sequence of human dematin 
The EMBOSS epestfind algorithm was used to identify potential PEST degradation 
motifs in the primary sequence of human dematin.  The preliminary scan revealed 7 
sites in dematin (blue boxes) which were then analysed for enrichment of DEPST 
residues and hydrophobicity, and given a rating here < 5.0 indicates a poor site 
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Cells were thoroughly washed and returned to DMEM media supplemented with 
excess methionine and cysteine.  Samples were taken at chase intervals of 0-20 
hours from the immediate end of the pulse period.  Cells were lysed, 
immunoprecipitated with an anti-FLAG antibody, and separated by SDS-PAGE.  Gels 
were exposed to a storage phosphor screen for 48 hours before imaging with a laser 
scanner.  The intensity of each band was quantified using densitometry software, 
and values were normalised against the 0 timepoint which was taken to be 100%.  
The intracellular degradation of dematin followed an exponential decay model 
(Figure 3.9), with a calculated half-life of 5.49 hours (95% confidence interval 5.49 
+/- 0.44 hours). 
3.4.3 The PEST motif in dematin enhances protein degradation in vivo 
In order to determine the effect of the PEST motif on dematin stability, site-directed 
mutagenesis was employed to create a full-length dematin construct lacking the 
PEST domain.  A primer was designed to delete aa 89-104, creating the 
pTrexDEST30FLAG-dematin_ΔPEST construct.  Pulse-chase degradation experiments 
were repeated as previously using this construct.  The data again fitted an 
exponential decay model (Figure 3.10), with a calculated half-life of 7.64 hours (95% 
confidence interval 7.64 +/- 0.72 hours).  This indicated that the PEST motif in 
dematin does increase the instability of the protein, and when these values were 
compared to the wild-type dematin using a t-test this difference was shown to be 
statistically significant (p<0.05). 
3.4.4 Potential regulation of dematin stability by p38 MAPK 
PEST motifs generally require activation before they mediate degradation of a 
protein, and this is commonly achieved through phosphorylation at internal serine 
or threonine residues.  The PEST motif in dematin contains two internal p38 
phosphorylation sites, and a further two sites flanking either side of the motif.  Here 
we aimed to investigate whether p38 regulates PEST mediated degradation of 
dematin, and if so which of these four residues are important.  Pulse-chase 
experiments were repeated as previously, but using only four timepoints; 0, 2, 4, 
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Figure 3.9: Pulse-chase degradation timecourse of overexpressed dematin 
C2C12 cells transfected with pTrexDEST30FLAG-dematin with depleted of 
intracellular methionine and cysteine stores before labelling for a 30-minute pulse 
period with 100 µCi / ml 35S labelled methionine and cysteine.  Samples were 
washed and chased for the time periods indicated in DMEM supplemented with 
methionine and cysteine.  Cells were lysed and the labelled proteins were 
immunoprecipitated with an anti-FLAG antibody and separated by SDS-PAGE.  
Following a 48 hour exposure to a phosphor storage plate, imaging was conducted 
using a laser scanner and bands quantified using densitometry software.  Values 
were normalised to the 0 hour chase timepoint, which was set at 100%.  (A) A one-
phase decay trendline was fitted to the data, and from this the intracellular half-life 
of dematin was calculated to be 5.49 hours (+/- 0.44 hours).  Data plotted is the 
mean value ± SEM. (B) A representative image of the gel (n=3). 
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Figure 3.10:  The effect deleting the PEST motif on the stability of dematin 
C2C12 cells transfected with pTrexDEST30FLAG-dematin_ΔPEST were depleted of 
intracellular methionine and cysteine stores before labelling for a 30-minute pulse 
period with 100 µCi / ml 35S labelled methionine and cysteine.  Samples were 
chased for the time periods indicated, from 0-20 hours.  Cells were lysed and the 
labelled proteins were immunoprecipitated with an anti-FLAG antibody and 
separated by SDS-PAGE.  Following a 48-hour exposure to a phosphor storage plate, 
imaging was conducted using a laser scanner and bands quantified using 
densitometry software.  Values were normalised to the 0 hour chase timepoint, 
which was set at 100%.  A one-phase decay trendline was fitted to the data, and 
from this the intracellular half-life of dematin_ΔPEST was calculated to be 7.64 
hours (+/- 0.72 hours).  Data plotted is the mean value ± SEM (n=3). 
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and 8 hours.  Data was subsequently plotted on a logarithmic scale to aid the fitting 
of a trendline to the reduced set of data points.  Cells were either pre-incubated 
with SB203580 to inhibit p38 (and maintained in SB203580 containing solutions 
throughout the experiment), or co-transfected with MKK6DD to specifically activate 
p38.  The untreated dematin had a calculated mean half-life of 5.98 hours.  This 
increased slightly in the p38 inhibited sample to 6.21 hours, and decreased in the 
p38 activated dematin to 5.77 hours (Figure 3.11).  This indicated that there was a 
small change towards increased instability upon p38 hyperactivation, however this 
was not a significant difference. 
3.4.5 Potential regulation of dematin stability by PEST phosphorylation 
Although p38 phosphorylation had no significant effect on the stability of dematin, 
there remained a possibility that the PEST motif could be regulated by an 
alternative kinase.  Two sets of mutants were therefore generated to study the 
effect of PEST phosphorylation on the stability of dematin.  The first approach was 
to create serine to alanine mutants, which were no longer capable of being 
phosphorylated.  A double mutant of the two internal serine residues (Ser92 and 
Ser96), and quadruple mutant of the two internal sites plus two flanking serine 
residues (Ser87 and Ser105) were created: dematin_S92/96A and 
dematin_S87/92/96/105A.  Mutagenesis of the same sites was then used to replace 
serine residues with negatively charged glutamic acid residues in order to mimic the 
effects of phosphorylation: dematin_S92/96E and dematin_S87/92/96/105E.  The 
template DNA used for mutagenesis reactions was pTrexDEST30FLAG-Dematin. 
Wild-type dematin had a calculated mean half-life of 5.98 hours.  The mean half-
lives of the dematin_S92/96A and dematin_S87/92/96/105A non-phosphorylatable 
mutants were 6.24 and 6.46 hours respectively.  The phospho-mimicking mutants 
dematin_S92/96E and dematin_S87/92/96/105E had mean half-lives of 6.66 and 
6.23 hours (Figure 3.12).  None of the mutants had half-lives that were statistically 
significantly different from the wild-type dematin, indicating that phosphorylation 
does not appear to affect the stability of dematin via the PEST motif.    
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Figure 3.11: The effect of p38 phosphorylation in the stability of dematin 
C2C12 cells were transfected with pTrexDEST30FLAG-dematin, and either left 
untreated (untreated), incubated with SB203580 throughout the experiment (-p38), 
or co-transfected with MKK6 to hyper-activate p38 (+p38). Cells were depleted of 
intracellular methionine and cysteine stores before labelling for a 30-minute pulse 
period with 100 µCi / ml 35S labelled methionine and cysteine.  Samples were 
chased for the time periods indicated, from 0-20 hours.  Cells were lysed and the 
labelled proteins were immunoprecipitated with an anti-FLAG antibody and 
separated by SDS-PAGE.  Following a 48-hour exposure to a phosphor storage plate, 
imaging was conducted using a laser scanner and bands quantified using 
densitometry software.  Values were normalised to the 0 hour chase timepoint, 
which was set at 100%.  Linear trendlines were fitted to the data, and from this the 
intracellular half-lives were calculated (n=3).  
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Figure 3.12: The effect of PEST site mutations on the stability of dematin 
C2C12 cells were transfected with pTrexDEST30FLAG-dematin, -dematinS92/96A 
(2A), -dematinS87/92/96/105A (4A), -dematinS92/96E (2E), or -
dematinS87/92/96/105E (4E). Cells were depleted of intracellular methionine and 
cysteine stores before labelling for a 30-minute pulse period with 100 µCi / ml 35S 
labelled methionine and cysteine.  Samples were chased for the time periods 
indicated, from 0-20 hours.  Cells were lysed and the labelled proteins were 
immunoprecipitated with an anti-FLAG antibody and separated by SDS-PAGE.  
Following a 48-hour exposure to a phosphor storage plate, imaging was conducted 
using a laser scanner and bands quantified using densitometry software.  Values 
were normalised to the 0 hour chase timepoint, which was set at 100%.  Linear 
trendlines were fitted to the data, and from this the intracellular half-lives were 
calculated (n=3).  
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3.5 Regulation of dematin headpiece / core binding by p38 
It has recently been shown that phosphorylation of the dematin HP at Ser381 [Ser403] 
induces a conformation change that increases the affinity of the HP for the core 
domain, which blocks one of the two actin-binding domains and therefore inhibits 
actin bundling (Chen et al., 2013).  Here we aimed to determine which region of the 
core domain the HP interacts with, in addition to determining whether p38 
phosphorylates the dematin HP, and if so whether this phosphorylation has a 
regulatory effect on the interaction between the HP and core domains. 
3.5.1 Binding of the dematin headpiece to the core domain 
In order to determine which region of the core domain the dematin HP binds to, 
cells were co-transfected with pDEST27FLAG-dematinHP and either 
pcDNA3.1DESTFLAG-dematin or -dematinN2, -dematinN3 or -dematinC1.  Following 
cell lysis under non-denaturing conditions, GST-pulldown assays were conducted to 
purify the GST-FLAG-dematinHP from solution.  The eluted products were subjected 
to SDS-PAGE separation, transferred onto nitrocellulose membrane, and probed 
with an anti-FLAG antibody.  Full-length dematin co-purified with GST-FLAG-
dematinHP, but the truncated constructs dematinN2, dematinN3 or dematinC1 did 
not (Figure 3.13).  This demonstrates that the dematin HP does bind to the core 
region, but suggests that binding occurs in either the region from aa 197-261 that is 
not covered by these constructs, or binds on the boundary of this region and either 
the dematinN3 or dematinC1 regions. 
3.5.2 The dematin headpiece is phosphorylated in vitro and in vivo at Ser383 
In order to investigate whether p38 plays a regulatory role in the interaction 
between the dematin HP and core domains, it was first necessary to confirm that 
the dematin HP is phosphorylated by p38.  The HP region contains a single p38 
motif at Ser383.  Observation of the minimised average solution NMR structure of 
the HP domain confirmed that this motif is located on the external surface of the 
protein, and therefore would be accessible for p38 phosphorylation (Figure 3.14B).  
The location of this motif was shown to be at the immediate N-terminal side of the  
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Figure 3.13: The dematin headpiece binds to the core domain at an undefined 
region. 
HEK293T cells were co-transfected with pDEST27FLAG-dematinHP and either 
pcDNA3.1FLAG-dematin, -dematinN2, -dematinN3, or -dematinC1.  Following cell 
lysis under non-denaturing conditions, the dematin HP was purified on a GST-
pulldown column, and the eluted proteins subjected to SDS-PAGE separation and 
transfer to nitrocellulose.  Membranes were probed with an ant-FLAG antibody 
(n=3) (HP; dematin headpiece, GST; glutathione S-transferase, HP; headpiece, wcl; 
whole-cell lysate) 
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Figure 3.14: Location of Ser383 in the folded conformation of the dematin 
headpiece 
A ribbon representation of the minimised average solution NMR structure of the 
headpiece domain of 48 KDa dematin.  The predicted α-helices are shown in dark 
blue, with the linker regions in light blue.  (A) The p38 phosphorylation motif at 
Ser383-Pro motif is highlighted in red, clearly showing its position at the N-terminal 
end of helix 2 (H2).  (B) The space fill models demonstrate that the Ser383-Pro motif 
is located on the external surface of the folded protein and therefore accessible for 
phosphorylation.  (The NMR structure was obtained from RCSB Protein Data Bank; 
structure of the human dematin headpiece domain, 1QZP.  The image was created 
using Swiss-PDB viewer 4.1.0). 
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second α-helix (Figure 3.14A).  This close proximity to the α-helix makes it plausible 
that phosphorylation of this site could induce a conformational change in the HP, 
which in turn could affect the HP / core interaction. 
In order to determine whether this Ser383 motif is phosphorylated by p38 in vitro, 
kinase assays were repeated using recombinant p38α and the pDEST27FLAG-
dematinHP (HP) and pDEST27FLAG-dematinHP_S383A (HP-A) constructs.  The wild-
type HP construct was phosphorylated by p38, while the HP-A construct was not 
(P<0.0001; Figure 3.16A).  Western blotting experiments using an anti-MPM2 
antibody were then used to determine whether this phosphorylation could be 
detected in vivo.  A band was detected for the wild-type dematinHP construct, but 
not for the dematinHP_S383A mutant (Figure 3.16B).  Taken together these results 
confirm the dematin HP is phosphorylated both in vitro and in vivo at Ser383, and the 
kinase assay suggests that this phosphorylation is attributable to p38. 
3.5.3 Regulation of the dematin headpiece / core interaction by p38 
Once it had been demonstrated that the dematin HP and core domains interacted 
in our system, and that the HP was phosphorylated at Ser383 both in vitro and in vivo, 
the GST-pulldown assays were repeated to determine whether p38 had a regulatory 
role in this interaction.  Site-directed mutagenesis was used to create a second 
mutant of the dematin HP with the Ser383 site mutated to an aspartic acid residue to 
mimic the negative charge of a phosphate group; pDEST27FLAG-dematinHP_S383D 
(HP-D).  Experiments were also repeated in the presence of the p38 inhibitor 
SB203580, and with MKK6DD co-transfection to hyperactivate p38.  Full-length 
dematin co-purified with the dematin HP under untreated, p38 inhibited, and p38 
hyper-activated conditions (Figure 3.16A).  This indicated that p38 does no inhibit 
the core / HP interaction.  Equally, full-length dematin co-purified with the HP-
S383A and HP-S383D constructs (Figure 3.16B).  This suggested that any phospho-
mediated change in the dematin HP does not affect the core / HP interaction. 
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Figure 3.15: The dematin headpiece is phosphorylated at Ser383 by p38 MAPK 
(A) pDEST27FLAG-dematinHP and pDEST27FLAG-dematinHP_S383A constructs were 
overexpressed in HEK293T cells, then purified on GST-pulldown columns following 
cell lysis.  Samples were incubated with recombinant p38α and γ-ATP 32P, separated 
by SDS-PAGE and exposed to radiographic film.  Bands were detected in the full-
length dematin sample and in all of the truncated constructs. Bands were quantified 
and normalised against the anti-FLAG expression controls.  Normalised values for 
the mutant were then further normalised to the wild-type which was set to 1.0.  
The statistical significance was determined using an unpaired t-test.  (B) Cells lysates 
of the same constructs were immunoblotted with an anti-MPM2 antibody to detect 
phsophrylated SP/TP motifs with an anti-FLAG control to confirm expression levels 
were comparable  (n=3).  (ATP; adenosine tri-phosphate, SDS-PAGE; sodium dodecyl 
sulphate polyacrylamide gel electrophoresis). 
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Figure 3.16: Phosphorylation of Ser383 does not inhibit the headpiece / core 
interaction  
(A) HEK293T cells were co-transfected with pDEST27FLAG-dematinHP and 
pcDNA3.1FLAG-dematin.  Cells were either untreated, p38 hyperactivated with 
MKK6-cotransfection, or p38 inhibited with SB203580.  Following cell lysis under 
non-denaturing conditions, the dematin HP was purified on a GST-pulldown column, 
and the eluted proteins subjected to SDS-PAGE separation and transfer to 
nitrocellulose.  Membranes were probed with an ant-FLAG antibody.  (B) Cells were 
co-transfected with pDEST27FLAG-dematinHP, -dematinHP_S383A, or –
dematinHP_S383D, and pcDNA3.1FLAG-dematin.  Samples were processed as above 
(n=3) (HP; dematin headpiece, GST; glutathione S-transferase, HP; headpiece, wcl; 
whole-cell lysate) 
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3.6 Discussion 
Here we have confirmed dematin as a novel substrate of the p38α MAPK, and 
demonstrated that this phosphorylation occurs in vitro and in vivo at multiple sites 
in both the core and HP regions.  The stability of dematin was shown to be 
regulated by the presence of a PEST degradation motif; however p38 
phosphorylation did not regulate this process.   Equally, phosphorylation of the HP 
by p38 did not regulate the association of the HP and core domains. 
3.6.1 Dematin is phosphorylated by p38α at multiple sites in vitro and in vivo 
It has been estimated that each MAPK family member has around 200-300 
substrates (Cuadrado & Nebreda, 2010).  To date around 100 substrates of p38α 
have been identified, which include protein kinases, nuclear proteins including 
transcription factors, and a wide array of other cytosolic targets (Trempolec et al., 
2013).  Here we have identified dematin, an actin-binding protein, as a novel 
substrate of p38α.  Other examples of p38 regulating cytoskeletal proteins have 
been previously documented.  Cytoskeletal remodelling in endothelial cells during 
inflammation has been demonstrated as a result of p38 phosphorylation of HSP27, 
a protein that enhances F-actin polymerisation and stabilisation (Wang & Doerschuk, 
2001).  This has also been identified in hepatocytes during ischemia and reperfusion 
(Keller et al., 2005).  Phosphorylation by p38 is also an important regulator of the 
keratin intermediate filament cytoskeleton (Wöll et al., 2007). 
MAPKs including p38 generally phosphorylate their substrates at SP or TP motifs, of 
which 13 were identified in the primary sequence of 52 KDa dematin.  In 
collaboration with Tine Tingholm (Lund University, Sweden), preliminary mass 
spectrometry analysis identified 11 phosphorylated motifs in dematin under p38-
hyperactivated conditions, at residues Ser11, Ser16, Ser26, Ser87, Ser92, Ser96, Ser105, 
Thr274, and Ser383.  These sites are distributed throughout the dematin sequence, in 
both the core and HP domains.  In support of these results, in vitro kinase assays 
confirmed that p38α phosphorylates dematin within each of the regions covered by 
the dematinN1, N3, and C1 constructs; aa 0-78, 79- 196 and 261-405 respectively.  
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Further mutagenesis to create truncated constructs each containing only a single 
p38 phosphorylation motif will be required to determine the precise complement of 
phosphorylation sites. 
The preliminary mass spectrometry results presented here identified residues that 
were phosphorylated under p38 hyper-activated conditions, however this does not 
confirm that they are directly phosphorylated by p38.  It would therefore be useful 
to repeat the experiment using cells co-transfected with MKK6DD to activate p38, 
and cells co-transfected with MKK6DD and treated with SB203580 to inhibit p38.  By 
activating and inhibiting p38 simultaneously in the inhibited sample, it will be 
possible to rule out any non-specific consequences of MKK6 activation.  Any 
differences in phosphorylation profiles at SP / TP motifs between these two samples 
can be attributed to p38.  Those that are the same under both conditions can be 
attributed to other proline-directed kinases, such as other MAPK family members, 
which could provide an interesting avenue to investigate further in the future.  In 
addition to the p38 activated and inhibited conditions, a third sample from 
untreated cells could be used to determine the basal p38 phosphorylation state in 
these cells.  The method used for analysing the preliminary MS sample involved a 
tryptic digest of dematin and subsequent enrichment of phosphorylated peptides, a 
process that may results in certain peptides being missed from the screening.  In 
order to increase the likelihood of all peptides being detected future MS will 
analyse the total protein sample to maximise the chance of detecting each peptide.  
If certain peptides are not mapped under the experimental conditions, the protocol 
can then be optimised to increase the detection of these fragments. 
In vivo characterisation of dematin phosphorylation by p38 was also conducted 
using western blotting with anti-MPM2 immuno-detection. This antibody is raised 
against proteins that are phosphorylated, either directly or indirectly by M-phase-
promoting factor, upon entry to mitosis in eukaryotic cells.  The limitation of this 
however is that detection of phosphorylated motifs with this antibody is sequence 
context dependent, and so although a positive detection is a useful aid, the lack of 
detection of a peptide is not confirmation that a particular site is not 
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phosphorylated.  The number of sites detected varies with species and cell type, 
and so sites have to be validated on an individual basis.  Detection of the same 
peptide can also be inconsistent.  We have demonstrated that this antibody is 
capable of detecting full-length dematin, and each of the truncated dematinN1, N3, 
and C1 regions, as being phosphorylated in vivo.  This phosphorylation decreased in 
the presence of p38 inhibition with SB203580, suggesting that at least some of 
these motifs are phosphorylated by p38 rather than other proline-directed kinases. 
Phosphorylated proteins may also be detected using gel-shift assays, working on the 
principle that the phosphorylated protein will migrate fractionally slower through 
an SDS-PAGE gel and therefore be detected as a discreet band of a slightly higher 
apparent molecular weight than the unphosphorylated form.  A band-shift was not 
detectable for full-length dematin or any of the truncated constructs, even with 
variation in the percentage acrylamide composition of the gel and total amount of 
protein loaded (data not shown).  An adaptation to this method is now 
commercially available that consists of a phosphate-retarding component that is 
added to the SDS-PAGE gel to enhance the migratory difference between the 
phosphorylated and unphosphorylated protein bands.  This method may be useful 
in future as a tool for validating the MS data.  As this is a rapid, high throughput, 
technique it would be ideal for screening multiple mutant constructs in order to 
determine the specific motifs that are phosphorylated by p38.  
Although p38 is generally considered to phosphorylate substrates at Ser-Pro and 
Thr-Pro motifs, instances of non-proline-directed phosphorylation have been 
documented (Cheung et al., 2003; Reynolds et al., 2000).  Analysis of known p38α 
phosphorylation sites indicated that around 85% are either SP or TP motifs, with the 
others constituting either serine or threonine residues followed by other amino 
acids (Trempolec et al., 2013).   It was therefore important to consider that dematin 
may be phosphorylated at sites other than the motifs that were initially identified.  
The p38 mutant constructs dematinN1_S11/16/26A, dematinN3_S87/92/96/105A, 
and dematinC1_T274A/S383A constructs were not detected as substrates of p38α, 
in either kinase assays or with MPM2 immuno-detection.  This indicates that 
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dematin is phosphorylated at one or more of the SP / TP motifs within each 
construct, and not at any non-consensus sites.   
3.6.2 Potential phosphorylation of dematin by other p38 isoforms and MAPKs 
Four isoforms of p38 have been identified in vivo: p38α, p38β, p38γ, and p38δ.  The 
in vitro kinase assay data presented here looked at the phosphorylation of dematin 
by p38α, but it remains to be determined whether this is specific or whether other 
isoforms can fulfil this function.  Both the p38α and p38β isoforms display 
ubiquitous tissue expression, and are sensitive to inhibition by the SB203580 
inhibitor, however the p38α isoform is expressed at higher levels in vivo and has 
therefore become the model isoform for p38 research (Cargnello & Roux, 2011).  
The p38γ isoform is found mainly in skeletal muscle, and p38δ expressed in the 
kidney, pancreas, small intestine, and testes (Ono & Han, 2000).  HEK293 cells have 
been shown to express all four p38 subtypes (Junttila et al., 2007; Lawson et al., 
2013; Sabio et al., 2010), and therefore the in vivo phosphorylation detected in the 
mass spectrometry and MPM2 experiments could be attributable to isoforms other 
than p38α.  Activation of p38 was achieved through co-transfection with MKK6DD, 
which is capable of activating all isoforms of p38, however the SB203580 inhibitor 
used only has an effect on the p38α and p38β isoforms.  A band was not detected 
when lysate from p38 inhibited HEK293T cells was immunoblotted with an anti-
phospho p38 antibody.  This suggests that the p38δ and p38γ isoforms are not 
active under these experimental conditions, and therefore we can assume that in 
the presence of SB203580 there is no signaling through p38.  It is possible that 
these isoforms are inactivate under basal conditions, but are activated upon 
hyperactivation of p38 through MKK6DD co-transfection, and therefore we cannot 
completely rule out the involvement of these isoforms.  However it seems likely 
that the p38α and p38β isoforms are the main contributors.  
Studies have shown that it is localisation, rather than substrate specificity, which 
distinguishes between p38α and p38β.  Overexpression of the two isoforms in 
C2C12 cells showed that expression of p38α is ubiquitous, whereas p38β locates 
only at the cell periphery.  Kinase assays confirmed that p38β is catalytically capable 
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of phosphorylating the same substrates, but is prevented from doing so in vivo due 
to lack of colocalisation (Knight et al., 2012).  Given the lack of substrate specificity   
between p38α and p38β it is likely that dematin can also be phosphorylated by 
p38β, however the in vivo localisation pattern of p38β may prevent it from 
accessing the total pool of dematin. 
The consensus recognition motif of p38 is shared by all MAPKs.  In our preliminary 
in vitro kinase and microarray experiments, dematin was identified as a substrate of 
p38, but not of ERK5.  The identified motifs may be targets of the ERK1/2 or JNK 
pathways however. Both the dematinN3 and dematinC1 constructs contain SP/TP 
motifs that were not identified as being phosphorylated in the MS analysis.  The 
dematinN3 region has two further p38 motifs at T120P and S156P, and dematinC1 has 
motifs at S307P and S315P.  These sites were also not detected in either the in vitro 
kinase or MPM2 assays suggesting that these are not targets for p38 
phosphorylation, but they may be regulated by other MAPKs.  Due to the broad 
recognition motif of the MAPK kinases, alternative mechanisms of substrate 
recognition are required; however this recognition process is not fully understood.  
The selectivity of MAPKs can be conferred by the presence of docking motifs, which 
greatly increase the affinity of a kinase for a substrate.  These display a far higher 
affinity for their chosen MAPK over the other MAPK family members, however 
some crossover in binding does occur (Bardwell et al., 2009)  Additionally many 
substrates do not contain a docking domain, and this therefore does not regulate all 
interactions.  Substrate recognition in these cases is thought to be controlled by 
availability, concentration, and subcellular localisation (Trempolec et al., 2013).  
Dematin may also be phosphorylated at the above sites by non-MAPK kinases.  The 
majority of serine / threonine specific protein kinases and phosphatases favour 
substrates that don’t contain proline residues in the +1 position, as proline cannot 
act as a hydrogen bond donor.  It is therefore unlikely that any of the identified 
motifs are phosphorylated by such kinases.  Proline-directed kinases overcome this 
by creating an apolar pocket which is unable to bond with the amide nitrogen of 
other amino acids (Gray et al., 2003).  Other proline directed kinases include the 
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cyclin-dependent kinases (CDKs) and glycogen-synthase kinase-3 (GSK-3).  A global 
analysis of proteins estimated that greater than one quarter of phosphorylation 
sites were either Ser-Pro or Thr-Pro motifs, suggesting that these proline-directed 
kinases regulate a larger number of substrates than the non-proline-directed 
kinases.  Of these sites, Ser-Pro motifs greatly outnumbered Thr-Pro sites with by a 
ratio of 5:1 (Ubersax & Ferrell, 2007), which is reflected in the motifs identified in 
dematin. 
3.6.3 The stability of dematin is regulated by the PEST motif but not p38 
The instability of dematin in protein purification experiments has been reported in 
the literature, but never investigated further or quantified.  Here we have used 
pulse-chase degradation analysis to calculate the intracellular half-life of the 52 KDa 
isoform of dematin to be 5.49 +/- 0.44 hours.  A recent large-scale analysis of over 
5000 mammalian proteins calculated the median half-life to be 46 hours 
(Schwanhäusser et al., 2013).  Relative to the total protein complement, this 
therefore classifies dematin as a short-lived protein.  The intracellular half-life of a 
protein correlates strongly with its in vivo function.  Proteins with a high turnover 
rate have functions that require high temporal regulation, such as roles in signalling 
pathways that are subjected to considerable variations in requirements.  This 
suggests that cells use the degradation of dematin a mechanism for regulating its 
function, and that at least some functions of dematin require time-dependent 
control.  
The presence of a PEST motif in dematin has been reported previously, however the 
exact location of this motif was not consistently defined.  The application of the 
EMBOSS epestfind algorithm enabled an unbiased definition of the PEST sequence, 
89KSTSPPPSPEVWADSR104, which was used for subsequent experiments.  Deletion of 
this region confirmed the involvement of the PEST motif in the instability of 
dematin in vivo, with the calculated half-life of the dematin_ΔPEST deficient 
construct significantly longer than wild-type dematin at 7.64 +/- 0.72 hours.  
Activation of PEST motifs has been linked to protein degradation through both the 
ubiquitin proteasome pathway (Rechsteiner & Rogers, 1996), and the lysosomal 
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pathway (Zhuang et al., 2012).  Determining the mechanism through which this 
occurs in dematin will provide further insight into the process.    
The majority of PEST motifs act as primary degrons, requiring a second activation 
mechanism to induce protein degradation.  Of these mechanisms phosphorylation 
within the PEST domain is the most prevalent, and the confirmation of active p38 
motifs both within and flanking the PEST motif made p38 a likely candidate for this 
function.  Phosphorylation of the dematinN3_S92/96A construct was consistently 
reduced compared to wild-type, whereas the dematinN3_S87/92/96/105A was 
unphosphorylated.  This suggests that dematin is phosphorylated in vitro by p38α at 
one or both of the S87 / S105 motifs which flank the PEST domain, in addition to 
one or both of the S92 / S96 motifs within the PEST domain.  However no significant 
change in degradation was identified in the presence of p38-hyperactivation or 
inhibition.  Equally the stability of dematin could not be significantly increased / 
decreased through the mutation of the S87/92/96/105 residues to either Ala or Glu 
residues.  This suggests that the PEST-mediated stability of dematin is not regulated 
by phosphorylation of theses residues.  However a trend towards phospho-
mediated instability was detected, and therefore there is a possibility that the 
technique used here was not sensitive enough to detect these changes. Confirming 
the mechanism that regulates dematin degradation will be beneficial in providing 
further information on the conditions under which its degradation is enhanced.  A 
small subpopulation of PEST motifs act as primary degrons and don’t require 
activation, so this remains an alternative possibility for dematin. 
Although these algorithms act as an indicator of physiologically relevant PEST motifs, 
not all of these are shown to be important in vivo.  Three high-scoring PEST motifs 
were identified in the sequence of c-Fos; however individual deletion of two of 
these had no effect on protein stability.  In contrast, deletion of the third site had a 
stabilising effect.  It may, however, be that proteins that contain multiple high-
scoring PEST motifs rely on each under different circumstances.  As dematin only 
contained a single motif above the threshold this is unlikely to be a mechanism that 
occurring here.  However the threshold is to some extent an arbitrary cut-off value 
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to determine potential biological significance, and any site with a positive score 
technically qualifies as a PEST motif.  The motif from 300-325 aa was attributed a 
score of 4.08, and therefore although it is unlikely that this has an impact on 
stability it remains a possibility. 
Previous attempts to overexpress dematin in E.coli in order to study the structure of 
core domain have reportedly been hindered by significant problems with 
proteolysis (Chen et al., 2009).  In an attempt to combat this, the group created a 
number of mutated constructs.  Mutation of Glu89 to a lysine residue to switch the 
charge was not successful; neither was substituting the phosphorylatable sequence 
90STS92 with the non-phosphorylatable 90AAA92.  They were able to prevent 
proteolysis by deletion the entire PEST motif (which they defined as 
89KSTSPPPSPEVWAD102), however concerns over the effect of removing such a large 
sequence on the native conformation of the core domain made the construct 
unsuitable for the desired experiments.  The final approach involved mutating all 
Pro, Glu, Ser, and Thr residues within the motif; Ser / Thr residues were mutated to 
Ala, Pro to Gly, and Glu to Lys.  This new construct containing 
89KAAAGGGAGKVWAD102 was reported to be resistant to proteolysis.  These 
experiments involved the expression of GST- fusion proteins in E.coli.  Interestingly 
there has been no documented evidence of the activity of the PEST degradation 
pathway in prokaryotic organisms.  However the deletion results are consistent with 
the results presented here using the dematin_ΔPEST construct. 
Although the PEST motif was identified as a regulator of dematin degradation, it is 
likely that there are other factors that control dematin stability.  The Expasy 
ProtParam calculator (Gasteiger E., 2005) gives an estimate of the stability of a 
protein in a test tube, which is referred to as an Instability Index (II) value.  This 
calculation is based upon statistical analysis of 12 unstable and 32 stable proteins, 
which identified certain dipeptides that had significantly different occurrences 
between the two groups (Guruprasad et al., 1990).  Each of the 400 dipeptides 
identified were scored according to their instability correlation, and these scores 
along with the length of the protein sequence to be analysed, are used to 
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determine the II value of a protein.  Values of 40 or below predict that a protein will 
be stable in a test tube, whereas values above this suggest instability.  The II values 
of the 48 and 52 KDa isoforms of dematin were computed to be 75.74 and 72.04 
respectively, which classifies both isoforms as unstable. 
3.6.4 The dematin HP / core domain interaction is not regulated by p38 
Chen et al (2013) recently demonstrated that upon phosphorylation of the dematin 
HP at Ser74 [Ser403] by PKA, a conformational change was induced that increased the 
affinity of the HP for the core domain, and subsequently inhibited actin bundling.  
We were able to demonstrate this interaction in our system, with the HP binding to 
full-length dematin.  An interaction was not detected between the HP and 
truncated constructs dematinN2, N3, or C1.  These constructs were initially 
designed to investigate p38 phosphorylation sites, and 14-3-3 binding motifs, and so 
do not cover the entire dematin sequence.  These results therefore suggest that the 
HP binds to the core domain either in the region not covered by these constructs 
(from aa 197-261), or at a site overlapping this untested region and either the 
dematinN3 or dematinC1 domains.  The cloning of further constructs will be 
required to precisely define the site within the core domain that the HP binds to. 
The dematin HP contains a single SP phosphorylation motif at Ser383, and here we 
have confirmed through MS and MPM2 immunoblotting that this site is 
phosphorylated in vivo.  Furthermore the site was directly phosphorylated by p38α 
in in vitro kinase assays, and in vivo phosphorylation was detected in the absence 
but not presence of the p38 inhibitor SB203580.  Localisation of this site at the 
extreme end of an α-alpha helical region, on the external surface of the protein, 
lead to the hypothesis that phosphorylation of this site might change the 
conformation of the dematin HP.  Using the HP / dematin binding model above, 
p38-hyperctivation or inhibition were shown to have no effect on the HP / core 
interaction.  Creating constructs where the Ser383 phosphorylation site had been 
mutated either to an non-phosphorylatable Ala residue, or to a phospho-mimicking 
Glu residue, further validated this finding as no disruption in the HP/core binding 
was detected.  This therefore suggests either that p38 phosphorylation of this site 
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does not induce a conformational change in the dematin HP, or that the 
conformational change occurs in a manner that is compatible with the HP / core 
binding mechanism.   
In order to fully characterise the potential change in conformation that occurs in the 
dematin HP upon phosphorylation of Ser383 by p38, it would be useful to determine 
the structure of the dematinHP_S383A and dematinHP_S383D constructs using 
solution NMR.  Comparison of the resulting structures to the currently available 
wild-type HP structure would enable an improved understanding of the potential 
for phosphor-regulation of the HP at Ser383.  If a phospho-mediated conformational 
change can be demonstrated, then p38 may act directly to inhibit actin binding / 
bundling.  The Ser383 site is located in the middle of the dematin HP actin-binding 
motif 367LERHLSAEDFSRVFAMSPEEFGKLALWKR395 and therefore a p38-mediated 
conformational change has the potential to directly inhibit actin binding at this 
motif.  This would leave only the core motif able to bind actin, and subsequently 
would prevent dematin from bundling actin. 
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4. Dematin interacts with 
the adaptor protein 14-3-3 
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4.1 Introduction 
14-3-3 proteins are ubiquitously expressed throughout the body, and interact with a 
vast array of target proteins to regulate important cellular functions (Hermeking & 
Benzinger, 2006; Kleppe et al., 2011).  In humans, seven distinct genes encoding 14-
3-3 isoforms β, γ, ε, ζ, η, τ and σ have now been identified (Wang & Shakes, 1996).  
The interaction between 14-3-3 and a target protein commonly occurs at 
phosphorylated mode I RSx(pS/pT)xP, or mode II Rxϕx(pS/pT)xP motifs, where 
pS/pT indicates a phosphorylated serine / threonine residue, ϕ is an aromatic or 
aliphatic residue, and x is any amino acid (Muslin et al., 1996; Yaffe et al., 1997).  In 
some instances 14-3-3 can also interact with the extreme carboxy-terminus of a 
protein at a mode III –(pS/pT)x1-2-COOH motif (Coblitz et al., 2005).  Although these 
conserved peptide motifs are the interaction sites in the majority of cases, 14-3-3 
displays some flexibility in target binding and there are examples that show motifs 
that deviate significantly from the above sequences (Johnson et al., 2010). 
To date more than 300 14-3-3 binding proteins have been identified, but there are 
likely to be many others that have yet to be characterised.  The primary sequence of 
dematin contains a number of 14-3-3 consensus motifs (Figure 1.2), and is therefore 
a likely substrate of 14-3-3.  Dematin is both an actin-binding and -bundling protein 
(Rana et al., 1993), and characterisation of a dematin / 14-3-3 interaction could 
therefore provide further evidence of an increasing role for the 14-3-3 protein 
family in regulating the cytoskeleton.   In addition, dematin is fairly ubiquitously 
expressed throughout the body (Kim et al., 1998; Rana et al., 1993) and identifying 
novel regulatory mechanisms therefore has widespread functional implications. 
In the majority of cases, 14-3-3 requires a consensus motif in the target protein to 
be phosphorylated for binding to occur (Yaffe et al., 1997).  As many 14-3-3 binding 
motifs contain an arginine residue in the -3 position, basophilic serine / threonine 
kinases commonly phosphorylate these motifs as it correlates with their own 
consensus motifs.  Known regulators of 14-3-3 binding include Akt (Mohammad et 
al., 2013), PKA (Neukamm et al., 2013), and AMPK (Shen et al., 2013). 
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In addition to requiring a phosphorylated binding motif, 14-3-3 binding can be 
negatively regulated by inhibitory phosphorylation of the target protein at residues 
neighbouring the binding motif.  In chapter 3 dematin was identified as a novel 
substrate of the p38 MAPK.  Several of the 14-3-3 binding motifs within dematin 
either overlap with, or border, p38 phosphorylation sites (Figure 1.2).  The potential 
regulation of the dematin / 14-3-3 interaction by inhibitory p38 phosphorylation will 
therefore also be investigated. 
The experiments presented in this chapter aimed to answer the following questions: 
1) Does dematin interact with 14-3-3β in vivo? 
2) Which 14-3-3 binding motifs in dematin mediate this interaction? 
3) Are these motifs phosphorylated by AKT, AMPK, or PKA? 
4) Is the dematin / 14-3-3β interaction regulated by p38 phosphorylation? 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 - Dematin interacts with 14-3-3 
 
125  
 
4.2 The interaction between dematin and 14-3-3β 
The seven human isoforms of 14-3-3 show variation in their subcellular expression 
patterns, with the β and ζ isoforms preferentially associating with cytosolic and 
cytoskeletal proteins (Roth et al., 1994).  As dematin known to be a cytoskeletal-
associated protein, the 14-3-3β isoform was selected as a basis for investigating the 
potential interaction between dematin and 14-3-3.   
4.2.1 The primary sequence of dematin contains seven 14-3-3 binding motifs 
14-3-3 family members interact with their target proteins at specific 
phosphorylated motifs.  These can be generally defined as Mode I (Rxx(pS/pT)xP), 
Mode II (Rxϕx(pS/pT)xP), or Mode III (-(pS/pT)x1-2-COOH).  This conservation allows 
potential novel 14-3-3 binding partners to be easily identified by scanning the 
primary sequences for the presence of these motifs.  Two isoforms of dematin exist 
of 48 and 52 KDa, which differ by a 22-amino acid insert (Figure 4.1).  The primary 
sequences of both isoforms (Homo Sapiens; NP_001107610.1 and NP_001107608.1) 
were analysed using the Scansite (Obenauer et al., 2003) and Eukaryotic Linear 
Motif resource (Dinkel et al., 2013) programmes to identify the presence of such 
motifs.  These databases also contain the sequences of non-standard motifs found 
in other validated 14-3-3 binding proteins, and so are capable of identifying less 
stringent potential binding sites. 
Sequence scans identified six 14-3-3 binding motifs that are found in both dematin 
isoforms, and an additional motif in the 52 KDa variant (Figure 4.1).  Of these seven 
sites, two were Mode I motifs at RDSS22VP and RGNS333LP, the second of which is 
only found in the longer 52 KDa isoform.  There was a single Mode II motif of 
RKTRS269LP, and a Mode III C-terminal KKKAS403LF binding motif.  In addition to 
these sites there were a further three motifs that didn’t fit into the strict mode I / II 
/ III groupings - RERS85LSP, RTS124LP, and KSSS289LP. 
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Figure 4.1: The 14-3-3 consensus motifs in the human dematin sequence 
14-3-3 proteins interact with their targets at well-defined sequence motifs.  Analysis 
of the primary sequences of the 48 and 52 KDa splice variants of human dematin 
identified seven 14-3-3 binding motifs in the longer isoform, and six in the shorter 
version (yellow boxes).  These are numbered according to the amino acid position 
of the phosphorylatable serine residue in the 52 KDa isoform.  
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4.2.2 Cloning of dematin constructs for use in this chapter 
Dematin constructs were cloned into mammalian expression vectors as described in 
chapter 3, section 3.2.2.  In addition to the constructs used in chapter 3, the shorter 
48 KDa isoform of dematin was also cloned using the same method, and was MYC 
tagged to differentiate it from the 52 KDa isoform.  As previously, constructs for 
GST-pulldown experiments had a GST-tag to facilitate purification, and a FLAG or 
MYC tag for immuno-detection.  Proteins for IP experiments were tagged only with 
FLAG or MYC.  A schematic of the dematin constructs used in this chapter is 
provided in Figure 4.2. 
4.2.3 14-3-3β binds to both the 48 and 52 KDa isoforms of dematin 
To determine whether 14-3-3β binds to dematin in vitro, co-immunoprecipitation 
experiments were conducted in HEK293T cells co-transfected with either 
pDEST27FLAG-dematin and pcDNA3.1MYC-14-3-3β or pDEST27MYC-dematin48 and 
pcDNA3.1FLAG-14-3-3β.  Cells were lysed under conditions which maintained 
protein-protein interactions, and then immunoprecipitated with either anti-FLAG or 
anti-MYC antibodies as appropriate.  Immunoprecipitates were subjected to SDS-
PAGE separation, and immunoblot analysis was conducted using either anti-FLAG or 
anti-MYC antibodies.  Results showed that 14-3-3β co-immunoprecipitated with 
dematin (Figure 4.3A) and dematin48 (Figure 4.3B).  In the reciprocal experiments, 
both dematin constructs co-immunoprecipitated with 14-3-3β (Figure 4.3).  In each 
experiment the negative control IPs in which dematin or 14-3-3β was expressed 
alone showed no non-specific protein bands in these regions.  This indicates that 
14-3-3β interacts with both the 48 KDa and 52 KDa isoforms of dematin. 
4.3 Sites of interaction between dematin and 14-3-3β 
Following the demonstration of an interaction between dematin and 14-3-3β, the 
regions of dematin that were involved in this interaction were investigated.  Site-
directed mutagenesis was used to create constructs with mutated 14-3-3 binding 
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Figure 4.2: Schematic illustrating the dematin constructs used in this chapter 
Diagram showing the relative positions of full-length and truncated dematin 
constructs cloned for use in this chapter, with the tags used for purification and 
detection.  Constructs for use in GST-pulldown experiments (A) all had N-terminal 
GST-tags followed by either a FLAG or MYC tag.  Those for IP experiments (B) had 
only an N-terminal FLAG or MYC tag.  (GST; glutathione-S-transferase, IP; 
immunoprecipitation). 
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Figure 4.3: Dematin and 14-3-3β co-immunoprecipitate in HEK293T cells 
The potential interactions between the 48 and 52 KDa isoforms of dematin and 14-
3-3β were investigated using co-immunoprecipitation experiments in HEK293T cells.  
Cells were co-transfected with pDEST27FLAG-Dematin and pcDNA3.1MYC-14-3-3β 
(A) or pDEST27MYC-dematin48 and pcDNA3.1FLAG-14-3-3β (B) and.  Cells lysates 
were immunoprecipitated with either anti-FLAG, or anti-MYC antibodies, as 
appropriate to purify dematin, and proteins separated by SDS-PAGE and transferred 
onto nitrocellulose.  Membranes were immunoblotted with anti-FLAG and anti-MYC 
antibodies of different species from those used for the immunoprecipitation. (n=3) 
(SDS-PAGE; sodium dodecyl sulphate polyacrylamide electrophoresis, wcl; whole cell 
lysate) 
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sites, and GST-pulldown experiments repeated with these mutants to determine 
which sites mediate this interaction. 
4.3.1 Full-length dematin contains three phosphorylated 14-3-3 binding motifs 
As the majority of interactions between 14-3-3 and its targets require a 
phosphorylated binding motif, identifying which of the seven motifs within dematin 
are phosphorylated provided a starting point for determining the active interaction 
sites.  Phosphorylated residues in the 52 KDa isoform of dematin were mapped 
using mass spectrometry (see chapter 3, section 3.3.3).  Analysis of the peptide 
fragments identified a total of 24 phosphorylated residues under our experimental 
conditions.  Of these phosphorylated residues, 3 corresponded with the previously 
identified 14-3-3 binding motifs: serine residues 22, 85, and 269 (Table 4.1).  This 
suggested that the motifs RDSS22VP, RERS85LSP, and RKTRS269LP were likely 
candidates for the dematin / 14-3-3 interaction. 
4.3.2 14-3-3β binds to the C-terminal region of dematin  
The mass spectrometry analysis identified 3 phosphorylated 14-3-3 binding motifs, 
which then needed to be tested to determine whether they mediate an interaction 
with 14-3-3β.  To facilitate this, four truncated dematin constructs were cloned,  
covering the following amino acid ranges: dematinN1 (0-78), dematinN2 (0-96), 
dematinN3 (69-196) and dematinC1 (261-405).  The relative positioning of each 
construct can be seen in Figure 4.2.  These constructs were expressed as fusion 
proteins in HEK293T cells, and purified on GST-binding columns.  Following SDS-
PAGE separation and western blotting, membranes were probed for anti-FLAG 
(dematin) and anti-MYC (14-3-3β) as previously.  All four truncated constructs were 
successfully purified out of the lysate via their GST tags, however 14-3-3β only co-
purified with dematinC1 (Figure 4.4).  This indicated that under these experimental 
conditions 14-3-3β binds to the C-terminal region of dematin between aa 261-405, 
but does not bind to the N-terminal region. 
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Table 4.1: Dematin contains three phsophorylated 14-3-3 binding motifs 
Mass spectrometry was used to identify phosphorylated residues in the 52 KDa 
isoform of dematin.  HEK293T cells were transfected with pDEST27-Flag-Dematin 
and pcDNA3.1-MKK6DD using calcium phosphate.  Cells were lysed and dematin 
purified on a GST pulldown column, and separated by SDS-PAGE.  After coomassie 
staining, the dematin protein band was excised from the gel and lyophilised.  The 
sample was analysed by mass spectrometry for the presence of phosphorylated 
residues.  These phosphorylation sites were then correlated with known 14-3-3 
binding motifs in dematin to determine which of these were phosphorylated.   
14-3-3 binding 
motif 
Phosphorylatable 
residue 
Phosphorylated in 
mass spectrometry? 
Truncated constructs 
containing this site 
RDSSVP serine 22 YES N1, N2 
RERSLSP serine 85 YES N2, N3 
RTSLP serine 124 NO N2, N3 
KTRSLP serine 269 YES C1 
KSSSLP serine 289 NO C1 
RGNSLP serine 333 NO C1 
KKKASLF serine 403 NO C1 
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Figure 4.4: Only the C-terminal region of dematin binds to 14-3-3β 
Co-immunoprecipitation experiments were conducted to determine which regions 
of dematin interact with 14-3-3β. HEK293T cells were co-transfected with the 
truncated dematin constructs N1, N2, N3 and C1 in pDEST27FLAG vector, and 
pcDNA3.1MYC-14-3-3β.  Cells lysates were purified on GST-pulldown columns, 
separated by SDS-PAGE and transferred onto nitrocellulose.  Membranes were 
immunoblotted with anti-FLAG and anti-MYC antibodies.  The truncated dematin 
constructs cover the following amino acid ranges relative to the full-length 52 KDa 
protein: N1 (0-78), N2 (0-96), N3 (69-196) and C1 (261-405). (n=3)  (GST; glutathione S-
transferase, wcl; whole cell lysate). 
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4.3.3 14-3-3β binds to the C-terminal region of dematin at Ser269 and Ser333 
Confirming that 14-3-3β co-immunoprecipitated with the dematinC1 provided a 
starting point for determining the essential 14-3-3 binding motifs within this region.  
The dematinC1 construct contains four 14-3-3 consensus motifs at residues Ser269, 
Ser289, Ser333, and Ser403.  The mass spectrometry analysis, however, only identified 
Ser269 as being phosphorylated under our experimental conditions.  Site-directed 
mutagenesis was employed to create a C1_S269A mutant with the 
phosphorylatable serine residue mutated to a non-phosphorylatable alanine 
residue.  The GST-pulldown experiment was then repeated to determine whether 
the loss of this single binding motif could prevent the interaction between 
dematinC1 and 14-3-3β.  As Figure 4.5 shows, 14-3-3β still co-purified with the 
dematinC1_S269A mutant.  This suggested either that the RKTRS269LP motif was not 
a site of interaction between dematinC1 and 14-3-3β, or that it was not the only site 
of interaction and that the other site(s) was capable of independent binding in the 
absence of Ser269.   
As none of the Ser289, Ser333, or Ser403 residues were detected as being 
phosphorylated in our mass spectrometry experiments, a systematic approach was 
taken to determining which of these binding sites were important.  Further serine 
to alanine mutants of the dematinC1 consensus motifs were created that each had 
three of the four binding sites mutated, leaving only a single binding motif; 
S289/333/403A, S269/333/403A, S269/289/403A and S269/289/333A.  GST-
pulldown experiments showed that RKTRS269LP (mutant S289/333/403A) and 
RGNS333LP (mutant S269/289/403A) were sufficient to independently bind 14-3-3 in 
the absence of the other motifs (Figure 4.6).  Having a single phosphorylatable motif 
at Ser289 (mutant S269/333/403A) or Ser403 (mutant S269/289/333A) was 
insufficient to maintain the dematinC1 / 14-3-3β interaction (Figure 4.6).  A double 
mutant of dematinC1_S269/333A was then created, to confirm that these two sites 
were the only motifs in dematinC1 required for 14-3-3β binding.  Repetition of the 
GST-pulldown experiments showed that 14-3-3β no longer co-purified with 
dematinC1 in the absence of Ser269 and Ser333 (Figure 4.6). 
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Figure 4.5: Ser269 is not the only 14-3-3 binding site in dematinC1  
Mass spectrometry identified a single phosphorylated 14-3-3 binding motif in the C-
terminal region of dematin at Ser269.  Co-immunoprecipitation experiments using a 
dematin_S269A mutant were conducted to determine whether this was sufficient 
to abolish the C1 / 14-3-3β interaction.  HEK293T cells were co-transfected with the 
given dematin construct in pDEST27FLAG vector, and pcDNA3.1MYC-14-3-3β.  Cells 
lysates were purified on GST-pulldown columns, separated by SDS-PAGE, and 
transferred onto nitrocellulose.  Membranes were immunoblotted with anti-FLAG 
and anti-MYC antibodies. (n=3)   (GST; glutathione S-transferase, wcl; whole cell 
lysate). 
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Figure 4.6: C-terminal region of dematin binds 14-3-3β at Ser269 and Ser333 
HEK293T cells were co-transfected with the stated dematin-C1 construct in the 
pDEST27FLAG vector, and pcDNA3.1MYC-14-3-3β.  Cells lysates were purified on 
GST-pulldown columns, separated by SDS-PAGE, and transferred onto nitrocellulose.  
Membranes were immunoblotted with anti-FLAG and anti-MYC antibodies.  Triple 
mutants with three potential binding sites mutated to alanine residues (A) were 
first conducted to narrow down the potential sites of interaction.  After showing 
that the S269 and S333 sites were capable of independent binding to 14-3-3β, the 
double mutant of these sites (B) was tested to confirm that this was sufficient to 
abolish the interaction. (n=3) (GST; glutathione S-transferase, wcl; whole cell lysate; 
WT, wild-type sequence). 
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4.3.4 14-3-3β binds to full-length dematin at serine residues 269 and 333 
Further mutants were then created in the pDEST27FLAG-dematin and 
pDEST27FLAG-dematin48 backbones to determine whether preventing binding at 
the RKTRS269LP and RGNS333LP motifs was sufficient to prevent the interaction 
between full-length dematin and 14-3-3β.  The GST-pulldown experiments were 
repeated with these new constructs, and the double S269/333A mutant was again 
sufficient to abolish the interaction between the 52 KDa isoform of dematin and 14-
3-3β (Figure 4.7A).  As seen with dematinC1, constructs that contained only one of 
the two phosphorylated binding motifs were still able to interact with 14-3-3β 
(Figure 4.7A).  The 48 KDa isoform of dematin lacks the RGNS333LP motif, therefore 
the single S269A mutation was sufficient to abolish the dematin48 / 14-3-3β 
interaction (Figure 4.7B).  From this we can conclude that 14-3-3β binds to the 52 
KDa isoform of dematin at the RKTRS269LP and RGNS333LP motifs, and to the 48 KDa 
isoform at RKTRS269LP. 
4.4 Candidate kinases for the phosphorylation of 14-3-3 motifs 
For an interaction to occur between 14-3-3 and a target protein, phosphorylation of 
a putative binding motif is generally required.  Binding motifs have previously been 
shown to be phosphorylatable by a range of protein kinases, and here we aimed to 
determine which kinases were phosphorylating the motifs identified in dematin.   
4.4.1 Phosphorylation of dematinC1 at Ser269 and Ser333 
The amino acid sequences surrounding the Ser269 and Ser333 phosphorylation sites 
were scanned for the presence of kinase phosphorylation motifs using the Scansite 
resource (Obenauer et al., 2003).  Protein sequences are compared to the optimal 
phosphorylation motifs of different Ser/Thr kinases, and given a score depending on 
how closely the surrounding amino acids correlate with ideal values.  High 
stringency sites are those within the top 0.2% of all sites found in the vertebrate 
collection of the Swiss-Prot protein database.  Medium or low stringency scores 
indicate that a sequence is within the top 1% or 5% respectively.  Ser269 was ranked 
 
Chapter 4 - Dematin interacts with 14-3-3 
 
137  
 
 
 
 
 
 
Figure 4.7: Dematin interacts with 14-3-3β at Ser269 and Ser333 
HEK293T cells were co-transfected with the stated dematin constructs in the 
pDEST27FLAG vector, and pcDNA3.1MYC-14-3-3β.  (Cells lysates were purified on 
GST-pulldown columns, separated by SDS-PAGE and transferred onto nitrocellulose.  
Membranes were immunoblotted with anti-FLAG and anti-MYC antibodies as 
shown.  (A) Interaction between 52 KDa dematin and 14-3-3β.  (B) Interaction 
between 48 KDa dematin and 14-3-3β (n=3) (GST; glutathione S-transferase, wcl; 
whole cell lysate) 
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as a high stringency Akt site and medium stringency for AMPK and PKA.  Ser333 was 
ranked as a medium stringency Akt site and low stringency PKA site.  However as 
these are only predictions, both sites were tested with inhibitors against all three.   
GST-pulldown experiments between pDEST27FLAG-dematinC1_S269A or 
pDEST27FLAG-dematinC1_S333A and pcDNA3MYC-14-3-3β were repeated in the 
presence of inhibitors of Akt, AMPK, and PKA.  Cells were transfected and 
maintained for 48 hours before 6 hours incubation with inhibitor immediately prior 
to cell lysis and IP.  Inhibition of Akt, AMPK or PKA were insufficient to abolish the 
interaction between 14-3-3β and dematinC1_333A (Figure 4.8A) or 
dematinC1_269A (Figure 4.8B).  This suggests that under our experimental 
conditions, Akt, AMPK, or PKA do not phosphorylate the RKTRS269LP and RGNS333LP 
binding sites in dematin.  To confirm the efficacy of the inhibitors used, an inhibitor 
timecourse could have been conducted using antibodies against phosphorylated 
downstream targets to quantify the level of inhibition from 0-6 hours.  
4.4.2 Phosphorylation of N-terminal 14-3-3 binding motifs 
Although the mass spectrometry identified phosphorylated 14-3-3 consensus motifs 
at serine residues 22 and 85, our standard experimental conditions failed to detect 
an interaction between the N-terminal of dematin and 14-3-3β.  To rule out the 
possibility that an interaction was not occurring due to these sites not being 
activated by their physiological kinases under these conditions, we attempted to 
identify potential regulators of these sites.  Sequence analysis identified Ser22 as a 
medium stringency Akt phosphorylation site, and a low stringency PKA site. 
Ser85 was reported to be a high stringency Akt site and low stringency AMPK / PKA. 
The GST-pulldown experiments with pDEST27FLAG-dematinN2 and pcDNA3.1MYC-
14-3-3β were repeated immediately after activation of these kinases.  Cells were 
incubated for 1 hour with 100 nm insulin, 500 μM AICAR, or 10 μM forskolin to 
activate Akt, AMPK, or PKA respectively.  Under these conditions, 14-3-3β still did 
not co-purify with dematinN2 (Figure 4.9A).  To determine whether these sites were 
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Figure 4.8: Inhibition of Akt, AMPK, or PKA does not inhibit the dematin / 14-3-3β 
interaction 
The interaction between dematin-C1 and 14-3-3β was investigated in the presence 
on various inhibitors to try and determine whether these kinases phosphorylate 
either the RKTRS269LP or RGNS333LP motifs.  HEK293T cells were co-transfected with 
pDEST27FLAG-dematin_S333A (A) or pDEST27FLAG-dematin_S269A (B), and 
pcDNA3.1MYC-14-3-3β.  After 48 hours, cells were treated with inhibitors of Akt, 
AMPK, and PKA for 6 hours.  Cells lysates were then purified on GST-pulldown 
columns, separated by SDS-PAGE and transferred onto nitrocellulose.  Membranes 
were immunoblotted with anti-FLAG and anti-MYC antibodies (n=3)  (GST; 
glutathione S-transferase, wcl; whole cell lysate) 
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Figure 4.9: Activation of Akt, AMPK, or PKA is not sufficient to induce an 
interaction between the N-terminal of dematin and 14-3-3β 
(A) The N-terminal dematin fragment was treated with compounds to activate Akt, 
AMPK and PKA to determine whether this could induce an interaction with 14-3-3β.  
HEK293T cells were co-transfected with pDEST27FLAG-dematinN2 and 
pcDNA3.1MYC-14-3-3β.  After 48 hours, cells were treated with activators of AKT 
(100 nM insulin), AMPK (500 μM AICAR), and PKA (10 µM forskolin) for 60 minutes.  
Cells lysates were then purified on GST-pulldown columns, separated by SDS-PAGE 
and transferred onto nitrocellulose.  Membranes were immunoblotted with anti-
FLAG and anti-MYC antibodies.  (B) The experiment was repeated following a one-
hour incubation with calyculin to inhibit protein phosphatases PP1 and PP2A activity 
(n=3) (GST; glutathione S-transferase, wcl; whole cell lysate). 
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being phosphorylated by alternative kinases, the experiments were repeated 
following a 60-minute incubation with 100 nM calyculin.  As calyculin inhibits the 
activity of protein phosphatases PP1 and PP2A, phosphorylation at all sites 
regulated by these phosphatases will increase under these conditions.  As in 
untreated conditions 14-3-3β still did not co-purify with dematinN2 (Figure 4.9B).   
This suggests that 14-3-3β does not bind to dematinN2 at phosphorylated residues 
Ser22 and Ser85, or that binding of these sites alone is not sufficient for an 
interaction.  Alternatively, it may be that one or both of these residues are 
dephosphorylated by phosphatases other than those of the PP1 and PP2A families, 
and so inhibition with calyculin did not increase phosphorylation at these sites. 
4.5 Effect of p38 phosphorylation on 14-3-3β binding 
In addition to the kinase required to phosphorylate the binding motif, the ability of 
14-3-3 proteins to interact with a target can be regulated by other inhibitory kinases.  
In chapter 3, dematin was identified as a novel substrate of the p38 MAPK, and we 
therefore aimed to investigate whether p38 plays a regulatory role in the 
interaction between dematin and 14-3-3β.  This was of particular interest as the 14-
3-3 binding motifs at Ser22, Ser85, and Ser269 that were identified in the mass 
spectrometry analysis all contain closely neighbouring or overlapping potential p38 
phosphorylation motifs.    
4.5.1 The dematinC1/ 14-3-3β interaction is not affected by p38 phosphorylation  
The effect of p38 phosphorylation was first tested on the known 14-3-3 binding 
sites at Ser269 and Ser333, with single serine-alanine mutants used to look at the 
regulation of each site individually.  Thr274 is a potential p38 phosphorylation motif 
that neighbours the Ser269 14-3-3 binding motif (Figure 4.10A), and this was 
identified as being phosphorylated in our mass spectrometry (Chapter 3, Figure 3.5).  
The GST pulldown experiment between pDEST27FLAG-dematinC1_S269A or 
pDEST27FLAG-dematinC1_S333A and pcDNA3.1MYC-14-3-3β were repeated under 
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Figure 4.10: Alterations in p38 phosphorylation state do not affect the interaction 
between 14-3-3β and the C-terminal of dematin 
HEK293T cells were co-transfected with pDEST27FLAG-dematin_S269A or 
pDEST27FLAG-dematin_S333A, and pcDNA3.1MYC-14-3-3β.  For p38 activation cells 
were co-transfected with pcDNA3FLAG-MKK6.  After 48 hours, p38 inhibited cells 
were treated with the specific inhibitor SB203580 for 4 hours.  Cells lysates were 
then purified on GST-pulldown columns, separated by SDS-PAGE and transferred 
onto nitrocellulose.  Membranes were immunoblotted with anti-FLAG and anti-MYC 
antibodies.  (GST; glutathione S-transferase, wcl; whole cell lysate). 
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conditions of varying p38 phosphorylation status.  p38 was hyper-activated through 
co-transfected with pcDNAFLAG-MKK6DD, a specific upstream activator, or inhibited 
with a 4 hour incubation with the specific inhibitor SB203580 immediately prior to 
cell lysis.  Alterations in p38 phosphorylation state were insufficient to prevent an 
interaction between dematinC1 and 14-3-3β at the RKTRS269LP (Figure 4.10B) motif 
or at the RGNS333LP motif (Figure 4.10C).  This suggests either that these sites are 
not being phosphorylated by p38, or that p38 phosphorylation of these 
neighbouring sites does not inhibit dematin / 14-3-3 association.  
4.5.2 p38 phosphorylation does not regulate an N-terminal / 14-3-3β interaction 
The N-terminal 14-3-3 binding motifs at Ser22 and Ser85 were unable to mediate an 
interaction between dematin and 14-3-3.  Here we aimed to investigate whether 
p38 phosphorylation of dematin was inhibiting this interaction by preventing the 
association of 14-3-3β.  Residues Ser16, Ser26, Ser87 and Ser92 were all 
phosphorylated in our mass spectrometry analysis of dematin (Chapter 3, Figure 
3.5).  As can be seen in Figure 4.11A, these phosphorylation sites either closely 
neighbour or overlap the 14-3-3 binding motif.  The co-immunoprecipitation 
experiments between pDEST27FLAG-dematinN1 or dematinN3 and pcDNA3.1MYC-
14-3-3β were repeated with co-transfection of pcDNAFLAG-MKK6DD or incubation 
with SB203580 inhibitor.  No co-immunoprecipitation of 14-3-3β was seen with 
either dematinN1 (Figure 4.11B) or dematinN3 (Figure 4.11C) under p38 hyper-
activated or inhibition conditions.  This suggests that the absence of a detectable 
interaction between 14-3-3β and dematin at the RDSS22VP or RERS85LSP motifs is 
not due to p38 phosphorylating neighbouring sites and hindering 14-3-3 binding.  
GST-pulldown experiments were conducted using HEK293T cells co-transfected with 
pDEST27FLAG-dematinN1_S16/26A or pDEST27FLAG-dematinN3_S87/92A and 
pcDNA3.1MYC-14-3-3β.  Co-purification of 14-3-3β was not detected with either the 
dematinN1_S16/26A (Figure 4.12B), nor dematinN3_S87/92A (Figure 4.12C), 
constructs.  This indicates that the absence of a detectable interaction between 
dematin and 14-3-3β at the RDSS22VP and RERS85LSP motifs is not due to the 
inhibitory phosphorylation of the neighbouring Ser16/ Ser26 and Ser87 / Ser92 residues.  
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Figure 4.11: Alterations in p38 phosphorylation state are not sufficient to induce 
and interaction between 14-3-3β and the N-terminal of dematin 
HEK293T cells were co-transfected with pDEST27FLAG-dematinN1 or dematinN3, 
and pcDNA3.1MYC-14-3-3β.  For p38 hyper-activation, cells were co-transfected 
with pcDNA3FLAG-MKK6.  After 48 hours, p38 inhibited cells were treated with the 
specific inhibitor SB203580 for 4 hours.  Cells lysates were then purified on GST-
pulldown columns, separated by SDS-PAGE and transferred onto nitrocellulose.  
Membranes were immunoblotted with anti-FLAG and anti-MYC antibodies.  (GST; 
glutathione S-transferase, wcl; whole cell lysate). 
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Figure 4.12: Phosphorylation of neighbouring residues does not prevent and N-
terminal dematin / 14-3-3β interaction  
(A) Site-directed mutagenesis was used to change serine residue neighbouring 14-3-
3 motifs to alanine residues.  HEK293T cells were co-transfected with (B) 
pDEST27FLAG-dematinN1 / pDEST27FLAG-dematinN1_S11/16A or (C) 
pDEST27FLAG-dematinN3 / pDEST27FLAG-dematinN3_S87/92A, and 
pcDNA3.1MYC-14-3-3β.  Cells lysates were purified on GST-pulldown columns, 
separated by SDS-PAGE and transferred onto nitrocellulose.  Membranes were 
immunoblotted with anti-FLAG and anti-MYC antibodies.  (GST; glutathione S-
transferase, wcl; whole cell lysate). 
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4.6 DISCUSSION           
In this chapter we have used co-immunoprecipitation experiments to confirm the 
interaction between dematin and 14-3-3β, and site-directed mutagenesis to identify 
RKTRS269LP and RGNS333LP as the specific motifs in dematin to which 14-3-3β binds.  
Preliminary investigations into the phospho-regulation of the interaction suggest 
that these sites are not phosphorylated by protein kinases Akt, PKA, or AMPK.  
Phosphorylation of dematin by the p38 MAPK did not regulate the interaction 
between dematin and 14-3-3β. 
4.6.1 14-3-3β binds to dematin at Ser269 and Ser333 
Interactions between either the 48 or 52 KDa isoform of human dematin and 
human 14-3-3β were demonstrated in a series of co-immunoprecipitation 
experiments.  This confirms dematin as one of more than 300 14-3-3 binding 
partners that have now been identified.  The majority of known interactions with 
14-3-3 occur via phosphorylated motifs in the target protein, and here we have 
shown that this is the mechanism exploited by the dematin / 14-3-3β interaction.  
Serine to alanine mutagenesis of Ser269 and Ser333 abolished the interaction with 14-
3-3β, while neither of the single mutations was sufficient to prevent binding.  This 
indicated that the interaction between 52 KDa dematin and 14-3-3β occurs at the 
RKTRS269LP and RGNS333LP motifs, while 48 KDa dematin is bound at just RKTRS269LP 
as it lacks the additional motif at Ser333.  Mass spectrometry analysis of 14-3-3 
binding motifs identified Ser269 as being phosphorylated, however Ser333 was not 
detected.  This may be because this site was not phosphorylated under the 
experimental conditions used, or because the peptide containing this motif was not 
mapped.  The mass spectrometry approach used involved first purifying 
phosphorylated peptide from the total protein sample, and this technique may not 
purify all phosphorylated proteins equally. 
Lalle et al (2011) have subsequently reported an interaction between erythrocyte 
dematin and plasmodium 14-3-3.  This was shown to be dependent upon 
phosphorylated residues Ser124 and Ser333, with Ser to Ala substitutions of each of 
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these sites showing a reduction in 14-3-3 binding.  However the relative reduction 
in binding cannot be accurately quantified from the data provided, as the western 
blots show only the band corresponding to the co-immunoprecipitated 14-3-3, and 
not the amount of dematin itself.  Despite the identification of other binding motifs 
in the dematin sequence, including that at Ser269, mutants of these sites were not 
created and the group failed to completely abolish the interaction with any of their 
constructs.  It is therefore possible that the RKTRS269LP motif that we have 
identified is also important for the interaction between dematin and plasmodium 
14-3-3.  Ser124 was not phosphorylated under our mass spectrometry conditions and 
we were unable to demonstrate an interaction between dematinN3, which contains 
the RTS124LP motif, and 14-3-3β. 
Yaffe (2002) proposed the gatekeeper phosphorylation theory, which states that 
most proteins with two active binding motifs contain one dominant ‘gatekeeper’ 
binding site to which 14-3-3 must always bind first.  Binding to this site brings the 
14-3-3 dimer into close proximity with the weaker binding site, which is then able to 
bind to the other 14-3-3 monomer.  Although the weaker site is not capable of 
independent binding, it may need to be bound to confer the full physiological 
function upon the target protein.  Examples of proteins displaying this mechanism 
include the pro-apoptotic Bcl-2-associated death promoter (BAD) protein; Ser136 
acts as a gatekeeper site but Ser112 is required to stabilise the complex (Chiang et al., 
2003).  Under serum-starved conditions, the scaffold protein KSR has two 
phosphorylated 14-3-3 binding motifs at Ser297 and Ser392 (Cacace et al., 1999).  
Here Ser392 constitutes the gatekeeper site, and mutation of this motif alone is 
sufficient to constitutively localise KSR1 to the plasma membrane.  The gatekeeper 
theory does not correlate with the binding sites we have identified in dematin, 
where both the RKTRS269LP and RGNS333LP motifs show comparable, independent 
binding to 14-3-3β.   
4.6.2 Binding of 14-3-3β to the N-terminal domain of dematin was not detected 
With the experiments presented here it was not possible to demonstrate an 
interaction between 14-3-3β and the N-terminal region of dematin.  This was 
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despite the mass spectrometry analysis identifying the RDSS22VP and RERS85LSP 
binding motifs as being phosphorylated.  These motifs were identified as potential 
Akt, AMPK, and PKA phosphorylation sites, but activation of these kinases was still 
not sufficient to induce an interaction.  Neither was an interaction seen in the 
presence of the phosphatase inhibitor calyculin; however this is only effective on 
protein phosphatases 1 and 2A and not on the acid or alkaline phosphatase families.  
Although the RDSS22VP and RERS85LSP motifs were identified as being 
phosphorylated, this alone is not sufficient for an interaction with 14-3-3.  The 
sequence surrounding a consensus motif has also been shown to be important for 
efficient binding (Uchida et al., 2006; Uhart et al., 2011).  It may therefore be the 
incorrect context of these N-terminal motifs that prevents an interaction with 14-3-
3β.  In addition to the localised context of a motif, its position in the tertiary 
structure of the target protein is also important.  A motif must be fully accessible on 
the external surface of the target protein when folded in its native conformation.  
As the N-terminus of dematin is known to be devoid of any significant secondary 
structure (Chen et al., 2009), a buried binding motif is unlikely to be preventing an 
interaction with 14-3-3β in this region.   
We cannot, however, rule out the possibility that the N-terminal of dematin and 14-
3-3β do interact under certain conditions.  It is notoriously difficult to detect weak 
interactions between 14-3-3 and a target protein, and so the absence of a positive 
interaction at a particular site is not evidence that binding doesn’t occur.  If a 
gatekeeper site is mutated, then the interaction with the weak site can also be lost.  
It is therefore possible that many of the characterised 14-3-3 binding partners have 
additional motifs to those that have been identified using simple mutagenesis 
techniques.  There remains a possibility that 14-3-3β binds to the N-terminal 
RDSS22VP and / or RERS85LSP motifs, after first binding to one of the two higher 
affinity RKTRS269LP and RGNS333LP sites.  Although a 14-3-3 dimer can only bind to 
two phosphorylated residues at once, substrates have been identified that contain 
more than two active binding sites, and so it would be plausible for dematin to 
contain active motifs other than the identified sites at Ser269 and Ser333.  Examples 
of this include Cdc25B which has three functional binding sites at Ser151, Ser230 and 
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Ser323 (Forrest & Gabrielli, 2001; Giles et al., 2003).  Regulation of the Raf-1 protein 
kinase also involves three 14-3-3 sites, at Ser259, Ser621, and a third undetermined 
site (Tzivion et al., 1998). 
4.6.3 Phosphorylation of the 14-3-3 binding motifs in dematin 
More than 50 proteins containing two active 14-3-3 binding sites have been 
identified, and the majority of these have been shown to have a different mode of 
motif at each interaction site (Johnson et al., 2010).  This is the case with dematin, 
where the identified sites are the Mode I motif RGNS333LP, and the Mode II motif 
RKTRS269LP.  The differing sequences means that the two sites have the potential to 
be regulated by different protein kinases, which each have their own sequence 
recognition motifs.  This provides two layers of regulation if both sites are needed 
for binding (or functional outcome), or alternative methods of activation if only one 
site is needed.   
Despite identifying a number of potential regulatory kinases of the RKTRS269LP and 
RGNS333LP motifs, inhibition of Akt, AMPK or PKA for 6 hours prior to GST-pulldown 
experiments was insufficient to abolish the interaction between dematin and 14-3-
3β at either of these binding sites.  Control western blots for downstream 
phosphorylated substrates to confirm the inhibition of these kinases were not 
conducted due to a lack of appropriate antibodies; however the inhibitors were all 
new and were used at concentrations widely reported in the literature.  14-3-3 
binding has previously been shown to directly protect residues from phosphatase-
mediated dephosphorylation (Gohla & Bokoch, 2002; Margolis et al., 2003).  A 6-
hour incubation may therefore be insufficient to dephosphorylate these motifs and 
reverse the binding.  However no decrease in binding was seen with any of the 
inhibitors tested, suggesting that this is unlikely as some natural turnover would be 
expected over this time period.  Sequence analysis also identified the RKTRS269LP as 
a low stringency PKC phsohporylation site, but no other potential regulators were 
identified for the RGNS333LP motif.  Contrary to our findings, Lalle et al. (2011) 
demonstrated that PKA phosphorylation of erythrocyte dematin induced an 
interaction with plasmodium 14-3-3 that was not seen under basal conditions.  The 
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specific PKA phosphorylation sites within erythrocyte dematin were not mapped, 
however, and therefore this does not confirm that this is a direct effect of PKA itself. 
Interestingly, 14-3-3 binding to a substrate can also be regulated by 
phosphorylation of other residues within the consensus binding motifs.  For 
example phosphorylation of the -2 position in both p52 and Cdc25c inhibits 14-3-3 
binding (Bulavin et al., 2003; Waterman et al., 1998).  This therefore acts as an 
additional regulatory mechanism for 14-3-3 binding.  Of the 14-3-3 motifs in 
dematin, two contain phosphorylatable residues at the -2 positions; RKTRS269LP and 
KSSS289LP.  A further motif contains a serine residue at the +2 position, RERS85LSP, 
which could potentially have the same effect.  As Ser87 was identified as being 
phosphorylated in the mass spectrometry results this provided a potential 
explanation for the lack of binding to the RERS85LSP motif, however mutating the 
Ser87 an alanine residue was insufficient to facilitate an interaction. 
4.6.4 p38 does not inhibit the interaction between dematin and 14-3-3β 
Analysis of the primary sequence of dematin indicated the presence of p38 
phosphorylation motifs in close proximity to 14-3-3 binding motifs, in particular at 
binding motifs RDSS22VP, RERS85LSP, and RKTRS269LP.  In chapter 3, dematin was 
confirmed as a novel substrate of p38 and in vitro kinase assays and MPM2 
detection using the truncated dematin constructs indicated that all regions of 
dematin contain p38 phosphorylation sites.  It was therefore hypothesised that p38 
may negatively regulate the association of 14-3-3 with dematin by physically 
hindering binding of the 14-3-3β dimer.  However no differences in binding affinity 
were noted under conditions of p38 activation with the specific upstream activator 
MKK6DD, or inhibition with SB203580.  Equally mutating these sites to non-
phosphorylatable alanine residues had no effect on binding, indicating that the site 
aren’t subject to inhibitory phosphorylation by other proline-directed kinases. 
4.6.5 Potential for dematin / 14-3-3 interactions in other isoforms and species 
Here we have investigated the interaction between human dematin, and human 14-
3-3β.  Sequence comparison of the seven unique human 14-3-3 isoforms indicated 
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that there are five distinct blocks of sequence conservation (Wang & Shakes, 1996).  
These regions are involved in dimer formation, lining of the ligand binding groove, 
and direct interaction with target proteins.  Although there is a high level of 
sequence and structural conservation between 14-3-3 family members, not all 
isoforms bind equally to all target proteins.  In the majority of cases it seems that 
binding is not limited to a particular isoform, however several interactions have 
been identified where a specific isotype is required for binding, or enhances binding.   
These include KSR1, which is efficiently bound by 14-3-3 isoforms β, γ, η, and ζ, 
weakly bound by the ϵ and τ isoforms, and unable to bind to 14-3-3 σ (Jagemann et 
al., 2008).  Equally other than 14-3-3σ, which preferentially homodimerises, all 
isoforms have the potential to hetero-dimerise which increases the potential for 
regulation (Wilker et al., 2005).  This specificity has not been well characterised to 
date, but may provide an interesting additional level of biological regulation for 14-
3-3 interactions.  Here were have used 14-3-3β, but the initial screening by Angrand 
et al (2006) identified dematin as a binding partner of 14-3-3ζ.  Interestingly, the 
phosphatase Cdc25 has been shown to bind to 14-3-3β at a different motif to that 
which 14-3-3σ binds, and the two isoforms have different regulatory effects on 
Cdc25 (Uchida et al., 2004).  It is therefore possible that other motifs in dematin, 
such as RDSS22VP and RERS85LSP, are only recognised by alternative isoforms of 14-
3-3.  Endogenous co-immunoprecipitation experiments could be conducted to 
determine which isoforms of 14-3-3 interact with dematin in vivo, facilitated by the 
commercial availability of isoform-specific 14-3-3 primary antibodies.  The motif 
binding preferences of any interacting isoforms could then be determined using 
overexpression studies with GST-pulldown assays and site-directed mutagenesis as 
conducted here. 
The expression patterns of particular 14-3-3 isoforms in mammals has been shown 
to be dependent upon the tissue or cell type in question, but all types investigated 
express more than one isoform (Aitken, 2006).  Subcellular variations in expression 
patterns are also seen, and isoform-specific variations have also been proposed to 
determine the subcellular localisation of 14-3-3 proteins.  The β and ζ isoforms 
preferentially associate with the cytosol and cytoskeletal proteins, while the γ 
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isoform associates with phospholipids (Roth et al., 1994).  As dematin is a 
cytoskeletal-associated protein the β and ζ isoforms are most likely to be expressed 
in the same subcellular locations in vivo.  This suggests that if dematin has any 
isoform-specific preferences then it is more likely to be with one of these forms. 
The N-terminal region of 14-3-3 isoforms display the highest degree of variability, 
and it is these regions which are important for dimer formation.  This variation is 
thought to limit the number of homo- or hetero-dimeric complexes which form, and 
preferences in dimerisation partners could potentially affect the functional 
outcome of these interactions.  In our experiments only 14-3-3β was overexpressed 
and therefore monomers were forced to create homo-dimeric complexes, as 
remaining monomeric is thermodynamically unfavourable (Chaudhri et al., 2003).  
Overexpressed 14-3-3β is also be capable of dimerising with other isoforms found 
endogenously within the cell, however endogenous expression levels are expressed 
at comparatively low levels and are therefore not likely to affect the overall 
patterns seen.  
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5.1 Introduction 
Actin binding proteins such as dematin are responsible for coordinating the dynamic 
actin structures found within the cell (dos Remedios et al., 2003).  Two main types 
of structure exist in vivo; actin networks, and actin bundles.  The formation of both 
structures is coordinated by actin crosslinking proteins, such as dematin, which hold 
filaments in place (Blanchoin et al., 2014). Dematin contains two actin binding 
motifs, one in the HP and a second in the core region (Vardar et al., 2002).  As each 
site operates independently, a single dematin monomer can bind to two AFs and 
bundle them together (Chen et al., 2013). 
In chapter 4 dematin was confirmed as a substrate of the adaptor protein 14-3-3β, 
and the specific motifs mediating this interaction in the 52 KDa isoform were 
identified as RKTRS269LP and RGNS333LP.  The 14-3-3 family are important regulatory 
molecules that can modulate a range of effects on their binding targets.  These 
effects can be due to 14-3-3 changing the structure of the target protein, changing 
the subcellular localisation of the target protein, or acting as a scaffold to enhance 
the binding properties of the target protein.  Altering the localisation of a protein 
can result from 14-3-3 masking specific sequences or structural features in the 
target.  This can impinge on the normal function of the protein by physically 
separating it from the other proteins and co-factors it either requires or regulates 
(Bridges & Moorhead, 2005).  The ability to bind actin is an essential property of all 
known functions of dematin, and relies on the presence of specific actin-binding 
sequence motifs.  Masking of these motifs could therefore provide a mechanism 
through which 14-3-3 binding could regulate the actin binding function dematin. 
The experiments presented in this chapter aimed to answer the following questions: 
1. Where does dematin localise in C2C12 skeletal muscle cells? 
2. Does 14-3-3 binding affect the subcellular localisation of dematin? 
3. Which 14-3-3 binding sites have an effect on the localisation of dematin? 
4. Does 14-3-3 association affect the actin binding ability of dematin? 
5. Does 14-3-3 association affect the actin bundling ability of dematin? 
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5.2 Subcellular localisation of dematin in C2C12 cells 
Dematin expression has been demonstrated in skeletal muscle tissue; however the 
subcellular localisation of the protein has not been investigated.  Here we used the 
C2C12 murine skeletal muscle cell line to characterise the subcellular expression 
pattern of dematin. 
5.2.1 Constructs used in this chapter 
The constructs used in this chapter were cloned into the pTrexDEST30 mammalian 
expression vector using the Invitrogen Gateway® recombination system, as 
described in chapter 3, section 3.2.  DNA constructs for use in confocal imaging 
experiments were tagged with epitope tags to facilitate immuno-detection (Figure 
5.1): a FLAG tag on the 52 KDa isoform, and a MYC tag on the 48 KDa variant.  The 
dematin construct created for use in actin binding and bundling experiments was 
PCR amplified with an N-terminal Strep-tag to facilitate efficient protein purification. 
5.2.2 Subcellular localisation of dematin in C2C12 cells 
C2C12 cells were seeded onto glass coverslips and transfected with 
pTrexDEST30FLAG-dematin.  After 48 hours cells were fixed with 4 % PFA, 
permeabilised in 0.2% triton X-100, blocked with 3% BSA, and incubated with either 
an anti-dematin or anti-FLAG primary antibody.  This was followed by an Alexa 
Fluor® 568 goat anti-mouse IgG antibody with DAPI to stain the nuclei.  Cells were 
imaged on a confocal microscope with sequential scanning between wavelengths.  
Expression of dematin was detected throughout the cytosol in a fairly uniform 
distribution, and in the membrane protrusions.  The staining observed using the 
anti-dematin and anti-FLAG primary antibodies was comparable, and no staining 
was observed in the primary only or secondary only controls (Figure 5.2). 
5.3 The effect of 14-3-3β association on dematin localisation 
One well characterised function of the 14-3-3 family of proteins is the ability to 
change the subcellular localisation of a target protein upon binding.  In order to 
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Figure 5.1: Schematic of the dematin constructs used in this chapter 
Diagram showing the relative positions, and epitope tags, of the dematin constructs 
cloned for use in this chapter.  (A) The constructs used for imaging experiments had 
either FLAG or MYC tags to facilitate immunodetection.  (B) The dematin construct 
for use in actin-binding and bundling assays had a Strep-tag to enable efficient 
purification of the protein, and a FLAG tag to facilitate immunodetection. 
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Figure 5.2: Localisation of overexpressed dematin in C2C12 cells 
C2C12 cells were seeded onto glass coverslips and transfected with 
pTrexDEST30FLAG-dematin.  After 24 hours cells were fixed with 4 % PFA, 
permeabilised in 0.2 % triton X-100, and blocked in 3 % BSA/PBS.  Cells were 
incubated at room temperature for one hour with either an anti-FLAG or anti-
dematin primary antibody, before washing in PBS.  Dematin was detected with an 
Alexa Fluor® 568 goat anti-mouse IgG antibody (red), and cell nuclei visualised with 
DAPI (blue).  Following further washes in PBS, followed by water, cells were 
mounted onto coverslips using Mowiol.  Cells were visualised on an SP5 Confocal 
Laser Scanning Microscope with a 100 x oil objective.  Controls show cells incubated 
with FLAG or dematin primary antibody and no secondary, or with only secondary 
antibody.  Scale bars indicate 10 µm.  Representative images from three 
independent experiments.    (BSA; bovine serum albumin, PBS; phosphate buffered 
saline, PFA; paraformaldehyde). 
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determine whether this effect is seen in dematin, the subcellular localisation of the 
wild-type dematin isoforms with 14-3-3β bound were compared to the 14-3-3 
binding mutant forms of dematin. 
5.3.1 Localisation of dematin and dematin_S269/333A in C2C12 cells 
Localisation of 52 KDa wild-type dematin was first compared to the 
dematin_S239/333A mutant that is unable to bind to 14-3-3β.  C2C12 cells were 
seeded, transfected, and stained using the same method as in section 5.2.2.  
Dematin was visualised with Alexa Fluor® 488 goat anti-mouse IgG fluorescent 
secondary antibody.  The F-actin cytoskeleton was stained with Alexa Fluor® 568 
conjugated Phalloidin, a toxin originating from the death cap mushroom Amanita 
phalloides.  This prevents depolymerisation of AFs by binding at the interface 
between individual actin monomers, and therefore acts as a convenient stain when 
conjugated to a fluorescent probe.   Images were captured of z-sections through the 
central region of the cells at the point where the F-actin staining was most defined.  
Images of the dematin and F-actin staining were merged to visually determine the 
extent of apparent co-localisation between the two proteins.   
As previously the wild-type 52 KDa had a disperse distribution throughout the 
cytosol.  The dematin staining showed minimal co-localisation with the F-actin 
cytoskeleton when the two images were merged (Figure 5.3).  The staining pattern 
of the dematin_S269/333A construct was markedly different, having an obviously 
striated patterning, which correlated with the image of the Phalloidin staining.  On 
merging the two images, extensive co-localisation between dematin_S269/333A 
and actin is indicated by the yellow pixels.  These results suggest that binding of 14-
3-3β to dematin is preventing it from co-localising with the F-actin cytoskeleton. 
5.3.2 Localisation of dematin_S269A and dematin_S333A in C2C12 cells 
In order to determine whether binding of 14-3-3β to the 52 KDa isoform of dematin 
at both of the identified RKTRS269LP and RGNS333LP motifs is required to change the 
subcellular localisation of dematin, the imaging experiments were repeated with 
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Figure 5.3: The effect of 14-3-3β binding on dematin localisation in C2C12 cells 
C2C12 cells were seeded onto glass coverslips and transfected with either 
pTrexDEST30FLAG-dematin or pTrexDEST30FLAG-dematin_S269/333A.  After 24 
hours cells were fixed with 4 % PFA, permeabilised in 0.2 % triton X-100, and 
blocked in 3 % BSA/PBS.  Cells were incubated at room temperature for one hour 
with an anti-FLAG antibody, before washing in PBS.  Dematin was detected with an 
Alexa Fluor® 488 goat anti-mouse IgG antibody (green), F-actin stained with Alexa 
Fluor® 568 Phalloidin (red), and cell nuclei visualised with DAPI (blue).  Following 
further washes in PBS, followed by water, cells were mounted onto coverslips using 
Mowiol.  Cells were visualised on an SP5 Confocal Laser Scanning Microscope with a 
60 x oil objective.  Images were captured of z-sections through the central region of 
the cells at the point where the F-actin staining was most defined. Representative 
images from three independent experiments.  (BSA; bovine serum albumin, PBS; 
phosphate buffered saline, PFA; paraformaldehyde). 
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the pTrexDEST30FLAGdematin_S269A and pTrexDEST30FLAGdematin_S333A 
constructs.  The staining pattern observed for each of these single mutants is 
comparable to wild-type dematin, with a fairly disperse pattern throughout the 
cytosol.  Again little co-localisation with F-actin was detected (Figure 5.4).  These 
observations suggest that binding of 14-3-3β to either the RKTRS269LP orRGNS333LP 
motif is sufficient for preventing dematin from co-localising with F-actin.  
5.3.3 Localisation of dematin48 and dematin48_S269A in C2C12 cells 
In chapter 3, the 48 KDa isoform of dematin was shown to bind to 14-3-3 via a 
single motif at RKTRS269LP.  Localisation of the dematin48 and dematin48_S269A 
constructs was visualised to determine whether 14-3-3 binding had the same 
regulatory effect as in the 52 KDa isoform of dematin.  As in the longer isoform, 
dematin48 was expressed throughout the cytosol and showed little co-localisation 
with F-actin (Figure 5.5).  The dematin48_S269A construct had a comparable 
staining pattern to the dematin_S269/333A mutant, with a definite striated staining 
that co-localised with the F-actin staining.  This suggests that 14-3-3β has the same 
regulatory effect on the 48 KDa isoform as demonstrated in the 52 KDa isoform, and 
prevents localisation of dematin with the F-actin cytoskeleton. 
5.4 The effect of 14-3-3β association on the actin binding and 
bundling properties of dematin 
Changes in subcellular localisation of a substrate upon 14-3-3 binding can result 
from the substrate being blocked from interacting with a protein it would normally 
associate with.  The confocal imaging results suggested that 14-3-3 prevents 
dematin from associating with F-actin, and this was therefore investigated using 
quantitative assays.  As dematin has been identified as both an actin-binding and 
actin-bundling protein, the effect of 14-3-3β binding on each of these properties 
was determined.  
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Figure 5.4: Localisation of dematin_S269A and dematin_S333A in C2C12 cells 
C2C12 cells were seeded onto glass coverslips and transfected with either 
pTrexDEST30FLAG-dematin_S269A or pTrexDEST30FLAG-dematin_S333A.  After 24 
hours cells were fixed with 4 % PFA, permeabilised in 0.2 % triton X-100, and 
blocked in 3 % BSA/PBS.  Cells were incubated at room temperature for one hour 
with an anti-FLAG antibody, before washing in PBS.  Dematin was detected with an 
Alexa Fluor® 488 goat anti-mouse IgG antibody (green), F-actin stained with Alexa 
Fluor® 568 Phalloidin (red), and cell nuclei visualised with DAPI (blue).  Following 
further washes in PBS, followed by water, cells were mounted onto coverslips using 
Mowiol.  Cells were visualised on an SP5 Confocal Laser Scanning Microscope with a 
100 x oil objective.  Images were captured of z-sections through the central region 
of the cells at the point where the F-actin staining was most defined.  
Representative images from three independent experiments.  (BSA; bovine serum 
albumin, PBS; phosphate buffered saline, PFA; paraformaldehyde). 
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Figure 5.5: Localisation of dematin48 and dematin48_S269A in C2C12 cells 
C2C12 cells were seeded onto glass coverslips and transfected with either 
pTrexDEST30MYC-dematin48 or pTrexDEST30MYC-dematin48_S269A.  After 24 
hours cells were fixed with 4 % PFA, permeabilised in 0.2 % triton X-100, and 
blocked in 3 % BSA/PBS.  Cells were incubated at room temperature for one hour 
with an anti-FLAG antibody, before washing in PBS.  Dematin was detected with an 
Alexa Fluor® 488 goat anti-mouse IgG antibody (green), F-actin stained with Alexa 
Fluor® 568 Phalloidin (red), and cell nuclei visualised with DAPI (blue).  Following 
further washes in PBS, followed by water, cells were mounted onto coverslips using 
Mowiol.  Cells were visualised on an SP5 Confocal Laser Scanning Microscope with a 
100 x oil objective.  Images were captured of z-sections through the central region 
of the cells at the point where the F-actin staining was most defined.  
Representative images from three independent experiments.  (BSA; bovine serum 
albumin, PBS; phosphate buffered saline, PFA; paraformaldehyde). 
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5.4.1 Constructs used for actin-binding and bundling experiments 
Purified dematin was required for both the actin-binding and -bundling assays.  To 
facilitate this, the wild-type dematin and dematin_S269/333A sequences were PCR 
amplified with an N-terminal Strep-tag.  A strep-tag was chosen as it enables 
efficient purification of the protein, but the short tag sequence should not interfere 
with normal protein function.   
5.4.2 The dematin - 14-3-3β interaction is maintained upon Strep-purification 
The Strep-tag purification procedure was optimised to ensure that the protein could 
be efficiently eluted from the Strep-resin, and importantly that upon elution of the 
wild-type dematin construct 14-3-3β remained bound to dematin.  HEK293T cells 
were co-transfected with pTrexDEST30FLAG-dematin and pcDNA3.1MYC-14-3-3β.  
After 48 hours cells were lysed under non-denaturing conditions and incubated with 
Strep-Tactin resin.   After thorough washing of the beads, the remaining bound 
protein was eluted with 2.5 mM desthiobiotin.   This eluted protein fraction, along 
with a sample of the original cell lysate, was subjected to SDS-PAGE separation and 
western blotting.  The membrane was probed with an anti-FLAG antibody to detect 
dematin, and anti-MYC to detect 14-3-3β.   As Figure 5.6 shows, elution of 
StrepFLAG-dematin from the strep column resulted in the successful co-elution of 
14-3-3β.   
5.4.3 14-3-3β regulation of the actin-binding ability of dematin  
Each of the StrepFLAG-dematin and StrepFLAG-dematin_S269/333A proteins were 
assayed for their actin binding ability.  In the control reaction the relevant protein 
was combined with freshly polymerised rabbit skeletal muscle F-actin, with the 
negative control reaction containing only protein and polymerisation buffer.  
Further control reactions were conducted containing proteins with known actin-
binding activities.  An F-actin only control was conducted to ensure that the actin 
was correctly polymerised, and that these polymers pelleted upon centrifugation.  
BSA, a protein known to have no actin-binding ability, was incubated with F-actin as  
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Figure 5.6: Co-purification of STREP-dematin and 14-3-3β 
HEK293T cells were co-transfected with pTrexDEST30-STREPFLAG-dematin and 
pcDNA3.1MYC14-3-3β.  Cells were lysed under non-denaturing conditions, and the 
cleared proteins incubated for 3 hours with Strep-Tactin resin.  After thorough 
washing of the beads, the remaining bound protein was eluted with 2.5 mM 
desthiobiotin.   This eluted protein fraction, along with a sample of the original cell 
lysate, was subjected to SDS-PAGE separation before immunoblotting with anti-
FLAG (dematin) and anti-MYC (14-3-3β) antibodies (n=3). 
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a measure of non-specific sedimentation.    Finally the well-characterised actin- 
binding protein α-actinin was used as a positive control.  Two reactions were 
conducted, one with and one without F-actin, to ensure that the reaction worked 
and that it was specific interaction that was causing sedimentation. Samples were 
incubated at 24°C for 30 minutes, before centrifugation at 150,000 x g for 1.5 hours 
at 24°C to sediment the F-actin.   The supernatant and pellet samples from each 
reaction were resuspended in 2 x Laemmlli reducing sample buffer and separated 
by SDS-PAGE.  Control gels were stained with coomassie dye, whereas test protein 
gels were subjected to western blotting and immunodetection with an anti-FLAG 
antibody.    
The control reactions confirmed that upon centrifugation at 150,000 x g for 1.5 
hours F-actin alone is found almost exclusively in the pellet fraction (Figure 5.7A).  
α-actinin, a known actin binding protein, did not sediment when assayed alone but 
co-sedimented when incubated with F-actin.  Finally the negative control confirmed 
that proteins which do not bind to actin remain in the supernatant fraction.  When 
assayed in the absence of F-actin, only a very small proportion of the StrepFLAG-
dematin and StrepFLAG-dematin_S269/333A test proteins were found in the pellet 
fraction (Figure 5.7B), with proportional values of 3.16% and 3.96% respectively.  
Statistical analysis confirmed that there was no significant difference between the 
sedimentational properties of these proteins.  In the presence of polymerised actin, 
both constructs were found in higher proportions in the pellet fractions, confirming 
that they both bound to actin; StrepFLAG-dematin at 27.11% and StrepFLAG-
dematin_S269/333A at 41.34%.  This indicates that binding of 14-3-3β to dematin 
reduces dematin’s actin-binding ability.  This equated to a statistically significant 
42.8% reduction in actin binding between the dematin_S269/333A and wild-type 
dematin constructs (Figure 5.7C). 
5.4.4 14-3-3β regulation of the actin-bundling ability of dematin  
Actin-bundling reactions and control were set up in the same way as in the actin-
binding experiment, but bundles were separated with a lower speed centrifugation  
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Figure 5.7: The effect of 14-3-3β binding on the actin-binding ability of dematin 
StrepFLAG-dematin/14-3-3β and StrepFLAG-dematin_S269/333A dematin were 
purified from HEK293T cells lysates on Strep-Tactin columns.  Test reactions were 
set up containing the eluted protein and skeletal muscle F-actin, with controls 
containing protein in polymerisation buffer.  Samples were incubated at 24°C for 30 
minutes before centrifugation at 150,000 x g for 1.5 h at 24°C.  Aliquots of the 
supernatant and pellet fractions were analysed.  (A) Control reactions of F-actin 
only, α-actinin (a known actin binding protein) alone and as a positive control with 
F-actin, and a negative control of BSA (which has no actin-binding ability) with F-
actin.  (B) Test reaction of wild-type dematin and the dematin_S269/333A mutants 
alone and with F-actin, visualized with anti-FLAG immunoblotting.  (C) 
Quantification of the amount of protein in the pellet and supernatant fractions, 
with data presented as mean values + SEM (n=3).  (SUP; supernatant, PEL; pellet). 
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at 14,000 x g for 1 hour at 24°C.  In the absence of test protein, the majority of F-
actin was retained in the supernatant fraction indicating that there was little non-
specific bundling occurring.  α-actinin remained in the supernatant when assayed 
alone, but co-sedimented with F-actin in the positive control reaction.  The BSA 
negative control was comparable to the F-actin only sample, with both proteins 
found predominantly in the supernatant (Figure 5.8A).  In the absence of F-actin, 
StrepFLAG-dematin and StrepFLAG-dematin_S269/333A were found predominantly 
in the supernatant, with mean values of 3.96% and 5.40% respectively (Figure 5.8B).  
There was no significant difference between the sedimentation properties of these 
proteins at 14,000 x g (Figure 5.8C).  In the F-actin test reactions, both proteins 
displayed actin-bundling ability (Figure 5.8B).  The proportion of dematin protein in 
the pellets increased to 51.96% and 74.31% for the StrepFLAG-dematin and 
StrepFLAG-dematin_S269/333A constructs respectively (Figure 5.8C).  This indicated 
that binding of 14-3-3β to dematin reduces its actin-bundling ability by a statistically 
significant 30.08%. 
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Figure 5.8: The effect of 14-3-3β binding on the actin-bundling ability of dematin 
StrepFLAG-dematin/14-3-3β and StrepFLAG-dematin_S269/333A dematin were 
purified from HEK293T cells lysates on Strep-Tactin columns.  Test reactions were 
set up containing the eluted protein and skeletal muscle F-actin, with controls 
containing protein in polymerisation buffer.  Samples were incubated at 24°C for 30 
minutes before centrifugation at 14,000 x g for 1 h at 24°C.  Aliquots of the 
supernatant and pellet fractions were analysed.  (A) Control reactions of F-actin 
only, α-actinin (a known actin bundling protein) alone and as a positive control with 
F-actin, and a negative control of BSA (which has no actin-bundling ability) with F-
actin.  (B) Test reaction of wild-type dematin and the dematin_S269/333A mutants 
alone and with F-actin, visualized with anti-FLAG immunoblotting.  (C) 
Quantification of the amount of protein in the pellet and supernatant fractions, 
with data presented as mean values + SEM (n=3).  (SUP; supernatant, PEL; pellet). 
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5.5 Discussion 
In this chapter 14-3-3 has been shown to regulate the subcellular localisation of 
dematin, preventing its association with the F-actin cytoskeleton.  This was shown 
to require only one of the RKTRS269LP or RGNS333LP consensus motifs in dematin to 
be bound by 14-3-3.  The localisation of dematin with F-actin was further confirmed 
in sedimentation based actin-binding and -bundling assays, which revealed that 
both the actin-binding and bundling abilities of dematin are decreased upon 
association with 14-3-3.  
5.5.1 14-3-3β binding regulates the subcellular localisation of dematin 
The subcellular localisation of overexpressed dematin in the C2C12 skeletal muscle 
cell line was visualised using immunodetection and confocal microscopy.  Dematin 
expression was observed throughout the cytosol, but not in the nucleus.  The 
pattern of dematin staining was fairly uniform in distribution and did not correlate 
with the expected patterns for a protein contained within a specific subcellular 
organelle.  Despite the widespread expression profile of dematin, there is currently 
little published data on its subcellular localisation in different tissues and cell lines.  
Expression of dematin in mouse embryonic fibroblasts (MEFs) was detected  in the 
cytosol, and in membrane protrusions (Mohseni & Chishti, 2008a), mimicking the 
results observed here in C2C12 cells.  Conversely, dematin staining in platelets 
produced a well-defined punctate staining pattern that did not correlate with the 
pattern seen here in C2C12 cells.  Approximately two thirds of protein expression 
was located at the periphery of the cell, with a second cluster at the centre of the 
platelet.  This central pool was shown to co-localise with protein disulphide 
isomerase (PDI), located in the dense tubular system (DTS) of the platelet, which is 
involved in thrombus formation (Wieschhaus et al., 2012). 
Attempts were also made to visualise the subcellular localisation of endogenous 
dematin in C2C12 cells, however this was unsuccessful due to the low protein 
expression levels.  It was not possible to detect dematin expression in the lysate of 
undifferentiated C2C12 cells using western blotting, and immunocytochemical 
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detection was also not possible in these cells.  Differentiation of C2C12 cells from 
myocytes to myoblasts was associated with a gradual increase in dematin 
expression levels that can be detected using immunoblotting (data not shown).  This 
increase was visible from day one of differentiation, and increased at each 
timepoint taken up to day 10.  However it was not possible to successfully 
differentiate these cells on glass coverslips as would be required for 
immunocytochemical staining.  If this technique can be optimised in future then it 
will be useful to confirm that the distribution of endogenous dematin correlates 
with the expressed constructs used here. 
The 14-3-3 family are known to have a broad range of effects on their targets, which 
can be generally classified as physically changing the structure of a substrate, 
altering its subcellular localisation, or acting as a scaffold to increase the likelihood 
of the substrate interacting with another protein.  Here 14-3-3β has been shown to 
regulate the subcellular localisation of dematin, preventing its colocalisation with 
the F-actin cytoskeleton.  Whereas overexpressed wild-type dematin had a uniform 
distribution throughout the cytosol, dematin_S269/333A localised to Phalloidin 
stained F-actin.   
In chapter 4, both the RKTRS269LP and RGNS333LP binding sites in dematin were 
shown to be high affinity motifs that are capable of independently mediating a 
stable interaction with 14-3-3β.  Here co-localisation experiments using the 
dematin_S269A and dematin_S333A constructs revealed that association of 14-3-3β 
with either of the motifs was sufficient to reduce the localisation of dematin to the 
F-actin cytoskeleton.  The staining patterns observed were comparable to the wild-
type protein localisation, however further experiments will be required as this 
technique is non-quantitative.  It is therefore not possible to conclude whether the 
full functional effect of 14-3-3 binding is achieved through single-site binding, or 
whether the phenotype observed is actually an intermediate state on the spectrum 
between unbound and double-bound 14-3-3.  If the dematin_S333A construct is 
shown to have full actin binding / bundling abilities RKTRS269LP 
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The locations of 14-3-3 binding sites within a target can provide preliminary 
information on the likely functional role of 14-3-3 binding.  Paired binding sites are 
often found on either side of important functional domains, meaning that binding 
of the 14-3-3 dimer masks these sequences, and therefore alters the function of the 
target protein (Silhan et al., 2009). Analysis of the amino acid sequence between 
the RKTRS269LP and RGNS333LP binding sites does not identify any known protein 
motifs that may be masked by 14-3-3 binding.  Dematin is known to contain two 
actin-binding motifs, one in the HP domain and a second in the core region.  The HP 
motif is located within the 367LERHLSAEDFSRVFAMSPEEFGKLALWKR395 region, 
whereas the core motif has not been defined.  It is therefore plausible that the core 
motif is located between the RKTRS269LP and RGNS333LP motifs, and is directly 
masked upon binding of 14-3-3.  Alternatively 14-3-3 binding may inhibit the HP 
actin-binding site.  The available NMR structure of the dematin HP is from the 48 
KDa isoform, which is lacking the HP insert and therefore the region containing the 
RGNS333LP motif is not mapped.  It is possible that although 14-3-3 does not directly 
mask the HP actin-binding region, the 3D conformation of the protein may be such 
that binding of 14-3-3 physically obscures the actin-binding motif.  Interestingly, the 
two 14-3-3 interaction sites are situated on either side of dematin core / HP 
boundary (at aa 315).  The core domain of dematin is intrinsically disordered, and 
therefore binding of the rigid 14-3-3 dimer may also affect the structure of the 
surrounding protein.  
One difficulty in interpreting the images presented here arises from the non-
uniform nature of the actin cytoskeleton.  The natural variation in F-actin staining 
patterns between cells hinders the determination of subtle mutation-specific 
changes in dematin localisation.  In future it may be beneficial to co-transfect cells 
with both a wild-type and a 14-3-3 mutant construct, one with an N-terminal FLAG 
tag the other with a MYC tag.  As the primary FLAG and MYC antibodies used for 
detection are raised in different species, the constructs could be detected with 
compatible Alexa Fluor® 488 and Alexa Fluor® 633 conjugated secondary antibodies 
(which would also allow co-detection of F-actin with Alexa Fluor® 568 conjugated 
Phalloidin).  This would permit images to be taken of the distribution of both wild-
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type and 14-3-3 mutant forms of dematin in the same cell, and facilitate the direct 
comparison of subcellular expression patterns.  This would be particularly useful for 
comparing wild-type dematin with the single-site mutations dematin_S269A, and 
dematin_S333A, as it was not possible to determine any differences in the data 
presented here due to the intrinsic variability of the actin staining patterns. 
Although imaging experiments act as a useful tool for visualising the subcellular 
distribution of a protein they are prone to inaccuracies in interpretation, and 
colocalisation data alone is therefore not sufficient evidence of a biological effect.  
Imaging data can be quantified using co-localisation software, which attempts to 
determine whether there is a spatial overlap between the pixels in the two different 
fluorophore images. Ultimately however it is essential that potential findings are 
validated using biochemical assays, particularly when looking at potential 
interactions between two proteins.  Attempts were made to quantify the degree of 
co-localisation in the images presented here; however the method could not be 
suitably optimised to provide consistent results.   
5.5.2 14-3-3β regulates the actin-binding and -bundling properties of dematin 
The observations from the imaging localisation data were validated using 
quantitative F-actin binding and bundling assays.  Experiments were conducted on 
the StrepFLAG-dematin and StrepFLAG-dematin_S269/333A constructs.  Both 
proteins were shown to have both actin-binding and -bundling function, but these 
properties decreased by 42.8% and 30.08% respectively upon 14-3-3 β association.   
This adds to an increasing body of evidence of 14-3-3 as a regulator of the actin 
cytoskeleton.  It was originally believed that 14-3-3 interacted directly with actin 
(Chen & Yu, 2002), but in line with the data presented here it is now evident that 
this interaction is actually an indirect mechanism involving the regulation of actin-
binding proteins (Birkenfeld et al., 2003).  A significant amount of wild-type dematin 
bound to and bundled F-actin, despite the localisation experiments showing little 
spatial correlation between the two.  This may be a true result, indicating that 14-3-
3 is only a partial regulator of the actin-binding activity of dematin.  Although there 
wasn’t an obvious correlation between wild-type dematin and actin distribution in 
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the cells, dematin was found throughout the cytosol and therefore it would be 
plausible to imagine that a significant proportion could still be bound to actin.  
Alternatively this may be an artefact of the experiment.  Although western blotting 
was used to confirm that 14-3-3 co-eluted with the wild-type dematin, it was not 
possible to confirm what proportion of the purified dematin was bound by 14-3-3.  
Equally it was not possible to determine whether any of the bound 14-3-3 
dissociated during the course of the assay.  It is therefore possible that a proportion 
of the actin-bound dematin was actually no longer associated with 14-3-3, which 
may partially or fully explain the binding and bundling activity seen here. 
The results presented here act as a basis for understanding the general regulatory 
function of the dematin / 14-3-3β interaction, through characterisation of the wild-
type and binding-inhibited dematin_S269/333A constructs.  Now that the efficacy 
of the technique has been demonstrated, it will be possible to characterise the actin 
regulatory properties of the single dematin_S269A and dematin_S333A mutants.  
This will confirm whether binding at a single motif is sufficient to induce the full 
physiological function.  In addition the shorter 48 KDa isoform of dematin will be 
assayed, along with the corresponding dematin48_S269A mutant.  The results 
presented in chapter 4 suggest that the 52 KDa isoform of dematin interacts with 
14-3-3β at residues RKTRS269LP and RGNS333LP, whereas the 48 KDa isoform only 
interacts at RKTRS269LP.  The two isoforms may therefore not bind to 14-3-3 with 
equal affinity.  When a synthetic peptide with two 14-3-3 binding motifs was 
compared to a similar peptide with only one site, the strength of interaction with 
14-3-3 was over 30 times greater (Yaffe et al., 1997).  It will be interesting to see 
what difference this makes to the physiological regulation of the two isoforms when 
14-3-3 is bound.   
The constructs used in the actin-binding and -bundling experiments were re-cloned 
with an N-terminal Strep-tag for purification rather than the previously used GST-
tag.  Under standard purification conditions GST-fusion proteins have been 
demonstrated to dimerise via the GST-tag.  There is no evidence of dimerisation of 
Strep-fusion proteins, which was essential for the actin-bundling experiments in 
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particular as the increased molecular weight of the dimerised complex may have 
produced a false positive pelleting of dematin.  Strep-tags are small and chemically 
inert and so should not interfere with the folding or activity of a recombinant 
protein, and therefore it was not necessary to cleave the tag prior to the 
experimentation.  Equally the desthiobiotin was not removed through dialysis or gel 
filtration, as this is compatible with the experimental design used here.   
5.5.3 Physiological regulation of the dematin / 14-3-3β interaction 
To date it has not been possible to identify the kinases that are responsible for 
phosphorylating the RKTRS269LP and RGNS333LP binding sites, and so further 
characterisation of these motifs will be required.  Equally identifying the 
phosphatases that negatively regulate these sites via dephosphorylation will also be 
important.  Identification of the regulatory kinases will be important for confirming 
the physiological regulation of the interaction between endogenous dematin and 
14-3-3.  Inhibition of these kinases will provide a mechanism for abolishing the 
dematin / 14-3-3 interaction which should mimic the effect of the 
dematin_S269/333A mutant used here.  Identification of these kinases will also 
provide information on the signalling pathways that are involved in regulating the 
dematin / actin interaction, allowing for the study of the upstream regulators of 
dematin.  Interestingly a number of other actin-binding proteins that have now 
been identified as 14-3-3 substrates, including SSH1L and cortactin, are 
phosphorylated by PKD.  
Analysis of 14-3-3 substrates that contain two active sites demonstrated that in the 
majority of cases these proteins contained two different modes of binding motif 
(Johnson et al., 2010).  This is the case with dematin, where the identified sites are 
the mode I motif RGNS333LP, and the mode II motif RKTRS269LP.  These differing 
sequences are targets for both shared, and unique, subsets of protein kinases.  If 
the two sites are phosphorylated by different kinases then this provides two layers 
of regulation if both sites are needed for binding (or functional outcome), or 
alternative methods of activation if only one site is needed.  Localisation 
experiments suggest that both the single dematin_S269A and dematin_S333A 
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mutants are capable of altering the subcellular localisation of dematin, although it 
remains to be determined exactly what level of functional effect they confer.  Based 
upon this preliminary data, the dematin / 14-3-3β interaction has the potential to 
be regulated by two different kinase pathways. 
5.5.4 Potential function of the dematin N-terminal 14-3-3 binding motifs 
The experiments conducted in chapter 4 were unable to verify an interaction 
between the N-terminal region of dematin and 14-3-3β, despite the mass 
spectrometry analysis identifying the RDSS22VP and RERS85LSP motifs as being 
phosphorylated.  This may be a true negative result or it may be that these are 
lower affinity sites which require cooperative binding or specific conditions, making 
them difficult to characterise.  Paired binding sites are frequently located within 
highly disordered protein regions, explaining how 14-3-3 association can have such 
a dramatic effect on the tertiary structure of a target protein (Obsilova et al., 2008).  
The N-terminal region of dematin is known to be intrinsically disordered (Chen et al., 
2009), and so binding at the RDSS22VP and RERS85LSP motifs could be predicted to 
significantly alter the conformation of dematin.  If an interaction at these sites can 
be demonstrated in the future, then this could be an important mechanism for 
regulating the structure and therefore function of dematin. 
Based upon the experiments performed to date, the 48 KDa isoform of dematin 
binds to 14-3-3β at the RKTRS269LP motif.  As 14-3-3 dimers are known to 
simultaneously bind to two motifs, this suggests that either there is a second low-
affinity binding site that we have not been able to characterise, or that the second 
site is occupied by a different protein.  It is possible that either the RDSS22VP or 
RERS85LSP motif are required for binding in the 48 KDa isoform of dematin, but not 
in the 52 KDa isoform where having two high-affinity sites would take binding 
preference.  If only a single site in dematin is bound, then this would enable 14-3-3 
to act as a scaffold protein and bring a second interacting protein into close 
proximity with 48 KDa dematin.  Alternatively 14-3-3 may act to bring together two 
monomers of 48 KDa dematin.  
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6.1 Introduction 
Dematin is an actin-binding and -bundling protein that was first identified in 
erythrocytes, where it is important for creating a stabilising linkage between the 
actin cytoskeleton and the cell membrane (Khan et al., 2008; Siegel & Branton, 
1985).  Despite the ubiquitous expression pattern of dematin throughout the body, 
little research has been conducted into understanding its functions in non-erythroid 
tissues.  Several roles have been described for dematin, including as a potential 
tumour suppressor, regulator of calcium mobilisation in platelets, and enhancer of 
wound healing (Lutchman et al., 1999; Mohseni & Chishti, 2008a; Wieschhaus et al., 
2012).  Interestingly the function of dematin in metabolically active tissues has not 
been investigated, despite confirmation of its expression in both skeletal muscle 
and adipose tissue, and validation of its direct interaction with the basal glucose 
transporter GLUT1 (Azim et al., 1995; Khan et al., 2008; Mohseni & Chishti, 2008b).  
Equally little is known about how dematin is regulated in vivo, in particular with 
respect to its well-characterised and fundamental ability to both bind and bundle F-
actin.  The work presented in this thesis aimed to gain an understanding of the 
function and regulation of dematin, using skeletal muscle as a model system.  In 
particular the project had two broad aims: 
1) To confirm dematin as a substrate of the p38 MAPK, and determine the 
effects of p38 phosphorylation on the stability of dematin, and on the 
dematin core / HP interaction. 
 
2) To determine whether dematin is a substrate of the 14-3-3 family of adaptor 
proteins, characterise the nature of the interaction, and identify the 
physiological function of 14-3-3 binding. 
This chapter brings together the findings of this thesis in relation to the above aims, 
summarising both the results themselves and their significance in furthering our 
understanding of the function and regulation of dematin.  The wider implications of 
these findings, and future research areas of interest, are also discussed. 
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6.2 Regulation of dematin by the p38 MAPK 
The experiments presented here confirm dematin as a substrate of the p38 MAPK, 
both in vitro and in vivo.  Multiple phosphorylation sites were identified in both the 
core and HP domains using mass spectrometry, in vitro kinase assays, and in vivo 
detection approaches.  The regions of dematin that were identified as being 
phosphorylated by p38 are summarised in Figure 6.1A.   
The unstable nature of dematin was confirmed in pulse-chase experiments where 
dematin was shown to have a short in-vivo half-life, which was linked at least in part 
to the presence of a PEST degradation motif.  As phosphorylation of intrinsic Ser 
and Thr residues is known to be the most common mechanism through which PEST 
motifs are activated, this lead to the hypothesis that p38 may regulate the stability 
of dematin.  Although a trend towards instability was seen under p38-
hyperactivated conditions, there was no significant effect (Figure 6.1B).  Equally no 
significant change in stability was seen when Ser / Thr residues were mutated to Ala 
or Glu, suggesting that phosphorylation may not be the activation method in place 
here.  It therefore remains to be determined how exactly the PEST motif is 
regulated, or whether it even requires a secondary activation mechanism.  
Elucidating this will provide further information on the function and regulation of 
dematin by identifying the conditions under which its degradation is enhanced. 
The HP domain is an important region that mediates most of the known functions 
of dematin.  Here p38 was shown to phosphorylate the HP at Ser383 (Figure 6.1C).  
PKA phosphorylation of the HP was recently shown to inhibit actin-bundling by 
inducing binding of the HP to the core domain.  As Ser383 is located at the end of an 
α-helix, we speculated that phosphorylation of this site may cause a conformational 
change that could inhibit the HP / core interaction.  Based on the experiments to 
date, the HP appears to bind to the core domain at a site either within or 
overlapping the aa 197-261 region.  No regulatory effect of p38 phosphorylation on 
this interaction was identified (Figure 6.1C).  It remains to be determined whether 
p38 phosphorylation of Ser383 does indeed induce a conformational change in the 
HP, and whether this could directly regulate the actin-binding ability of dematin.  
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Figure 6.1: Summary of the effects of p38 phosphorylation of dematin 
A schematic representation of the p38 phosphorylation sites in dematin that were 
identified in this thesis (A), and the effects of p38 phosphorylation on the PEST-
mediated stability of dematin (B), and on the interaction between the dematin core 
and headpiece domains (C). 
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6.3 Regulation of dematin by 14-3-3 
The data presented in chapter 4 confirmed dematin as a novel substrate of the 14-
3-3 family, with the experiments in chapter 5 beginning to elucidate the function of 
this interaction.  Seven 14-3-3 consensus motifs were identified in the primary 
sequence of the 52 KDa dematin isoform, and through Co-IP and mutagenesis 
approaches, two active binding sites were identified at RKTRS269LP and RGNS333LP 
(Figure 6.2A).  These were both shown to be high affinity binding sites, each capable 
of independently binding to 14-3-3β.  The shorter 42 KDa isoform lacks the 
RGNS333LP sequence, and appeared to bind only the RKTRS269LP motif.  Interestingly 
the original mass spectrometry analysis also identified he N-terminal RDSS22VP and 
RERS85LSP motifs as being phosphorylated.  We therefore cannot rule out the 
possibility that these are lower affinity sites that may have important functional 
roles that have yet to be determined. 
To date it has not been possible to determine the kinases responsible for 
phosphorylating these motifs, but Akt, AMPK, and PKA were ruled out as regulators 
of these sites.  Identification of these regulatory kinases, in addition to their 
opposing phosphatases, will aid in confirming the physiological regulation of the 
interaction in addition to providing further information on the pathways that are 
involved in regulating this process.  Despite identifying p38 phosphorylation motifs 
in close proximity to the 14-3-3 binding sites, phosphorylation by p38 did not 
negatively regulate the dematin / 14-3-3 interaction (Figure 6.2A).   
Association of 14-3-3 was shown to alter the subcellular distribution of dematin.  
Inhibiting binding at either one of the RKTRS269LP or RGNS333LP motifs reduced the 
apparent localisation of dematin with the F-actin cytoskeleton (Figure 6.2B).  
Dematin is well characterised as an actin-binding and -bundling protein, but the 
regulation of these functions are not well understood.  The experiments presented 
here provide evidence that binding of 14-3-3 to dematin regulates dematin’s ability 
to both bind and bundle F-actin.  Actin sedimentation assays confirmed that 
localisation images and revealed that binding of 14-3-3 to dematin resulted in a 
significant decrease in both actin binding and actin bundling (Figure 6.2B). 
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Figure 6.2: Summary of the effect of 14-3-3 regulation on dematin 
A schematic representation of the interaction between dematin and 14-3-3, 
confirming the identified sites of interaction (A), and the effect of 14-3-3 binding on 
the subcellular localisation and actin binding/bundling properties of dematin (B). 
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6.4 Relevance of these findings in cytoskeletal remodelling 
The confirmation of dematin as a substrate of 14-3-3β adds to increasing evidence 
of essential roles for 14-3-3 proteins in the regulation of the actin cytoskeleton.  
What was initially considered to be a coordination of actin by 14-3-3 is now known 
to be an indirect regulatory mechanism via control of actin-binding and -bundling 
proteins.  The regulation of actin binding and bundling by 14-3-3 identified here in 
skeletal muscle cells has implications for the regulation of dematin in many other 
cells types.  Dematin is ubiquitously expressed, and both 14-3-3 and actin are found 
in all tissues, suggesting the potential for a conserved regulatory mechanism. 
The ability of dematin to regulate the actin cytoskeleton has been linked to its 
control of RhoA.  In the GTP-bound state, RhoA acts upon two known effector 
proteins, Rho-associated coiled-coil containing protein kinase 1a (ROCK1) and 
(diaphanous homolog 1 (Drosophila) (DIAPH1), to regulate actin dynamics and 
control cell migration.  Fibroblasts from dematin HPKO mice showed defects in 
migration as a result of enhanced adhesive properties and elevated FAK activation, 
leading to the confirmation that dematin operates upstream of RhoA and FAK, and 
acts as a suppressor of RhoA activation (Mohseni & Chishti, 2008a). Activation of 
RhoA is mediated by RhoGEFs, while RhoGAPs return RhoA to the inactive GDP-
bound state.  A third set of proteins, the RhoGDIs, can tether RhoA in an inactive 
complex.  Cytoskeletal-associated proteins can coordinate RhoA activity through 
direct interaction with these factors.  The regulation of this process in dematin has 
not been defined, however a direct interaction between dematin and the GEFs 
RasGRF2, and GEF domain of Trio, has been demonstrated.  There is no direct 
evidence for the binding of dematin to RhoGAPs but other ABPs, such as actopaxin 
and VRP1, spatially and temporally regulate RhoGAPs thereby inhibiting Rho activity.  
Equally no direct binding has been confirmed between dematin and any RhoGDIs.   
As a direct interaction between dematin and GEFs but not GAPs or GDIs has been 
demonstrated, current evidence suggests that the negative regulation of RhoA by 
dematin is most likely to be as a result of dematin binding to RhoGEFs and 
preventing nucleotide exchange.  Identification of 14-3-3 as a novel regulator of the 
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actin-binding and -bundling functions of dematin raises the possibility that this 
interaction may also regulate RhoA.  The interaction between dematin and the GEF 
RasGRF2 was localised to residues 224-383 in the 48 KDa dematin isoform.  This 
overlaps with the RKTRS269LP 14-3-3 binding motif identified here, which suggests 
that binding of 14-3-3 to dematin could potentially displace RasGRF2.  Although 
RasGRF2 bound to dematin, it was only capable of catalysing the nucleotide 
exchange of Rac1 and not RhoA.  However the DH-domain of other GEFs is likely to 
bind to dematin in the same region.  14-3-3 could therefore act as a positive 
regulator of RhoA activation by binding to dematin, thereby preventing dematin 
from tethering GEFs to the actin cytoskeleton where they are unable to activate 
RhoA (Figure 6.3).  The above model would also be relevant to a dematin / GDI 
interaction if an interaction between dematin and any GDI proteins is identified in 
future.  Equally this could be applied to the regulation of a dematin / GAP 
interaction if the mechanism was reversed, and 14-3-3 instead acted as a negative 
regulator of RhoA.  In this instance dematin would tether GAP to the actin 
cytoskeleton in the RhoA active state, and 14-3-3 binding to dematin would release 
GAP allowing for nucleotide hydrolysis. 
The involvement of 14-3-3 in mediating the RhoA suppressive activity of an actin-
regulating protein has previously been demonstrated in kidney ankyrin repeat 
protein (Kank).  Although the precise mechanism of this regulation is not 
understood, the AKT mediated association of Kank with 14-3-3 resulted in a 
reduction in actin stress fibre formation and decreased insulin-induced migration.   
14-3-3 has also been shown to bind directly to GEFs, including the RhoA activators 
p190GEF and AKAP-Lbc.  Based on the data collected here binding of 14-3-3 to the 
48 KDa isoform of dematin occurs at only the RKTRS269LP motif, thereby leaving one 
free binding site in the 14-3-3 dimer.  The ability of 14-3-3 to bind to two 
independent proteins to act as a scaffold protein has been well documented.  It is 
therefore possible that 14-3-3 could enhance the interaction between dematin and 
a GEF via this alternative mechanism, and subsequently prevent RhoA activation. 
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Figure 6.3: Potential mechanisms of dematin/14-3-3 regulating RhoA activation 
The cytoskeletal regulator RhoA is activated by guanine nucleotide exchange factors 
(GEFs) and returned to an inactive state by GTPase activating proteins (GAPs).  
Dematin is known to suppress RhoA activation, and here has been shown to be a 
substrate of 14-3-3.  Model 1 proposes a potential role for 14-3-3 in preventing 
dematin from retaining GEFs at the actin cytoskeleton, thereby activating RhoA.  
Model 2 proposes a potential role for 14-3-3 in preventing dematin from retaining 
GAPs at actin cytoskeleton, thereby inactivating RhoA. 
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Although the 52 KDa isoform of dematin was shown to mediate an interaction with 
14-3-3 via both the RKTRS269LP and RGNS333LP, each of these were high affinity sites 
and capable of independent binding.  If future investigation determines that these 
motifs are activated by different kinases, then it is plausible that under certain 
conditions 52 KDa dematin only associated with 14-3-3 via one motif thereby 
facilitating the co-binding of a GEF. 
6.4.1 Implications of these findings for wound healing 
Relatively few functions of dematin have been characterised, but expression has 
been confirmed in fibroblasts and platelets, both of which are essential for normal 
wound healing.  Platelets are essential for preventing blood loss via their 
aggregation and fibrin formation, and also secrete factors that promote tissue 
repair.  Fibroblast involvement includes aiding in the breakdown of the fibrin clot 
and forming extracellular matrix structures to support other recruited cells.  The 
expression pattern of dematin in fibroblasts was shown to be comparable to that 
observed here in C2C12 cells (Mohseni & Chishti, 2008a).  Dematin HPKO fibroblasts 
displayed impaired cell migration in culture, and this corresponded to markedly 
decreased wound healing vivo (Mohseni & Chishti, 2008a).  Dematin therefore has 
an essential role in fibroblast migration, and 14-3-3 regulation could represent a 
mechanism through which the actin cytoskeleton is regulated in this process.  The 
subcellular localisation of a protein is not always consistent between cells types 
however, and this has been demonstrated in platelets where  dematin expression 
was visualised as discrete puncta that localised with the cell periphery  (Wieschhaus 
et al., 2012).  This regulatory mechanism identified here may therefore not be 
relevant to the regulation of platelets, as dematin in these cells may be confined to 
specific intracellular vesicles, and therefore not in direct contact with the actin 
cytoskeleton.  This does not rule out a possible function of the dematin / 14-3-3 
interaction in these cells however as 14-3-3 binding to a protein can mediate 
multiple functions depending on the context of the interaction.  Equally it is possible 
that this mechanism is not important in circulating conditions, but that upon 
activation regulation of actin becomes more important. 
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6.4.2 Implications for these findings in cancer 
Tumour cells are known to subvert the actin cytoskeleton in order to fulfil their 
growth, motile, and invasive requirements, and alterations in the expression 
pattern and activity of actin-bundling proteins correlate with tumour formation and 
cancer progression.  In order to metastasise from the primary tumour location, 
cancerous cells coordinate actin bundles to form membrane protrusions with 
sufficient mechanical force to invade the surrounding tissues.  However the 
mechanisms by which tumour cells manipulate the normal physiological actin-
bundling processes are not well understood.  The dematin gene has been localised 
to chromosome 8p21.1 in humans, at a region between two markers (D8S258 and 
D8S137) that are frequently deleted in prostate cancer (Azim et al., 1995; Lutchman 
et al., 1999).  Deletions in this region have also been confirmed in breast, colon, and 
bladder cancers.  This lead to the suggestion that dematin may function as a tumour 
suppressor, which was validated by the finding that the majority of 8p21.1-linked 
prostate tumours displayed a loss of dematin heterozygosity (Lutchman et al., 1999).   
As important regulators of cell migration, the RhoA family has naturally been linked 
to invasion and metastasis in cancer cells.  Importantly, activation of the RhoA 
pathway correlates closely with the invasive and metastatic potential of a tumour, 
thus explaining why loss of dematin (a RhoA suppressor) results in a highly 
metastatic prostate cancer phenotype.   Activation of RhoA is thought to induce a 
metastatic phenotype via two mechanisms: involvement in membrane protrusions, 
and promotion of invadopodia.   A strong correlation is also emerging between 14-
3-3 and a wide variety of cancers with numerous suggested pro-oncogenic roles for 
these proteins, in particular with regards to invasion and metastasis.  Whilst 
dematin has been shown to be downregulated in human prostate tumours, 
isoforms of 14-3-3 including 14-3-3τ and 14-3-3ε were shown to be overexpressed.  
6.4.3 Implications for these findings in diabetes and obesity 
Expression of dematin has been confirmed in skeletal muscle (Azim et al., 1995; 
Rana et al., 1993) and adipose tissue (Mohseni & Chishti, 2008b), the two main 
metabolic tissues of the body, and it is therefore plausible that dematin may have 
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specific metabolic functions that have yet to be determined.  Dematin HPKO mice 
are reported to display an obese phenotype (data referenced in the text but not 
shown (Khan et al., 2008)), suggesting defects in glucose control.  A small-scale 
animal study also showed a complete loss of erythroid dematin in diabetic animals 
(Kaymaz et al., 2005), however expression levels in skeletal muscle and adipocytes 
has never been measured.  The potential involvement of dematin in glucose uptake 
is supported by the finding that dematin binds directly to the basal glucose 
transporter GLUT1 in erythrocytes, where it provides shape and mechanical stability 
to the cell (Khan et al., 2008).  This interaction has been replicated in our lab in 
C2C12 skeletal muscle cells between overexpressed dematin (due to the low 
endogenous levels in undifferentiated cells) and endogenous GLUT1 (data not 
shown).  The region of GLUT1 that was shown to bind dematin is highly homologous 
between GLUT1 and the insulin-stimulated GLUT4 transporter, leading to 
speculation that dematin may also bind to other GLUT family members.  This would 
provide a mechanism through which glucose transport and the actin cytoskeleton 
are connected via dematin.  GLUT4 is responsible for insulin-stimulated glucose 
uptake in skeletal muscle and adipose tissue, and is mis-regulated in both diabetes 
and obesity.  Under basal conditions GLUT4 is almost exclusively found in 
intracellular storage vesicles.  Upon stimulation with insulin, increased recruitment 
of GLUT4 to the cell surface enables dramatic increases in glucose uptake, a process 
which is dependent upon coordination of the actin cytoskeleton. 
To date it has not been possible to confirm an interaction between dematin and 
GLUT4 in Co-IP experiments in our lab.  One explanation for this is that the 
interaction is not stable, and therefore sufficient amounts are not bound at any one 
time to be detectable using this technique.  Whereas the interaction between 
dematin and GLUT1 provides mechanical support to erythrocytes and therefore 
needs to be a sustained interaction, the proposed function of dematin in GLUT4 
translocation would be more transient.  In this thesis dematin has been identified as 
a substrate of the 14-3-3 protein family.  As 14-3-3 proteins have previously been 
implicated in the regulation of glucose uptake, this raises the interesting possibility 
that they may mediate a dematin / GLUT4 interaction.  Consistent with this 
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hypothesis, the dematin / 14-3-3 interaction identified here was maintained under 
both basal and insulin-stimulated conditions (data not shown).  In addition to this, 
an essential role for 14-3-3 in glucose uptake through the regulation of GLUT4 
membrane translocation has previously been documented.  GLUT4 translocation is 
coordinated by Rab-mediated vesicular transport, which requires inhibitive binding 
of 14-3-3 to Rab-GAPs such as AS160 to function.  Mice overexpressing a mutant 
form of AS160 that cannot bind to 14-3-3 display reduced GLUT4 translocation.  
The confirmation of dematin as a substrate of the p38 MAPK also has implications 
for the regulation of glucose homeostasis.  There is increasing evidence that the 
MAPK family are important regulators of metabolism, with a potential involvement 
of p38 signalling in insulin resistance and type II diabetes mellitus (T2DM) now 
emerging (Gehart et al., 2010).  Insulin resistance, T2DM, and obesity are associated 
with high glucose concentrations, increased plasma free fatty acid levels and 
inflammatory cytokines, all stress factors which have been implicated in the 
activation of p38 signalling (Cuadrado & Nebreda, 2010).  This correlates with 
elevated basal p38 phosphorylation levels in skeletal muscle and adipocytes in 
patients with these conditions (Carlson et al., 2003; Koistinen et al., 2003).  The 
nature of p38 involvement in these processes, however, has yet to be clearly 
defined.  The identification of dematin as a p38 substrate raises the possibility that 
dematin phosphorylation is elevated in metabolic disorders, and the effect of this 
on actin-regulation by dematin will require further investigation. 
6.5    Conclusion 
The data presented in this thesis provides the first evidence for the regulation of 
human dematin by the p38 MAPK and the adaptor protein 14-3-3.  In particular, a 
novel mechanism for regulating the actin-binding and -bundling function of dematin 
via an interaction with 14-3-3 has been demonstrated.  Given the ubiquitous nature 
of dematin, 14-3-3, and p38, the results presented here are likely to be of 
significance far beyond the regulation of skeletal muscle.  Regulation of the actin-
cytoskeleton underlies many essential cellular processes, and these findings 
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therefore have consequences for all of the currently known functions of dematin, 
from its structural role in erythrocytes to its potential function as a tumour 
suppressor and regulator of wound healing.  In addition, this provides a basis for 
more in depth characterisation of the metabolic functions of dematin, including the 
potential for regulating trafficking of GLUT4 and glucose uptake, which have 
implications for obesity and diabetes.  
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